id	sid	tid	token	lemma	pos
fbem-25594	1	1	frontiers	frontier	NOUN
fbem-25594	1	2	in	in	ADP
fbem-25594	1	3	business	business	NOUN
fbem-25594	1	4	,	,	PUNCT
fbem-25594	1	5	economics	economic	NOUN
fbem-25594	1	6	and	and	CCONJ
fbem-25594	1	7	management	management	NOUN
fbem-25594	1	8	issn	issn	PROPN
fbem-25594	1	9	:	:	PUNCT
fbem-25594	1	10	2766	2766	NUM
fbem-25594	1	11	-	-	PUNCT
fbem-25594	1	12	824x	824x	NUM
fbem-25594	1	13	|	|	ADJ
fbem-25594	1	14	vol	vol	NOUN
fbem-25594	1	15	.	.	PUNCT
fbem-25594	2	1	16	16	NUM
fbem-25594	2	2	,	,	PUNCT
fbem-25594	2	3	no	no	INTJ
fbem-25594	2	4	.	.	NOUN
fbem-25594	2	5	2	2	NUM
fbem-25594	2	6	,	,	PUNCT
fbem-25594	2	7	2024	2024	NUM
fbem-25594	2	8	200	200	NUM
fbem-25594	2	9	performance	performance	NOUN
fbem-25594	2	10	research	research	NOUN
fbem-25594	2	11	of	of	ADP
fbem-25594	2	12	chinese	chinese	ADJ
fbem-25594	2	13	patent	patent	NOUN
fbem-25594	2	14	medicine	medicine	NOUN
fbem-25594	2	15	enterprises	enterprise	NOUN
fbem-25594	2	16	to	to	ADP
fbem-25594	2	17	innovative	innovative	ADJ
fbem-25594	2	18	medicine	medicine	NOUN
fbem-25594	2	19	research	research	NOUN
fbem-25594	2	20	and	and	CCONJ
fbem-25594	2	21	development	development	NOUN
fbem-25594	2	22	strategy	strategy	NOUN
fbem-25594	2	23	transformation	transformation	PROPN
fbem-25594	2	24	-take	-take	PROPN
fbem-25594	2	25	zhejiang	zhejiang	PROPN
fbem-25594	2	26	conba	conba	PROPN
fbem-25594	2	27	pharmaceutical	pharmaceutical	PROPN
fbem-25594	2	28	co.	co.	PROPN
fbem-25594	2	29	,	,	PUNCT
fbem-25594	2	30	ltd	ltd	PROPN
fbem-25594	2	31	.	.	PROPN
fbem-25594	3	1	as	as	ADP
fbem-25594	3	2	an	an	DET
fbem-25594	3	3	example	example	NOUN
fbem-25594	3	4	yufan	yufan	PROPN
fbem-25594	3	5	liu	liu	PROPN
fbem-25594	3	6	durham	durham	PROPN
fbem-25594	3	7	university	university	PROPN
fbem-25594	3	8	,	,	PUNCT
fbem-25594	3	9	durham	durham	PROPN
fbem-25594	3	10	,	,	PUNCT
fbem-25594	3	11	uk	uk	PROPN
fbem-25594	3	12	nthf68@durham.ac.uk	nthf68@durham.ac.uk	VERB
fbem-25594	3	13	abstract	abstract	NOUN
fbem-25594	3	14	:	:	PUNCT
fbem-25594	3	15	this	this	DET
fbem-25594	3	16	paper	paper	NOUN
fbem-25594	3	17	takes	take	VERB
fbem-25594	3	18	the	the	DET
fbem-25594	3	19	chinese	chinese	ADJ
fbem-25594	3	20	patent	patent	NOUN
fbem-25594	3	21	medicine	medicine	NOUN
fbem-25594	3	22	enterprise	enterprise	NOUN
fbem-25594	3	23	conba	conba	NOUN
fbem-25594	3	24	as	as	ADP
fbem-25594	3	25	an	an	DET
fbem-25594	3	26	example	example	NOUN
fbem-25594	3	27	,	,	PUNCT
fbem-25594	3	28	and	and	CCONJ
fbem-25594	3	29	deeply	deeply	ADV
fbem-25594	3	30	analyzes	analyze	VERB
fbem-25594	3	31	the	the	DET
fbem-25594	3	32	performance	performance	NOUN
fbem-25594	3	33	of	of	ADP
fbem-25594	3	34	its	its	PRON
fbem-25594	3	35	transformation	transformation	NOUN
fbem-25594	3	36	from	from	ADP
fbem-25594	3	37	traditional	traditional	ADJ
fbem-25594	3	38	chinese	chinese	ADJ
fbem-25594	3	39	patent	patent	NOUN
fbem-25594	3	40	medicine	medicine	NOUN
fbem-25594	3	41	to	to	ADP
fbem-25594	3	42	innovative	innovative	ADJ
fbem-25594	3	43	medicine	medicine	NOUN
fbem-25594	3	44	research	research	NOUN
fbem-25594	3	45	and	and	CCONJ
fbem-25594	3	46	development	development	NOUN
fbem-25594	3	47	strategy	strategy	NOUN
fbem-25594	3	48	.	.	PUNCT
fbem-25594	4	1	through	through	ADP
fbem-25594	4	2	the	the	DET
fbem-25594	4	3	comparative	comparative	ADJ
fbem-25594	4	4	study	study	NOUN
fbem-25594	4	5	of	of	ADP
fbem-25594	4	6	the	the	DET
fbem-25594	4	7	transformation	transformation	NOUN
fbem-25594	4	8	background	background	NOUN
fbem-25594	4	9	,	,	PUNCT
fbem-25594	4	10	the	the	DET
fbem-25594	4	11	strategy	strategy	NOUN
fbem-25594	4	12	implementation	implementation	NOUN
fbem-25594	4	13	process	process	NOUN
fbem-25594	4	14	and	and	CCONJ
fbem-25594	4	15	the	the	DET
fbem-25594	4	16	performance	performance	NOUN
fbem-25594	4	17	before	before	ADV
fbem-25594	4	18	and	and	CCONJ
fbem-25594	4	19	after	after	ADP
fbem-25594	4	20	the	the	DET
fbem-25594	4	21	transformation	transformation	NOUN
fbem-25594	4	22	,	,	PUNCT
fbem-25594	4	23	the	the	DET
fbem-25594	4	24	key	key	ADJ
fbem-25594	4	25	factors	factor	NOUN
fbem-25594	4	26	and	and	CCONJ
fbem-25594	4	27	challenges	challenge	NOUN
fbem-25594	4	28	of	of	ADP
fbem-25594	4	29	its	its	PRON
fbem-25594	4	30	successful	successful	ADJ
fbem-25594	4	31	transformation	transformation	NOUN
fbem-25594	4	32	are	be	AUX
fbem-25594	4	33	revealed	reveal	VERB
fbem-25594	4	34	.	.	PUNCT
fbem-25594	5	1	the	the	DET
fbem-25594	5	2	research	research	NOUN
fbem-25594	5	3	results	result	NOUN
fbem-25594	5	4	show	show	VERB
fbem-25594	5	5	that	that	SCONJ
fbem-25594	5	6	conba	conba	NOUN
fbem-25594	5	7	has	have	AUX
fbem-25594	5	8	successfully	successfully	ADV
fbem-25594	5	9	realized	realize	VERB
fbem-25594	5	10	the	the	DET
fbem-25594	5	11	strategic	strategic	ADJ
fbem-25594	5	12	transformation	transformation	NOUN
fbem-25594	5	13	from	from	ADP
fbem-25594	5	14	traditional	traditional	ADJ
fbem-25594	5	15	chinese	chinese	ADJ
fbem-25594	5	16	patent	patent	NOUN
fbem-25594	5	17	medicine	medicine	NOUN
fbem-25594	5	18	to	to	ADP
fbem-25594	5	19	innovative	innovative	ADJ
fbem-25594	5	20	medicine	medicine	NOUN
fbem-25594	5	21	by	by	ADP
fbem-25594	5	22	increasing	increase	VERB
fbem-25594	5	23	r	r	NOUN
fbem-25594	5	24	&	&	CCONJ
fbem-25594	5	25	d	d	PROPN
fbem-25594	5	26	investment	investment	NOUN
fbem-25594	5	27	,	,	PUNCT
fbem-25594	5	28	optimizing	optimize	VERB
fbem-25594	5	29	research	research	NOUN
fbem-25594	5	30	and	and	CCONJ
fbem-25594	5	31	development	development	NOUN
fbem-25594	5	32	structure	structure	NOUN
fbem-25594	5	33	and	and	CCONJ
fbem-25594	5	34	integrating	integrate	VERB
fbem-25594	5	35	internal	internal	ADJ
fbem-25594	5	36	and	and	CCONJ
fbem-25594	5	37	external	external	ADJ
fbem-25594	5	38	resources	resource	NOUN
fbem-25594	5	39	,	,	PUNCT
fbem-25594	5	40	and	and	CCONJ
fbem-25594	5	41	achieved	achieve	VERB
fbem-25594	5	42	significant	significant	ADJ
fbem-25594	5	43	performance	performance	NOUN
fbem-25594	5	44	improvement	improvement	NOUN
fbem-25594	5	45	.	.	PUNCT
fbem-25594	6	1	the	the	DET
fbem-25594	6	2	research	research	NOUN
fbem-25594	6	3	in	in	ADP
fbem-25594	6	4	this	this	DET
fbem-25594	6	5	paper	paper	NOUN
fbem-25594	6	6	not	not	PART
fbem-25594	6	7	only	only	ADV
fbem-25594	6	8	provides	provide	VERB
fbem-25594	6	9	practical	practical	ADJ
fbem-25594	6	10	reference	reference	NOUN
fbem-25594	6	11	for	for	ADP
fbem-25594	6	12	the	the	DET
fbem-25594	6	13	strategic	strategic	ADJ
fbem-25594	6	14	transformation	transformation	NOUN
fbem-25594	6	15	of	of	ADP
fbem-25594	6	16	chinese	chinese	ADJ
fbem-25594	6	17	patent	patent	NOUN
fbem-25594	6	18	medicine	medicine	NOUN
fbem-25594	6	19	enterprises	enterprise	NOUN
fbem-25594	6	20	such	such	ADJ
fbem-25594	6	21	as	as	ADP
fbem-25594	6	22	conba	conba	NOUN
fbem-25594	6	23	,	,	PUNCT
fbem-25594	6	24	but	but	CCONJ
fbem-25594	6	25	also	also	ADV
fbem-25594	6	26	provides	provide	VERB
fbem-25594	6	27	useful	useful	ADJ
fbem-25594	6	28	reference	reference	NOUN
fbem-25594	6	29	for	for	ADP
fbem-25594	6	30	the	the	DET
fbem-25594	6	31	transformation	transformation	NOUN
fbem-25594	6	32	and	and	CCONJ
fbem-25594	6	33	upgrading	upgrading	NOUN
fbem-25594	6	34	of	of	ADP
fbem-25594	6	35	other	other	ADJ
fbem-25594	6	36	enterprises	enterprise	NOUN
fbem-25594	6	37	.	.	PUNCT
fbem-25594	7	1	keywords	keyword	NOUN
fbem-25594	7	2	:	:	PUNCT
fbem-25594	7	3	conba	conba	NOUN
fbem-25594	7	4	,	,	PUNCT
fbem-25594	7	5	chinese	chinese	ADJ
fbem-25594	7	6	patent	patent	NOUN
fbem-25594	7	7	medicine	medicine	NOUN
fbem-25594	7	8	enterprises	enterprise	NOUN
fbem-25594	7	9	,	,	PUNCT
fbem-25594	7	10	innovative	innovative	ADJ
fbem-25594	7	11	drug	drug	NOUN
fbem-25594	7	12	research	research	NOUN
fbem-25594	7	13	and	and	CCONJ
fbem-25594	7	14	development	development	NOUN
fbem-25594	7	15	,	,	PUNCT
fbem-25594	7	16	strategic	strategic	ADJ
fbem-25594	7	17	transformation	transformation	NOUN
fbem-25594	7	18	,	,	PUNCT
fbem-25594	7	19	and	and	CCONJ
fbem-25594	7	20	performance	performance	NOUN
fbem-25594	7	21	research	research	NOUN
fbem-25594	7	22	.	.	PUNCT
fbem-25594	8	1	1	1	X
fbem-25594	8	2	.	.	X
fbem-25594	8	3	introduction	introduction	NOUN
fbem-25594	8	4	in	in	ADP
fbem-25594	8	5	recent	recent	ADJ
fbem-25594	8	6	years	year	NOUN
fbem-25594	8	7	,	,	PUNCT
fbem-25594	8	8	with	with	ADP
fbem-25594	8	9	the	the	DET
fbem-25594	8	10	continuous	continuous	ADJ
fbem-25594	8	11	expansion	expansion	NOUN
fbem-25594	8	12	of	of	ADP
fbem-25594	8	13	the	the	DET
fbem-25594	8	14	global	global	ADJ
fbem-25594	8	15	pharmaceutical	pharmaceutical	NOUN
fbem-25594	8	16	market	market	NOUN
fbem-25594	8	17	and	and	CCONJ
fbem-25594	8	18	the	the	DET
fbem-25594	8	19	improvement	improvement	NOUN
fbem-25594	8	20	of	of	ADP
fbem-25594	8	21	consumers	consumer	NOUN
fbem-25594	8	22	'	'	PART
fbem-25594	8	23	health	health	NOUN
fbem-25594	8	24	awareness	awareness	NOUN
fbem-25594	8	25	,	,	PUNCT
fbem-25594	8	26	people	people	NOUN
fbem-25594	8	27	's	's	PART
fbem-25594	8	28	demand	demand	NOUN
fbem-25594	8	29	for	for	ADP
fbem-25594	8	30	drugs	drug	NOUN
fbem-25594	8	31	has	have	AUX
fbem-25594	8	32	gradually	gradually	ADV
fbem-25594	8	33	changed	change	VERB
fbem-25594	8	34	from	from	ADP
fbem-25594	8	35	therapeutic	therapeutic	ADJ
fbem-25594	8	36	to	to	ADP
fbem-25594	8	37	preventive	preventive	ADJ
fbem-25594	8	38	and	and	CCONJ
fbem-25594	8	39	health	health	NOUN
fbem-25594	8	40	care	care	NOUN
fbem-25594	8	41	.	.	PUNCT
fbem-25594	9	1	at	at	ADP
fbem-25594	9	2	the	the	DET
fbem-25594	9	3	same	same	ADJ
fbem-25594	9	4	time	time	NOUN
fbem-25594	9	5	,	,	PUNCT
fbem-25594	9	6	the	the	DET
fbem-25594	9	7	rapid	rapid	ADJ
fbem-25594	9	8	development	development	NOUN
fbem-25594	9	9	of	of	ADP
fbem-25594	9	10	biotechnology	biotechnology	NOUN
fbem-25594	9	11	also	also	ADV
fbem-25594	9	12	provides	provide	VERB
fbem-25594	9	13	more	more	ADJ
fbem-25594	9	14	possibilities	possibility	NOUN
fbem-25594	9	15	and	and	CCONJ
fbem-25594	9	16	means	mean	VERB
fbem-25594	9	17	for	for	ADP
fbem-25594	9	18	the	the	DET
fbem-25594	9	19	development	development	NOUN
fbem-25594	9	20	of	of	ADP
fbem-25594	9	21	new	new	ADJ
fbem-25594	9	22	drugs	drug	NOUN
fbem-25594	9	23	.	.	PUNCT
fbem-25594	10	1	in	in	ADP
fbem-25594	10	2	this	this	DET
fbem-25594	10	3	context	context	NOUN
fbem-25594	10	4	,	,	PUNCT
fbem-25594	10	5	with	with	ADP
fbem-25594	10	6	the	the	DET
fbem-25594	10	7	rapid	rapid	ADJ
fbem-25594	10	8	development	development	NOUN
fbem-25594	10	9	of	of	ADP
fbem-25594	10	10	the	the	DET
fbem-25594	10	11	global	global	ADJ
fbem-25594	10	12	pharmaceutical	pharmaceutical	NOUN
fbem-25594	10	13	market	market	NOUN
fbem-25594	10	14	and	and	CCONJ
fbem-25594	10	15	the	the	DET
fbem-25594	10	16	increasingly	increasingly	ADV
fbem-25594	10	17	fierce	fierce	ADJ
fbem-25594	10	18	competition	competition	NOUN
fbem-25594	10	19	,	,	PUNCT
fbem-25594	10	20	chinese	chinese	ADJ
fbem-25594	10	21	patent	patent	NOUN
fbem-25594	10	22	medicine	medicine	NOUN
fbem-25594	10	23	enterprises	enterprise	NOUN
fbem-25594	10	24	are	be	AUX
fbem-25594	10	25	facing	face	VERB
fbem-25594	10	26	unprecedented	unprecedented	ADJ
fbem-25594	10	27	challenges	challenge	NOUN
fbem-25594	10	28	and	and	CCONJ
fbem-25594	10	29	opportunities	opportunity	NOUN
fbem-25594	10	30	.	.	PUNCT
fbem-25594	11	1	in	in	ADP
fbem-25594	11	2	the	the	DET
fbem-25594	11	3	market	market	NOUN
fbem-25594	11	4	competition	competition	NOUN
fbem-25594	11	5	,	,	PUNCT
fbem-25594	11	6	the	the	DET
fbem-25594	11	7	traditional	traditional	ADJ
fbem-25594	11	8	chinese	chinese	ADJ
fbem-25594	11	9	patent	patent	NOUN
fbem-25594	11	10	medicine	medicine	NOUN
fbem-25594	11	11	gradually	gradually	ADV
fbem-25594	11	12	shows	show	VERB
fbem-25594	11	13	the	the	DET
fbem-25594	11	14	problems	problem	NOUN
fbem-25594	11	15	such	such	ADJ
fbem-25594	11	16	as	as	ADP
fbem-25594	11	17	serious	serious	ADJ
fbem-25594	11	18	homogenization	homogenization	NOUN
fbem-25594	11	19	,	,	PUNCT
fbem-25594	11	20	lagging	lag	VERB
fbem-25594	11	21	research	research	NOUN
fbem-25594	11	22	and	and	CCONJ
fbem-25594	11	23	development	development	NOUN
fbem-25594	11	24	,	,	PUNCT
fbem-25594	11	25	and	and	CCONJ
fbem-25594	11	26	insufficient	insufficient	ADJ
fbem-25594	11	27	innovation	innovation	NOUN
fbem-25594	11	28	ability	ability	NOUN
fbem-25594	11	29	,	,	PUNCT
fbem-25594	11	30	which	which	PRON
fbem-25594	11	31	is	be	AUX
fbem-25594	11	32	difficult	difficult	ADJ
fbem-25594	11	33	to	to	PART
fbem-25594	11	34	meet	meet	VERB
fbem-25594	11	35	the	the	DET
fbem-25594	11	36	increasingly	increasingly	ADV
fbem-25594	11	37	diversified	diversify	VERB
fbem-25594	11	38	market	market	NOUN
fbem-25594	11	39	demand	demand	NOUN
fbem-25594	11	40	.	.	PUNCT
fbem-25594	12	1	therefore	therefore	ADV
fbem-25594	12	2	,	,	PUNCT
fbem-25594	12	3	the	the	DET
fbem-25594	12	4	transformation	transformation	NOUN
fbem-25594	12	5	to	to	ADP
fbem-25594	12	6	innovative	innovative	ADJ
fbem-25594	12	7	drug	drug	NOUN
fbem-25594	12	8	research	research	NOUN
fbem-25594	12	9	and	and	CCONJ
fbem-25594	12	10	development	development	NOUN
fbem-25594	12	11	strategy	strategy	NOUN
fbem-25594	12	12	has	have	AUX
fbem-25594	12	13	become	become	VERB
fbem-25594	12	14	an	an	DET
fbem-25594	12	15	inevitable	inevitable	ADJ
fbem-25594	12	16	choice	choice	NOUN
fbem-25594	12	17	for	for	SCONJ
fbem-25594	12	18	chinese	chinese	ADJ
fbem-25594	12	19	patent	patent	NOUN
fbem-25594	12	20	medicine	medicine	NOUN
fbem-25594	12	21	enterprises	enterprise	NOUN
fbem-25594	12	22	to	to	PART
fbem-25594	12	23	achieve	achieve	VERB
fbem-25594	12	24	sustainable	sustainable	ADJ
fbem-25594	12	25	development	development	NOUN
fbem-25594	12	26	and	and	CCONJ
fbem-25594	12	27	maintain	maintain	VERB
fbem-25594	12	28	market	market	NOUN
fbem-25594	12	29	competition	competition	NOUN
fbem-25594	12	30	.	.	PUNCT
fbem-25594	13	1	as	as	ADP
fbem-25594	13	2	a	a	DET
fbem-25594	13	3	well	well	ADV
fbem-25594	13	4	-	-	PUNCT
fbem-25594	13	5	known	know	VERB
fbem-25594	13	6	chinese	chinese	ADJ
fbem-25594	13	7	patent	patent	NOUN
fbem-25594	13	8	medicine	medicine	NOUN
fbem-25594	13	9	enterprise	enterprise	NOUN
fbem-25594	13	10	in	in	ADP
fbem-25594	13	11	china	china	PROPN
fbem-25594	13	12	,	,	PUNCT
fbem-25594	13	13	conba	conba	PROPN
fbem-25594	13	14	has	have	AUX
fbem-25594	13	15	actively	actively	ADV
fbem-25594	13	16	responded	respond	VERB
fbem-25594	13	17	to	to	ADP
fbem-25594	13	18	the	the	DET
fbem-25594	13	19	national	national	ADJ
fbem-25594	13	20	pharmaceutical	pharmaceutical	PROPN
fbem-25594	13	21	innovation	innovation	NOUN
fbem-25594	13	22	policy	policy	NOUN
fbem-25594	13	23	in	in	ADP
fbem-25594	13	24	recent	recent	ADJ
fbem-25594	13	25	years	year	NOUN
fbem-25594	13	26	,	,	PUNCT
fbem-25594	13	27	actively	actively	ADV
fbem-25594	13	28	adjusted	adjust	VERB
fbem-25594	13	29	the	the	DET
fbem-25594	13	30	strategic	strategic	ADJ
fbem-25594	13	31	direction	direction	NOUN
fbem-25594	13	32	,	,	PUNCT
fbem-25594	13	33	increased	increase	VERB
fbem-25594	13	34	the	the	DET
fbem-25594	13	35	research	research	NOUN
fbem-25594	13	36	and	and	CCONJ
fbem-25594	13	37	development	development	NOUN
fbem-25594	13	38	investment	investment	NOUN
fbem-25594	13	39	of	of	ADP
fbem-25594	13	40	innovative	innovative	ADJ
fbem-25594	13	41	drugs	drug	NOUN
fbem-25594	13	42	,	,	PUNCT
fbem-25594	13	43	and	and	CCONJ
fbem-25594	13	44	strive	strive	VERB
fbem-25594	13	45	to	to	PART
fbem-25594	13	46	realize	realize	VERB
fbem-25594	13	47	the	the	DET
fbem-25594	13	48	transformation	transformation	NOUN
fbem-25594	13	49	and	and	CCONJ
fbem-25594	13	50	upgrading	upgrading	NOUN
fbem-25594	13	51	from	from	ADP
fbem-25594	13	52	traditional	traditional	ADJ
fbem-25594	13	53	chinese	chinese	ADJ
fbem-25594	13	54	patent	patent	NOUN
fbem-25594	13	55	medicine	medicine	NOUN
fbem-25594	13	56	to	to	ADP
fbem-25594	13	57	innovative	innovative	ADJ
fbem-25594	13	58	drugs	drug	NOUN
fbem-25594	13	59	.	.	PUNCT
fbem-25594	14	1	in	in	ADP
fbem-25594	14	2	this	this	DET
fbem-25594	14	3	process	process	NOUN
fbem-25594	14	4	,	,	PUNCT
fbem-25594	14	5	conba	conba	NOUN
fbem-25594	14	6	is	be	AUX
fbem-25594	14	7	faced	face	VERB
fbem-25594	14	8	with	with	ADP
fbem-25594	14	9	technology	technology	NOUN
fbem-25594	14	10	,	,	PUNCT
fbem-25594	14	11	capital	capital	NOUN
fbem-25594	14	12	,	,	PUNCT
fbem-25594	14	13	talent	talent	NOUN
fbem-25594	14	14	and	and	CCONJ
fbem-25594	14	15	other	other	ADJ
fbem-25594	14	16	challenges	challenge	NOUN
fbem-25594	14	17	to	to	PART
fbem-25594	14	18	overcome	overcome	VERB
fbem-25594	14	19	difficulties	difficulty	NOUN
fbem-25594	14	20	and	and	CCONJ
fbem-25594	14	21	achieved	achieve	VERB
fbem-25594	14	22	significant	significant	ADJ
fbem-25594	14	23	performance	performance	NOUN
fbem-25594	14	24	improvement	improvement	NOUN
fbem-25594	14	25	and	and	CCONJ
fbem-25594	14	26	market	market	NOUN
fbem-25594	14	27	recognition	recognition	NOUN
fbem-25594	14	28	.	.	PUNCT
fbem-25594	15	1	this	this	DET
fbem-25594	15	2	paper	paper	NOUN
fbem-25594	15	3	aims	aim	VERB
fbem-25594	15	4	to	to	PART
fbem-25594	15	5	discuss	discuss	VERB
fbem-25594	15	6	the	the	DET
fbem-25594	15	7	performance	performance	NOUN
fbem-25594	15	8	of	of	ADP
fbem-25594	15	9	the	the	DET
fbem-25594	15	10	transformation	transformation	NOUN
fbem-25594	15	11	of	of	ADP
fbem-25594	15	12	chinese	chinese	ADJ
fbem-25594	15	13	patent	patent	NOUN
fbem-25594	15	14	medicine	medicine	NOUN
fbem-25594	15	15	enterprises	enterprise	NOUN
fbem-25594	15	16	as	as	ADP
fbem-25594	15	17	an	an	DET
fbem-25594	15	18	example	example	NOUN
fbem-25594	15	19	.	.	PUNCT
fbem-25594	16	1	through	through	ADP
fbem-25594	16	2	the	the	DET
fbem-25594	16	3	comparative	comparative	ADJ
fbem-25594	16	4	analysis	analysis	NOUN
fbem-25594	16	5	of	of	ADP
fbem-25594	16	6	conba	conba	NOUN
fbem-25594	16	7	's	's	PART
fbem-25594	16	8	strategic	strategic	ADJ
fbem-25594	16	9	transformation	transformation	NOUN
fbem-25594	16	10	background	background	NOUN
fbem-25594	16	11	,	,	PUNCT
fbem-25594	16	12	strategic	strategic	ADJ
fbem-25594	16	13	implementation	implementation	NOUN
fbem-25594	16	14	process	process	NOUN
fbem-25594	16	15	and	and	CCONJ
fbem-25594	16	16	the	the	DET
fbem-25594	16	17	performance	performance	NOUN
fbem-25594	16	18	before	before	ADV
fbem-25594	16	19	and	and	CCONJ
fbem-25594	16	20	after	after	ADP
fbem-25594	16	21	the	the	DET
fbem-25594	16	22	transformation	transformation	NOUN
fbem-25594	16	23	,	,	PUNCT
fbem-25594	16	24	the	the	DET
fbem-25594	16	25	key	key	ADJ
fbem-25594	16	26	factors	factor	NOUN
fbem-25594	16	27	and	and	CCONJ
fbem-25594	16	28	challenges	challenge	NOUN
fbem-25594	16	29	of	of	ADP
fbem-25594	16	30	its	its	PRON
fbem-25594	16	31	successful	successful	ADJ
fbem-25594	16	32	transformation	transformation	NOUN
fbem-25594	16	33	are	be	AUX
fbem-25594	16	34	revealed	reveal	VERB
fbem-25594	16	35	.	.	PUNCT
fbem-25594	17	1	at	at	ADP
fbem-25594	17	2	the	the	DET
fbem-25594	17	3	same	same	ADJ
fbem-25594	17	4	time	time	NOUN
fbem-25594	17	5	,	,	PUNCT
fbem-25594	17	6	this	this	DET
fbem-25594	17	7	paper	paper	NOUN
fbem-25594	17	8	also	also	ADV
fbem-25594	17	9	hopes	hope	VERB
fbem-25594	17	10	to	to	PART
fbem-25594	17	11	provide	provide	VERB
fbem-25594	17	12	useful	useful	ADJ
fbem-25594	17	13	reference	reference	NOUN
fbem-25594	17	14	and	and	CCONJ
fbem-25594	17	15	reference	reference	NOUN
fbem-25594	17	16	for	for	ADP
fbem-25594	17	17	the	the	DET
fbem-25594	17	18	transformation	transformation	NOUN
fbem-25594	17	19	and	and	CCONJ
fbem-25594	17	20	upgrading	upgrading	NOUN
fbem-25594	17	21	of	of	ADP
fbem-25594	17	22	other	other	ADJ
fbem-25594	17	23	chinese	chinese	ADJ
fbem-25594	17	24	patent	patent	NOUN
fbem-25594	17	25	medicine	medicine	NOUN
fbem-25594	17	26	enterprises	enterprise	NOUN
fbem-25594	17	27	through	through	ADP
fbem-25594	17	28	this	this	DET
fbem-25594	17	29	research	research	NOUN
fbem-25594	17	30	.	.	PUNCT
fbem-25594	18	1	this	this	DET
fbem-25594	18	2	paper	paper	NOUN
fbem-25594	18	3	will	will	AUX
fbem-25594	18	4	conduct	conduct	VERB
fbem-25594	18	5	in	in	ADP
fbem-25594	18	6	-	-	PUNCT
fbem-25594	18	7	depth	depth	NOUN
fbem-25594	18	8	analysis	analysis	NOUN
fbem-25594	18	9	and	and	CCONJ
fbem-25594	18	10	research	research	NOUN
fbem-25594	18	11	on	on	ADP
fbem-25594	18	12	the	the	DET
fbem-25594	18	13	performance	performance	NOUN
fbem-25594	18	14	of	of	ADP
fbem-25594	18	15	conbe	conbe	NOUN
fbem-25594	18	16	's	's	PART
fbem-25594	18	17	transformation	transformation	NOUN
fbem-25594	18	18	to	to	ADP
fbem-25594	18	19	innovative	innovative	ADJ
fbem-25594	18	20	drug	drug	NOUN
fbem-25594	18	21	research	research	NOUN
fbem-25594	18	22	and	and	CCONJ
fbem-25594	18	23	development	development	NOUN
fbem-25594	18	24	strategy	strategy	NOUN
fbem-25594	18	25	by	by	ADP
fbem-25594	18	26	consulting	consult	VERB
fbem-25594	18	27	relevant	relevant	ADJ
fbem-25594	18	28	materials	material	NOUN
fbem-25594	18	29	,	,	PUNCT
fbem-25594	18	30	industry	industry	NOUN
fbem-25594	18	31	reports	report	NOUN
fbem-25594	18	32	and	and	CCONJ
fbem-25594	18	33	academic	academic	ADJ
fbem-25594	18	34	literature	literature	NOUN
fbem-25594	18	35	,	,	PUNCT
fbem-25594	18	36	as	as	ADV
fbem-25594	18	37	well	well	ADV
fbem-25594	18	38	as	as	ADP
fbem-25594	18	39	collecting	collect	VERB
fbem-25594	18	40	relevant	relevant	ADJ
fbem-25594	18	41	data	datum	NOUN
fbem-25594	18	42	and	and	CCONJ
fbem-25594	18	43	information	information	NOUN
fbem-25594	18	44	.	.	PUNCT
fbem-25594	19	1	2	2	X
fbem-25594	19	2	.	.	X
fbem-25594	19	3	enterprise	enterprise	NOUN
fbem-25594	19	4	strategy	strategy	NOUN
fbem-25594	19	5	implementation	implementation	NOUN
fbem-25594	19	6	process	process	NOUN
fbem-25594	19	7	2.1	2.1	NUM
fbem-25594	19	8	.	.	PUNCT
fbem-25594	20	1	innovative	innovative	ADJ
fbem-25594	20	2	strategic	strategic	ADJ
fbem-25594	20	3	goals	goal	NOUN
fbem-25594	20	4	faced	face	VERB
fbem-25594	20	5	with	with	ADP
fbem-25594	20	6	the	the	DET
fbem-25594	20	7	fierce	fierce	ADJ
fbem-25594	20	8	competition	competition	NOUN
fbem-25594	20	9	and	and	CCONJ
fbem-25594	20	10	rapid	rapid	ADJ
fbem-25594	20	11	changes	change	NOUN
fbem-25594	20	12	in	in	ADP
fbem-25594	20	13	the	the	DET
fbem-25594	20	14	pharmaceutical	pharmaceutical	ADJ
fbem-25594	20	15	industry	industry	NOUN
fbem-25594	20	16	,	,	PUNCT
fbem-25594	20	17	conba	conba	PROPN
fbem-25594	20	18	realized	realize	VERB
fbem-25594	20	19	that	that	SCONJ
fbem-25594	20	20	a	a	DET
fbem-25594	20	21	single	single	ADJ
fbem-25594	20	22	tcm	tcm	PROPN
fbem-25594	20	23	pharmaceutical	pharmaceutical	NOUN
fbem-25594	20	24	business	business	NOUN
fbem-25594	20	25	could	could	AUX
fbem-25594	20	26	no	no	ADV
fbem-25594	20	27	longer	long	ADV
fbem-25594	20	28	meet	meet	VERB
fbem-25594	20	29	the	the	DET
fbem-25594	20	30	needs	need	NOUN
fbem-25594	20	31	of	of	ADP
fbem-25594	20	32	its	its	PRON
fbem-25594	20	33	future	future	ADJ
fbem-25594	20	34	development	development	NOUN
fbem-25594	20	35	.	.	PUNCT
fbem-25594	21	1	therefore	therefore	ADV
fbem-25594	21	2	,	,	PUNCT
fbem-25594	21	3	the	the	DET
fbem-25594	21	4	company	company	NOUN
fbem-25594	21	5	decided	decide	VERB
fbem-25594	21	6	to	to	PART
fbem-25594	21	7	make	make	VERB
fbem-25594	21	8	strategic	strategic	ADJ
fbem-25594	21	9	adjustment	adjustment	NOUN
fbem-25594	21	10	and	and	CCONJ
fbem-25594	21	11	put	put	VERB
fbem-25594	21	12	forward	forward	ADV
fbem-25594	21	13	the	the	DET
fbem-25594	21	14	development	development	NOUN
fbem-25594	21	15	framework	framework	NOUN
fbem-25594	21	16	of	of	ADP
fbem-25594	21	17	"	"	PUNCT
fbem-25594	21	18	one	one	NUM
fbem-25594	21	19	core	core	NOUN
fbem-25594	21	20	and	and	CCONJ
fbem-25594	21	21	two	two	NUM
fbem-25594	21	22	wings	wing	NOUN
fbem-25594	21	23	"	"	PUNCT
fbem-25594	21	24	.	.	PUNCT
fbem-25594	22	1	the	the	DET
fbem-25594	22	2	"	"	PUNCT
fbem-25594	22	3	one	one	NUM
fbem-25594	22	4	core	core	NOUN
fbem-25594	22	5	and	and	CCONJ
fbem-25594	22	6	two	two	NUM
fbem-25594	22	7	wings	wing	NOUN
fbem-25594	22	8	"	"	PUNCT
fbem-25594	22	9	strategy	strategy	NOUN
fbem-25594	22	10	was	be	AUX
fbem-25594	22	11	proposed	propose	VERB
fbem-25594	22	12	by	by	ADP
fbem-25594	22	13	hu	hu	PROPN
fbem-25594	22	14	jiqiang	jiqiang	PROPN
fbem-25594	22	15	,	,	PUNCT
fbem-25594	22	16	chairman	chairman	NOUN
fbem-25594	22	17	of	of	ADP
fbem-25594	22	18	conba	conba	NOUN
fbem-25594	22	19	.	.	PUNCT
fbem-25594	23	1	as	as	ADP
fbem-25594	23	2	the	the	DET
fbem-25594	23	3	leader	leader	NOUN
fbem-25594	23	4	of	of	ADP
fbem-25594	23	5	connbe	connbe	PROPN
fbem-25594	23	6	company	company	NOUN
fbem-25594	23	7	,	,	PUNCT
fbem-25594	23	8	hu	hu	PROPN
fbem-25594	24	1	jiqiang	jiqiang	PROPN
fbem-25594	24	2	is	be	AUX
fbem-25594	24	3	deeply	deeply	ADV
fbem-25594	24	4	aware	aware	ADJ
fbem-25594	24	5	of	of	ADP
fbem-25594	24	6	the	the	DET
fbem-25594	24	7	changes	change	NOUN
fbem-25594	24	8	and	and	CCONJ
fbem-25594	24	9	challenges	challenge	NOUN
fbem-25594	24	10	in	in	ADP
fbem-25594	24	11	the	the	DET
fbem-25594	24	12	pharmaceutical	pharmaceutical	ADJ
fbem-25594	24	13	industry	industry	NOUN
fbem-25594	24	14	,	,	PUNCT
fbem-25594	24	15	and	and	CCONJ
fbem-25594	24	16	actively	actively	ADV
fbem-25594	24	17	promotes	promote	VERB
fbem-25594	24	18	the	the	DET
fbem-25594	24	19	strategic	strategic	ADJ
fbem-25594	24	20	transformation	transformation	NOUN
fbem-25594	24	21	of	of	ADP
fbem-25594	24	22	the	the	DET
fbem-25594	24	23	company	company	NOUN
fbem-25594	24	24	.	.	PUNCT
fbem-25594	25	1	through	through	ADP
fbem-25594	25	2	the	the	DET
fbem-25594	25	3	strategy	strategy	NOUN
fbem-25594	25	4	of	of	ADP
fbem-25594	25	5	"	"	PUNCT
fbem-25594	25	6	one	one	NUM
fbem-25594	25	7	core	core	NOUN
fbem-25594	25	8	and	and	CCONJ
fbem-25594	25	9	two	two	NUM
fbem-25594	25	10	wings	wing	NOUN
fbem-25594	25	11	"	"	PUNCT
fbem-25594	25	12	,	,	PUNCT
fbem-25594	25	13	enterprises	enterprise	NOUN
fbem-25594	25	14	hope	hope	VERB
fbem-25594	25	15	to	to	PART
fbem-25594	25	16	realize	realize	VERB
fbem-25594	25	17	the	the	DET
fbem-25594	25	18	diversification	diversification	NOUN
fbem-25594	25	19	and	and	CCONJ
fbem-25594	25	20	sustainable	sustainable	ADJ
fbem-25594	25	21	development	development	NOUN
fbem-25594	25	22	of	of	ADP
fbem-25594	25	23	the	the	DET
fbem-25594	25	24	company	company	NOUN
fbem-25594	25	25	's	's	PART
fbem-25594	25	26	business	business	NOUN
fbem-25594	25	27	to	to	PART
fbem-25594	25	28	cope	cope	VERB
fbem-25594	25	29	with	with	ADP
fbem-25594	25	30	market	market	NOUN
fbem-25594	25	31	competition	competition	NOUN
fbem-25594	25	32	and	and	CCONJ
fbem-25594	25	33	industry	industry	NOUN
fbem-25594	25	34	changes	change	NOUN
fbem-25594	25	35	.	.	PUNCT
fbem-25594	26	1	"	"	PUNCT
fbem-25594	26	2	one	one	NUM
fbem-25594	26	3	core	core	NOUN
fbem-25594	26	4	and	and	CCONJ
fbem-25594	26	5	two	two	NUM
fbem-25594	26	6	wings	wing	NOUN
fbem-25594	26	7	"	"	PUNCT
fbem-25594	26	8	is	be	AUX
fbem-25594	26	9	an	an	DET
fbem-25594	26	10	important	important	ADJ
fbem-25594	26	11	concept	concept	NOUN
fbem-25594	26	12	put	put	VERB
fbem-25594	26	13	forward	forward	ADV
fbem-25594	26	14	by	by	ADP
fbem-25594	26	15	comnbe	comnbe	NOUN
fbem-25594	26	16	in	in	ADP
fbem-25594	26	17	its	its	PRON
fbem-25594	26	18	development	development	NOUN
fbem-25594	26	19	strategy	strategy	NOUN
fbem-25594	26	20	.	.	PUNCT
fbem-25594	27	1	this	this	DET
fbem-25594	27	2	strategic	strategic	ADJ
fbem-25594	27	3	201	201	NUM
fbem-25594	27	4	framework	framework	NOUN
fbem-25594	27	5	was	be	AUX
fbem-25594	27	6	proposed	propose	VERB
fbem-25594	27	7	around	around	ADP
fbem-25594	27	8	2018	2018	NUM
fbem-25594	27	9	and	and	CCONJ
fbem-25594	27	10	the	the	DET
fbem-25594	27	11	transformation	transformation	NOUN
fbem-25594	27	12	will	will	AUX
fbem-25594	27	13	be	be	AUX
fbem-25594	27	14	completed	complete	VERB
fbem-25594	27	15	between	between	ADP
fbem-25594	27	16	2022	2022	NUM
fbem-25594	27	17	-	-	SYM
fbem-25594	27	18	2023	2023	NUM
fbem-25594	27	19	.	.	PUNCT
fbem-25594	28	1	2.1.1	2.1.1	NUM
fbem-25594	28	2	.	.	PUNCT
fbem-25594	28	3	industry	industry	NOUN
fbem-25594	28	4	background	background	NOUN
fbem-25594	28	5	as	as	ADP
fbem-25594	28	6	a	a	DET
fbem-25594	28	7	strategic	strategic	ADJ
fbem-25594	28	8	emerging	emerge	VERB
fbem-25594	28	9	industry	industry	NOUN
fbem-25594	28	10	,	,	PUNCT
fbem-25594	28	11	medicine	medicine	NOUN
fbem-25594	28	12	and	and	CCONJ
fbem-25594	28	13	tcm	tcm	PROPN
fbem-25594	28	14	have	have	AUX
fbem-25594	28	15	benefited	benefit	VERB
fbem-25594	28	16	from	from	ADP
fbem-25594	28	17	policy	policy	NOUN
fbem-25594	28	18	support	support	NOUN
fbem-25594	28	19	and	and	CCONJ
fbem-25594	28	20	the	the	DET
fbem-25594	28	21	overall	overall	ADJ
fbem-25594	28	22	recovery	recovery	NOUN
fbem-25594	28	23	of	of	ADP
fbem-25594	28	24	the	the	DET
fbem-25594	28	25	national	national	ADJ
fbem-25594	28	26	economy	economy	NOUN
fbem-25594	28	27	,	,	PUNCT
fbem-25594	28	28	and	and	CCONJ
fbem-25594	28	29	ensured	ensure	VERB
fbem-25594	28	30	people	people	NOUN
fbem-25594	28	31	's	's	PART
fbem-25594	28	32	livelihood	livelihood	NOUN
fbem-25594	28	33	.	.	PUNCT
fbem-25594	29	1	in	in	ADP
fbem-25594	29	2	the	the	DET
fbem-25594	29	3	field	field	NOUN
fbem-25594	29	4	of	of	ADP
fbem-25594	29	5	medicine	medicine	NOUN
fbem-25594	29	6	and	and	CCONJ
fbem-25594	29	7	health	health	NOUN
fbem-25594	29	8	care	care	NOUN
fbem-25594	29	9	,	,	PUNCT
fbem-25594	29	10	the	the	DET
fbem-25594	29	11	state	state	PROPN
fbem-25594	29	12	council	council	PROPN
fbem-25594	29	13	,	,	PUNCT
fbem-25594	29	14	the	the	DET
fbem-25594	29	15	national	national	PROPN
fbem-25594	29	16	health	health	PROPN
fbem-25594	29	17	commission	commission	PROPN
fbem-25594	29	18	and	and	CCONJ
fbem-25594	29	19	other	other	ADJ
fbem-25594	29	20	departments	department	NOUN
fbem-25594	29	21	have	have	AUX
fbem-25594	29	22	issued	issue	VERB
fbem-25594	29	23	hundreds	hundred	NOUN
fbem-25594	29	24	of	of	ADP
fbem-25594	29	25	policy	policy	NOUN
fbem-25594	29	26	documents	document	NOUN
fbem-25594	29	27	on	on	ADP
fbem-25594	29	28	the	the	DET
fbem-25594	29	29	joint	joint	ADJ
fbem-25594	29	30	reform	reform	NOUN
fbem-25594	29	31	of	of	ADP
fbem-25594	29	32	the	the	DET
fbem-25594	29	33	three	three	NUM
fbem-25594	29	34	medical	medical	ADJ
fbem-25594	29	35	institutions	institution	NOUN
fbem-25594	29	36	,	,	PUNCT
fbem-25594	29	37	and	and	CCONJ
fbem-25594	29	38	continue	continue	VERB
fbem-25594	29	39	to	to	PART
fbem-25594	29	40	deepen	deepen	VERB
fbem-25594	29	41	various	various	ADJ
fbem-25594	29	42	medical	medical	ADJ
fbem-25594	29	43	reform	reform	NOUN
fbem-25594	29	44	measures	measure	NOUN
fbem-25594	29	45	.	.	PUNCT
fbem-25594	30	1	according	accord	VERB
fbem-25594	30	2	to	to	ADP
fbem-25594	30	3	the	the	DET
fbem-25594	30	4	chinese	chinese	ADJ
fbem-25594	30	5	pharmaceutical	pharmaceutical	NOUN
fbem-25594	30	6	industry	industry	NOUN
fbem-25594	30	7	information	information	NOUN
fbem-25594	30	8	center	center	NOUN
fbem-25594	30	9	of	of	ADP
fbem-25594	30	10	the	the	DET
fbem-25594	30	11	latest	late	ADJ
fbem-25594	30	12	2023	2023	NUM
fbem-25594	30	13	pharmaceutical	pharmaceutical	NOUN
fbem-25594	30	14	industry	industry	NOUN
fbem-25594	30	15	operation	operation	NOUN
fbem-25594	30	16	report	report	NOUN
fbem-25594	30	17	[	[	X
fbem-25594	30	18	1	1	NUM
fbem-25594	30	19	]	]	PUNCT
fbem-25594	30	20	,	,	PUNCT
fbem-25594	30	21	according	accord	VERB
fbem-25594	30	22	to	to	ADP
fbem-25594	30	23	the	the	DET
fbem-25594	30	24	affected	affect	VERB
fbem-25594	30	25	by	by	ADP
fbem-25594	30	26	demand	demand	NOUN
fbem-25594	30	27	,	,	PUNCT
fbem-25594	30	28	the	the	DET
fbem-25594	30	29	main	main	ADJ
fbem-25594	30	30	revenue	revenue	NOUN
fbem-25594	30	31	,	,	PUNCT
fbem-25594	30	32	profit	profit	NOUN
fbem-25594	30	33	and	and	CCONJ
fbem-25594	30	34	other	other	ADJ
fbem-25594	30	35	indicators	indicator	NOUN
fbem-25594	30	36	are	be	AUX
fbem-25594	30	37	negative	negative	ADJ
fbem-25594	30	38	,	,	PUNCT
fbem-25594	30	39	but	but	CCONJ
fbem-25594	30	40	each	each	DET
fbem-25594	30	41	industry	industry	NOUN
fbem-25594	30	42	trend	trend	NOUN
fbem-25594	30	43	differentiation	differentiation	NOUN
fbem-25594	30	44	,	,	PUNCT
fbem-25594	30	45	biological	biological	ADJ
fbem-25594	30	46	products	product	NOUN
fbem-25594	30	47	,	,	PUNCT
fbem-25594	30	48	health	health	NOUN
fbem-25594	30	49	materials	material	NOUN
fbem-25594	30	50	and	and	CCONJ
fbem-25594	30	51	medical	medical	ADJ
fbem-25594	30	52	supplies	supply	NOUN
fbem-25594	30	53	five	five	NUM
fbem-25594	30	54	sub	sub	NOUN
fbem-25594	30	55	industry	industry	NOUN
fbem-25594	30	56	economic	economic	ADJ
fbem-25594	30	57	indicators	indicator	NOUN
fbem-25594	30	58	appear	appear	VERB
fbem-25594	30	59	a	a	DET
fbem-25594	30	60	certain	certain	ADJ
fbem-25594	30	61	decline	decline	NOUN
fbem-25594	30	62	.	.	PUNCT
fbem-25594	31	1	in	in	ADP
fbem-25594	31	2	2023	2023	NUM
fbem-25594	31	3	,	,	PUNCT
fbem-25594	31	4	the	the	DET
fbem-25594	31	5	operating	operating	NOUN
fbem-25594	31	6	revenue	revenue	NOUN
fbem-25594	31	7	and	and	CCONJ
fbem-25594	31	8	profit	profit	NOUN
fbem-25594	31	9	of	of	ADP
fbem-25594	31	10	the	the	DET
fbem-25594	31	11	two	two	NUM
fbem-25594	31	12	sub	sub	NOUN
fbem-25594	31	13	-	-	NOUN
fbem-25594	31	14	industries	industry	NOUN
fbem-25594	31	15	of	of	ADP
fbem-25594	31	16	chinese	chinese	ADJ
fbem-25594	31	17	patent	patent	NOUN
fbem-25594	31	18	medicine	medicine	NOUN
fbem-25594	31	19	and	and	CCONJ
fbem-25594	31	20	tcm	tcm	PROPN
fbem-25594	31	21	decoction	decoction	NOUN
fbem-25594	31	22	piece	piece	NOUN
fbem-25594	31	23	increased	increase	VERB
fbem-25594	31	24	by	by	ADP
fbem-25594	31	25	4.85	4.85	NUM
fbem-25594	31	26	%	%	NOUN
fbem-25594	31	27	year	year	NOUN
fbem-25594	31	28	on	on	ADP
fbem-25594	31	29	year	year	NOUN
fbem-25594	31	30	,	,	PUNCT
fbem-25594	31	31	with	with	ADP
fbem-25594	31	32	some	some	DET
fbem-25594	31	33	growth	growth	NOUN
fbem-25594	31	34	rate	rate	NOUN
fbem-25594	31	35	reaching	reach	VERB
fbem-25594	31	36	double	double	ADJ
fbem-25594	31	37	digits	digit	NOUN
fbem-25594	31	38	,	,	PUNCT
fbem-25594	31	39	continuing	continue	VERB
fbem-25594	31	40	to	to	PART
fbem-25594	31	41	show	show	VERB
fbem-25594	31	42	a	a	DET
fbem-25594	31	43	good	good	ADJ
fbem-25594	31	44	development	development	NOUN
fbem-25594	31	45	trend	trend	NOUN
fbem-25594	31	46	.	.	PUNCT
fbem-25594	32	1	2.1.2	2.1.2	X
fbem-25594	32	2	.	.	PUNCT
fbem-25594	32	3	implementation	implementation	NOUN
fbem-25594	32	4	content	content	NOUN
fbem-25594	32	5	among	among	ADP
fbem-25594	32	6	them	they	PRON
fbem-25594	32	7	,	,	PUNCT
fbem-25594	32	8	tcm	tcm	PROPN
fbem-25594	32	9	pharmaceutical	pharmaceutical	PROPN
fbem-25594	32	10	business	business	NOUN
fbem-25594	32	11	is	be	AUX
fbem-25594	32	12	the	the	DET
fbem-25594	32	13	core	core	NOUN
fbem-25594	32	14	business	business	NOUN
fbem-25594	32	15	of	of	ADP
fbem-25594	32	16	conba	conba	NOUN
fbem-25594	32	17	company	company	NOUN
fbem-25594	32	18	,	,	PUNCT
fbem-25594	32	19	namely	namely	ADV
fbem-25594	32	20	"	"	PUNCT
fbem-25594	32	21	core	core	NOUN
fbem-25594	32	22	"	"	PUNCT
fbem-25594	32	23	.	.	PUNCT
fbem-25594	33	1	this	this	DET
fbem-25594	33	2	core	core	NOUN
fbem-25594	33	3	business	business	NOUN
fbem-25594	33	4	will	will	AUX
fbem-25594	33	5	continue	continue	VERB
fbem-25594	33	6	to	to	PART
fbem-25594	33	7	be	be	AUX
fbem-25594	33	8	the	the	DET
fbem-25594	33	9	foundation	foundation	NOUN
fbem-25594	33	10	of	of	ADP
fbem-25594	33	11	the	the	DET
fbem-25594	33	12	company	company	NOUN
fbem-25594	33	13	,	,	PUNCT
fbem-25594	33	14	maintaining	maintain	VERB
fbem-25594	33	15	a	a	DET
fbem-25594	33	16	leading	lead	VERB
fbem-25594	33	17	position	position	NOUN
fbem-25594	33	18	in	in	ADP
fbem-25594	33	19	technology	technology	NOUN
fbem-25594	33	20	and	and	CCONJ
fbem-25594	33	21	products	product	NOUN
fbem-25594	33	22	.	.	PUNCT
fbem-25594	34	1	with	with	ADP
fbem-25594	34	2	featured	feature	VERB
fbem-25594	34	3	chemicals	chemical	NOUN
fbem-25594	34	4	and	and	CCONJ
fbem-25594	34	5	featured	feature	VERB
fbem-25594	34	6	health	health	NOUN
fbem-25594	34	7	consumer	consumer	NOUN
fbem-25594	34	8	goods	good	NOUN
fbem-25594	34	9	as	as	ADP
fbem-25594	34	10	the	the	DET
fbem-25594	34	11	two	two	NUM
fbem-25594	34	12	wings	wing	NOUN
fbem-25594	34	13	;	;	PUNCT
fbem-25594	34	14	with	with	ADP
fbem-25594	34	15	featured	feature	VERB
fbem-25594	34	16	health	health	NOUN
fbem-25594	34	17	consumer	consumer	NOUN
fbem-25594	34	18	goods	good	NOUN
fbem-25594	34	19	as	as	ADP
fbem-25594	34	20	the	the	DET
fbem-25594	34	21	main	main	ADJ
fbem-25594	34	22	product	product	NOUN
fbem-25594	34	23	line	line	NOUN
fbem-25594	34	24	,	,	PUNCT
fbem-25594	34	25	the	the	DET
fbem-25594	34	26	business	business	NOUN
fbem-25594	34	27	covers	cover	VERB
fbem-25594	34	28	health	health	NOUN
fbem-25594	34	29	food	food	NOUN
fbem-25594	34	30	,	,	PUNCT
fbem-25594	34	31	health	health	NOUN
fbem-25594	34	32	products	product	NOUN
fbem-25594	34	33	,	,	PUNCT
fbem-25594	34	34	medical	medical	ADJ
fbem-25594	34	35	devices	device	NOUN
fbem-25594	34	36	and	and	CCONJ
fbem-25594	34	37	other	other	ADJ
fbem-25594	34	38	related	related	ADJ
fbem-25594	34	39	fields	field	NOUN
fbem-25594	34	40	.	.	PUNCT
fbem-25594	35	1	by	by	ADP
fbem-25594	35	2	entering	enter	VERB
fbem-25594	35	3	the	the	DET
fbem-25594	35	4	big	big	ADJ
fbem-25594	35	5	health	health	NOUN
fbem-25594	35	6	industry	industry	NOUN
fbem-25594	35	7	,	,	PUNCT
fbem-25594	35	8	conbe	conbe	NOUN
fbem-25594	35	9	hopes	hope	VERB
fbem-25594	35	10	to	to	PART
fbem-25594	35	11	broaden	broaden	VERB
fbem-25594	35	12	its	its	PRON
fbem-25594	35	13	revenue	revenue	NOUN
fbem-25594	35	14	streams	stream	NOUN
fbem-25594	35	15	to	to	PART
fbem-25594	35	16	meet	meet	VERB
fbem-25594	35	17	growing	grow	VERB
fbem-25594	35	18	consumer	consumer	NOUN
fbem-25594	35	19	demand	demand	NOUN
fbem-25594	35	20	for	for	ADP
fbem-25594	35	21	health	health	NOUN
fbem-25594	35	22	products	product	NOUN
fbem-25594	35	23	.	.	PUNCT
fbem-25594	36	1	according	accord	VERB
fbem-25594	36	2	to	to	ADP
fbem-25594	36	3	the	the	DET
fbem-25594	36	4	data	datum	NOUN
fbem-25594	36	5	[	[	X
fbem-25594	36	6	2	2	NUM
fbem-25594	36	7	]	]	PUNCT
fbem-25594	36	8	of	of	ADP
fbem-25594	36	9	minenet	minenet	NOUN
fbem-25594	36	10	,	,	PUNCT
fbem-25594	36	11	the	the	DET
fbem-25594	36	12	processing	processing	NOUN
fbem-25594	36	13	market	market	NOUN
fbem-25594	36	14	size	size	NOUN
fbem-25594	36	15	of	of	ADP
fbem-25594	36	16	tcm	tcm	PROPN
fbem-25594	36	17	decoction	decoction	NOUN
fbem-25594	36	18	pieces	piece	NOUN
fbem-25594	36	19	has	have	AUX
fbem-25594	36	20	exceeded	exceed	VERB
fbem-25594	36	21	210	210	NUM
fbem-25594	36	22	billion	billion	NUM
fbem-25594	36	23	yuan	yuan	NOUN
fbem-25594	36	24	in	in	ADP
fbem-25594	36	25	2022	2022	NUM
fbem-25594	36	26	,	,	PUNCT
fbem-25594	36	27	and	and	CCONJ
fbem-25594	36	28	the	the	DET
fbem-25594	36	29	company	company	NOUN
fbem-25594	36	30	acquired	acquire	VERB
fbem-25594	36	31	66	66	NUM
fbem-25594	36	32	%	%	NOUN
fbem-25594	36	33	of	of	ADP
fbem-25594	36	34	the	the	DET
fbem-25594	36	35	equity	equity	NOUN
fbem-25594	36	36	of	of	ADP
fbem-25594	36	37	decoction	decoction	NOUN
fbem-25594	36	38	pieces	piece	NOUN
fbem-25594	36	39	company	company	NOUN
fbem-25594	36	40	of	of	ADP
fbem-25594	36	41	zhejiang	zhejiang	PROPN
fbem-25594	36	42	university	university	PROPN
fbem-25594	36	43	of	of	ADP
fbem-25594	36	44	traditional	traditional	ADJ
fbem-25594	36	45	chinese	chinese	ADJ
fbem-25594	36	46	medicine	medicine	NOUN
fbem-25594	36	47	in	in	ADP
fbem-25594	36	48	2022	2022	NUM
fbem-25594	36	49	.	.	PUNCT
fbem-25594	37	1	in	in	ADP
fbem-25594	37	2	2023	2023	NUM
fbem-25594	37	3	,	,	PUNCT
fbem-25594	37	4	the	the	DET
fbem-25594	37	5	company	company	NOUN
fbem-25594	37	6	's	's	PART
fbem-25594	37	7	revenue	revenue	NOUN
fbem-25594	37	8	of	of	ADP
fbem-25594	37	9	chinese	chinese	ADJ
fbem-25594	37	10	herbal	herbal	ADJ
fbem-25594	37	11	medicine	medicine	NOUN
fbem-25594	37	12	and	and	CCONJ
fbem-25594	37	13	chinese	chinese	ADJ
fbem-25594	37	14	herbal	herbal	ADJ
fbem-25594	37	15	medicine	medicine	NOUN
fbem-25594	37	16	decoction	decoction	NOUN
fbem-25594	37	17	pieces	piece	NOUN
fbem-25594	37	18	reached	reach	VERB
fbem-25594	37	19	851	851	NUM
fbem-25594	37	20	million	million	NUM
fbem-25594	37	21	yuan	yuan	NOUN
fbem-25594	37	22	,	,	PUNCT
fbem-25594	37	23	with	with	ADP
fbem-25594	37	24	a	a	DET
fbem-25594	37	25	year	year	NOUN
fbem-25594	37	26	-	-	PUNCT
fbem-25594	37	27	on	on	ADP
fbem-25594	37	28	-	-	PUNCT
fbem-25594	37	29	year	year	NOUN
fbem-25594	37	30	growth	growth	NOUN
fbem-25594	37	31	of	of	ADP
fbem-25594	37	32	26.79	26.79	NUM
fbem-25594	37	33	%	%	NOUN
fbem-25594	37	34	.	.	PUNCT
fbem-25594	38	1	in	in	ADP
fbem-25594	38	2	the	the	DET
fbem-25594	38	3	aspect	aspect	NOUN
fbem-25594	38	4	of	of	ADP
fbem-25594	38	5	internet	internet	NOUN
fbem-25594	38	6	+	+	CCONJ
fbem-25594	38	7	medical	medical	ADJ
fbem-25594	38	8	services	service	NOUN
fbem-25594	38	9	.	.	PUNCT
fbem-25594	39	1	through	through	ADP
fbem-25594	39	2	the	the	DET
fbem-25594	39	3	investment	investment	NOUN
fbem-25594	39	4	and	and	CCONJ
fbem-25594	39	5	development	development	NOUN
fbem-25594	39	6	of	of	ADP
fbem-25594	39	7	internet	internet	NOUN
fbem-25594	39	8	medical	medical	ADJ
fbem-25594	39	9	platform	platform	NOUN
fbem-25594	39	10	,	,	PUNCT
fbem-25594	39	11	conba	conba	NOUN
fbem-25594	39	12	provides	provide	VERB
fbem-25594	39	13	online	online	ADJ
fbem-25594	39	14	medical	medical	ADJ
fbem-25594	39	15	consultation	consultation	NOUN
fbem-25594	39	16	,	,	PUNCT
fbem-25594	39	17	health	health	NOUN
fbem-25594	39	18	management	management	NOUN
fbem-25594	39	19	and	and	CCONJ
fbem-25594	39	20	other	other	ADJ
fbem-25594	39	21	services	service	NOUN
fbem-25594	39	22	,	,	PUNCT
fbem-25594	39	23	conforming	conform	VERB
fbem-25594	39	24	to	to	ADP
fbem-25594	39	25	the	the	DET
fbem-25594	39	26	trend	trend	NOUN
fbem-25594	39	27	of	of	ADP
fbem-25594	39	28	digitalization	digitalization	NOUN
fbem-25594	39	29	and	and	CCONJ
fbem-25594	39	30	internet	internet	NOUN
fbem-25594	39	31	era	era	NOUN
fbem-25594	39	32	,	,	PUNCT
fbem-25594	39	33	and	and	CCONJ
fbem-25594	39	34	improves	improve	VERB
fbem-25594	39	35	its	its	PRON
fbem-25594	39	36	service	service	NOUN
fbem-25594	39	37	capacity	capacity	NOUN
fbem-25594	39	38	and	and	CCONJ
fbem-25594	39	39	market	market	NOUN
fbem-25594	39	40	competitiveness	competitiveness	NOUN
fbem-25594	39	41	.	.	PUNCT
fbem-25594	40	1	by	by	ADP
fbem-25594	40	2	increasing	increase	VERB
fbem-25594	40	3	the	the	DET
fbem-25594	40	4	brand	brand	NOUN
fbem-25594	40	5	extension	extension	NOUN
fbem-25594	40	6	,	,	PUNCT
fbem-25594	40	7	the	the	DET
fbem-25594	40	8	brand	brand	NOUN
fbem-25594	40	9	and	and	CCONJ
fbem-25594	40	10	products	product	NOUN
fbem-25594	40	11	from	from	ADP
fbem-25594	40	12	disease	disease	NOUN
fbem-25594	40	13	treatment	treatment	NOUN
fbem-25594	40	14	to	to	ADP
fbem-25594	40	15	health	health	NOUN
fbem-25594	40	16	care	care	NOUN
fbem-25594	40	17	prevention	prevention	PROPN
fbem-25594	40	18	development	development	NOUN
fbem-25594	40	19	.	.	PUNCT
fbem-25594	41	1	since	since	SCONJ
fbem-25594	41	2	the	the	DET
fbem-25594	41	3	strategic	strategic	ADJ
fbem-25594	41	4	transformation	transformation	NOUN
fbem-25594	41	5	,	,	PUNCT
fbem-25594	41	6	combain	combain	NOUN
fbem-25594	41	7	has	have	AUX
fbem-25594	41	8	made	make	VERB
fbem-25594	41	9	great	great	ADJ
fbem-25594	41	10	changes	change	NOUN
fbem-25594	41	11	in	in	ADP
fbem-25594	41	12	its	its	PRON
fbem-25594	41	13	marketing	marketing	NOUN
fbem-25594	41	14	mode	mode	NOUN
fbem-25594	41	15	.	.	PUNCT
fbem-25594	42	1	the	the	DET
fbem-25594	42	2	company	company	NOUN
fbem-25594	42	3	will	will	AUX
fbem-25594	42	4	strengthen	strengthen	VERB
fbem-25594	42	5	the	the	DET
fbem-25594	42	6	development	development	NOUN
fbem-25594	42	7	of	of	ADP
fbem-25594	42	8	digital	digital	ADJ
fbem-25594	42	9	management	management	NOUN
fbem-25594	42	10	and	and	CCONJ
fbem-25594	42	11	marketing	marketing	NOUN
fbem-25594	42	12	[	[	X
fbem-25594	42	13	3	3	X
fbem-25594	42	14	]	]	PUNCT
fbem-25594	42	15	in	in	ADP
fbem-25594	42	16	2021	2021	NUM
fbem-25594	42	17	.	.	PUNCT
fbem-25594	43	1	by	by	ADP
fbem-25594	43	2	building	build	VERB
fbem-25594	43	3	a	a	DET
fbem-25594	43	4	nationwide	nationwide	ADJ
fbem-25594	43	5	operation	operation	NOUN
fbem-25594	43	6	network	network	NOUN
fbem-25594	43	7	,	,	PUNCT
fbem-25594	43	8	conba	conba	NOUN
fbem-25594	43	9	has	have	VERB
fbem-25594	43	10	a	a	DET
fbem-25594	43	11	professional	professional	ADJ
fbem-25594	43	12	marketing	marketing	NOUN
fbem-25594	43	13	subsidiary	subsidiary	NOUN
fbem-25594	43	14	nationwide	nationwide	ADV
fbem-25594	43	15	,	,	PUNCT
fbem-25594	43	16	forming	form	VERB
fbem-25594	43	17	a	a	DET
fbem-25594	43	18	national	national	ADJ
fbem-25594	43	19	sales	sale	NOUN
fbem-25594	43	20	channel	channel	NOUN
fbem-25594	43	21	and	and	CCONJ
fbem-25594	43	22	terminal	terminal	ADJ
fbem-25594	43	23	network	network	NOUN
fbem-25594	43	24	.	.	PUNCT
fbem-25594	44	1	in	in	ADP
fbem-25594	44	2	2023	2023	NUM
fbem-25594	44	3	,	,	PUNCT
fbem-25594	44	4	the	the	DET
fbem-25594	44	5	number	number	NOUN
fbem-25594	44	6	of	of	ADP
fbem-25594	44	7	terminal	terminal	ADJ
fbem-25594	44	8	retail	retail	ADJ
fbem-25594	44	9	pharmacies	pharmacy	NOUN
fbem-25594	44	10	will	will	AUX
fbem-25594	44	11	exceed	exceed	VERB
fbem-25594	44	12	30	30	NUM
fbem-25594	44	13	0,000	0,000	NUM
fbem-25594	44	14	,	,	PUNCT
fbem-25594	44	15	and	and	CCONJ
fbem-25594	44	16	the	the	DET
fbem-25594	44	17	coverage	coverage	NOUN
fbem-25594	44	18	of	of	ADP
fbem-25594	44	19	major	major	ADJ
fbem-25594	44	20	grade	grade	NOUN
fbem-25594	44	21	hospitals	hospital	NOUN
fbem-25594	44	22	and	and	CCONJ
fbem-25594	44	23	primary	primary	ADJ
fbem-25594	44	24	medical	medical	ADJ
fbem-25594	44	25	institutions	institution	NOUN
fbem-25594	44	26	will	will	AUX
fbem-25594	44	27	be	be	AUX
fbem-25594	44	28	achieved	achieve	VERB
fbem-25594	44	29	.	.	PUNCT
fbem-25594	45	1	kang	kang	PROPN
fbem-25594	45	2	company	company	PROPN
fbem-25594	45	3	established	establish	VERB
fbem-25594	45	4	new	new	ADJ
fbem-25594	45	5	in	in	ADP
fbem-25594	45	6	2019	2019	NUM
fbem-25594	45	7	retail	retail	ADJ
fbem-25594	45	8	division	division	NOUN
fbem-25594	45	9	,	,	PUNCT
fbem-25594	45	10	and	and	CCONJ
fbem-25594	45	11	"	"	PUNCT
fbem-25594	45	12	ali	ali	PROPN
fbem-25594	45	13	health	health	PROPN
fbem-25594	45	14	"	"	PUNCT
fbem-25594	45	15	,	,	PUNCT
fbem-25594	45	16	"	"	PUNCT
fbem-25594	45	17	jingdong	jingdong	ADP
fbem-25594	45	18	health	health	NOUN
fbem-25594	45	19	"	"	PUNCT
fbem-25594	45	20	and	and	CCONJ
fbem-25594	45	21	"	"	PUNCT
fbem-25594	45	22	meituan	meituan	NOUN
fbem-25594	45	23	"	"	PUNCT
fbem-25594	45	24	,	,	PUNCT
fbem-25594	45	25	"	"	PUNCT
fbem-25594	45	26	hungry	hungry	ADJ
fbem-25594	45	27	"	"	PUNCT
fbem-25594	45	28	third	third	ADJ
fbem-25594	45	29	party	party	NOUN
fbem-25594	45	30	platform	platform	NOUN
fbem-25594	45	31	to	to	PART
fbem-25594	45	32	establish	establish	VERB
fbem-25594	45	33	strategic	strategic	ADJ
fbem-25594	45	34	cooperation	cooperation	NOUN
fbem-25594	45	35	,	,	PUNCT
fbem-25594	45	36	establish	establish	VERB
fbem-25594	45	37	new	new	ADJ
fbem-25594	45	38	retail	retail	ADJ
fbem-25594	45	39	system	system	NOUN
fbem-25594	45	40	,	,	PUNCT
fbem-25594	45	41	online	online	ADJ
fbem-25594	45	42	synergy	synergy	NOUN
fbem-25594	45	43	drug	drug	NOUN
fbem-25594	45	44	industry	industry	NOUN
fbem-25594	45	45	online	online	ADJ
fbem-25594	45	46	revenue	revenue	NOUN
fbem-25594	45	47	in	in	ADP
fbem-25594	45	48	2022	2022	NUM
fbem-25594	45	49	562	562	NUM
fbem-25594	45	50	million	million	NUM
fbem-25594	45	51	yuan	yuan	NOUN
fbem-25594	45	52	,	,	PUNCT
fbem-25594	45	53	up	up	ADV
fbem-25594	45	54	37	37	NUM
fbem-25594	45	55	%	%	NOUN
fbem-25594	45	56	year	year	NOUN
fbem-25594	45	57	on	on	ADP
fbem-25594	45	58	year	year	NOUN
fbem-25594	45	59	,	,	PUNCT
fbem-25594	45	60	accounted	account	VERB
fbem-25594	45	61	for	for	ADP
fbem-25594	45	62	9.4	9.4	NUM
fbem-25594	45	63	%	%	NOUN
fbem-25594	45	64	of	of	ADP
fbem-25594	45	65	revenue	revenue	NOUN
fbem-25594	45	66	,	,	PUNCT
fbem-25594	45	67	achieve	achieve	VERB
fbem-25594	45	68	rapid	rapid	ADJ
fbem-25594	45	69	growth	growth	NOUN
fbem-25594	45	70	.	.	PUNCT
fbem-25594	46	1	as	as	SCONJ
fbem-25594	46	2	the	the	DET
fbem-25594	46	3	company	company	NOUN
fbem-25594	46	4	continues	continue	VERB
fbem-25594	46	5	to	to	PART
fbem-25594	46	6	promote	promote	VERB
fbem-25594	46	7	the	the	DET
fbem-25594	46	8	innovation	innovation	NOUN
fbem-25594	46	9	of	of	ADP
fbem-25594	46	10	marketing	marketing	NOUN
fbem-25594	46	11	system	system	NOUN
fbem-25594	46	12	and	and	CCONJ
fbem-25594	46	13	strengthen	strengthen	VERB
fbem-25594	46	14	the	the	DET
fbem-25594	46	15	digital	digital	ADJ
fbem-25594	46	16	transformation	transformation	NOUN
fbem-25594	46	17	,	,	PUNCT
fbem-25594	46	18	the	the	DET
fbem-25594	46	19	company	company	NOUN
fbem-25594	46	20	's	's	PART
fbem-25594	46	21	marketing	marketing	NOUN
fbem-25594	46	22	efficiency	efficiency	NOUN
fbem-25594	46	23	has	have	AUX
fbem-25594	46	24	steadily	steadily	ADV
fbem-25594	46	25	improved	improve	VERB
fbem-25594	46	26	and	and	CCONJ
fbem-25594	46	27	the	the	DET
fbem-25594	46	28	sales	sale	NOUN
fbem-25594	46	29	expense	expense	NOUN
fbem-25594	46	30	ratio	ratio	NOUN
fbem-25594	46	31	has	have	AUX
fbem-25594	46	32	gradually	gradually	ADV
fbem-25594	46	33	decreased	decrease	VERB
fbem-25594	46	34	.	.	PUNCT
fbem-25594	47	1	in	in	ADP
fbem-25594	47	2	recent	recent	ADJ
fbem-25594	47	3	years	year	NOUN
fbem-25594	47	4	,	,	PUNCT
fbem-25594	47	5	the	the	DET
fbem-25594	47	6	company	company	NOUN
fbem-25594	47	7	's	's	PART
fbem-25594	47	8	sales	sale	NOUN
fbem-25594	47	9	expense	expense	NOUN
fbem-25594	47	10	ratio	ratio	NOUN
fbem-25594	47	11	has	have	AUX
fbem-25594	47	12	dropped	drop	VERB
fbem-25594	47	13	from	from	ADP
fbem-25594	47	14	more	more	ADJ
fbem-25594	47	15	than	than	ADP
fbem-25594	47	16	50	50	NUM
fbem-25594	47	17	%	%	NOUN
fbem-25594	47	18	to	to	PART
fbem-25594	47	19	42	42	NUM
fbem-25594	47	20	%	%	NOUN
fbem-25594	47	21	in	in	ADP
fbem-25594	47	22	2020	2020	NUM
fbem-25594	47	23	,	,	PUNCT
fbem-25594	47	24	and	and	CCONJ
fbem-25594	47	25	then	then	ADV
fbem-25594	47	26	to	to	ADP
fbem-25594	47	27	34.4	34.4	NUM
fbem-25594	47	28	%	%	NOUN
fbem-25594	47	29	in	in	ADP
fbem-25594	47	30	2022	2022	NUM
fbem-25594	47	31	.	.	PUNCT
fbem-25594	48	1	according	accord	VERB
fbem-25594	48	2	to	to	ADP
fbem-25594	48	3	the	the	DET
fbem-25594	48	4	"	"	PUNCT
fbem-25594	48	5	plan	plan	NOUN
fbem-25594	48	6	of	of	ADP
fbem-25594	48	7	scientific	scientific	ADJ
fbem-25594	48	8	and	and	CCONJ
fbem-25594	48	9	technology	technology	NOUN
fbem-25594	48	10	innovation	innovation	NOUN
fbem-25594	48	11	driven	drive	VERB
fbem-25594	48	12	development	development	NOUN
fbem-25594	48	13	project	project	NOUN
fbem-25594	48	14	,	,	PUNCT
fbem-25594	48	15	conba	conba	NOUN
fbem-25594	48	16	has	have	AUX
fbem-25594	48	17	steadily	steadily	ADV
fbem-25594	48	18	promoted	promote	VERB
fbem-25594	48	19	the	the	DET
fbem-25594	48	20	research	research	NOUN
fbem-25594	48	21	and	and	CCONJ
fbem-25594	48	22	development	development	NOUN
fbem-25594	48	23	of	of	ADP
fbem-25594	48	24	innovative	innovative	ADJ
fbem-25594	48	25	drugs	drug	NOUN
fbem-25594	48	26	,	,	PUNCT
fbem-25594	48	27	consistency	consistency	NOUN
fbem-25594	48	28	evaluation	evaluation	NOUN
fbem-25594	48	29	of	of	ADP
fbem-25594	48	30	generic	generic	ADJ
fbem-25594	48	31	drugs	drug	NOUN
fbem-25594	48	32	,	,	PUNCT
fbem-25594	48	33	and	and	CCONJ
fbem-25594	48	34	the	the	DET
fbem-25594	48	35	secondary	secondary	ADJ
fbem-25594	48	36	development	development	NOUN
fbem-25594	48	37	of	of	ADP
fbem-25594	48	38	large	large	ADJ
fbem-25594	48	39	brands	brand	NOUN
fbem-25594	48	40	and	and	CCONJ
fbem-25594	48	41	large	large	ADJ
fbem-25594	48	42	varieties	variety	NOUN
fbem-25594	48	43	of	of	ADP
fbem-25594	48	44	products	product	NOUN
fbem-25594	48	45	.	.	PUNCT
fbem-25594	49	1	the	the	DET
fbem-25594	49	2	innovation	innovation	NOUN
fbem-25594	49	3	vitality	vitality	NOUN
fbem-25594	49	4	has	have	AUX
fbem-25594	49	5	been	be	AUX
fbem-25594	49	6	further	far	ADV
fbem-25594	49	7	stimulated	stimulate	VERB
fbem-25594	49	8	and	and	CCONJ
fbem-25594	49	9	the	the	DET
fbem-25594	49	10	innovation	innovation	NOUN
fbem-25594	49	11	ability	ability	NOUN
fbem-25594	49	12	has	have	AUX
fbem-25594	49	13	been	be	AUX
fbem-25594	49	14	significantly	significantly	ADV
fbem-25594	49	15	enhanced	enhance	VERB
fbem-25594	49	16	.	.	PUNCT
fbem-25594	50	1	in	in	ADP
fbem-25594	50	2	2023	2023	NUM
fbem-25594	50	3	,	,	PUNCT
fbem-25594	50	4	the	the	DET
fbem-25594	50	5	overall	overall	ADJ
fbem-25594	50	6	r	r	NOUN
fbem-25594	50	7	&	&	CCONJ
fbem-25594	50	8	d	d	NOUN
fbem-25594	50	9	investment	investment	NOUN
fbem-25594	50	10	of	of	ADP
fbem-25594	50	11	conba	conba	NOUN
fbem-25594	50	12	company	company	NOUN
fbem-25594	50	13	was	be	AUX
fbem-25594	50	14	312	312	NUM
fbem-25594	50	15	million	million	NUM
fbem-25594	50	16	yuan	yuan	NOUN
fbem-25594	50	17	,	,	PUNCT
fbem-25594	50	18	up	up	ADV
fbem-25594	50	19	18.80	18.80	NUM
fbem-25594	50	20	%	%	NOUN
fbem-25594	50	21	year	year	NOUN
fbem-25594	50	22	on	on	ADP
fbem-25594	50	23	year	year	NOUN
fbem-25594	50	24	,	,	PUNCT
fbem-25594	50	25	accounting	account	VERB
fbem-25594	50	26	for	for	ADP
fbem-25594	50	27	5.29	5.29	NUM
fbem-25594	50	28	%	%	NOUN
fbem-25594	50	29	of	of	ADP
fbem-25594	50	30	the	the	DET
fbem-25594	50	31	annual	annual	ADJ
fbem-25594	50	32	industrial	industrial	ADJ
fbem-25594	50	33	revenue.57	revenue.57	PROPN
fbem-25594	50	34	new	new	ADJ
fbem-25594	50	35	research	research	NOUN
fbem-25594	50	36	and	and	CCONJ
fbem-25594	50	37	development	development	NOUN
fbem-25594	50	38	projects	project	NOUN
fbem-25594	50	39	were	be	AUX
fbem-25594	50	40	approved	approve	VERB
fbem-25594	50	41	to	to	PART
fbem-25594	50	42	lay	lay	VERB
fbem-25594	50	43	a	a	DET
fbem-25594	50	44	good	good	ADJ
fbem-25594	50	45	front	front	ADJ
fbem-25594	50	46	-	-	PUNCT
fbem-25594	50	47	end	end	NOUN
fbem-25594	50	48	foundation	foundation	NOUN
fbem-25594	50	49	for	for	ADP
fbem-25594	50	50	the	the	DET
fbem-25594	50	51	construction	construction	NOUN
fbem-25594	50	52	of	of	ADP
fbem-25594	50	53	product	product	NOUN
fbem-25594	50	54	echelon	echelon	NOUN
fbem-25594	50	55	.	.	PUNCT
fbem-25594	51	1	in	in	ADP
fbem-25594	51	2	the	the	DET
fbem-25594	51	3	field	field	NOUN
fbem-25594	51	4	of	of	ADP
fbem-25594	51	5	innovative	innovative	ADJ
fbem-25594	51	6	chinese	chinese	ADJ
fbem-25594	51	7	medicine	medicine	NOUN
fbem-25594	51	8	,	,	PUNCT
fbem-25594	51	9	the	the	DET
fbem-25594	51	10	registration	registration	NOUN
fbem-25594	51	11	of	of	ADP
fbem-25594	51	12	2.1	2.1	NUM
fbem-25594	51	13	improved	improve	VERB
fbem-25594	51	14	innovative	innovative	ADJ
fbem-25594	51	15	drug	drug	NOUN
fbem-25594	51	16	of	of	ADP
fbem-25594	51	17	chinese	chinese	ADJ
fbem-25594	51	18	medicine	medicine	NOUN
fbem-25594	51	19	,	,	PUNCT
fbem-25594	51	20	the	the	DET
fbem-25594	51	21	clinical	clinical	ADJ
fbem-25594	51	22	approval	approval	NOUN
fbem-25594	51	23	of	of	ADP
fbem-25594	51	24	ivy	ivy	PROPN
fbem-25594	51	25	leaf	leaf	NOUN
fbem-25594	51	26	extract	extract	NOUN
fbem-25594	51	27	and	and	CCONJ
fbem-25594	51	28	oral	oral	ADJ
fbem-25594	51	29	liquid	liquid	NOUN
fbem-25594	51	30	;	;	PUNCT
fbem-25594	51	31	in	in	ADP
fbem-25594	51	32	the	the	DET
fbem-25594	51	33	field	field	NOUN
fbem-25594	51	34	of	of	ADP
fbem-25594	51	35	characteristic	characteristic	ADJ
fbem-25594	51	36	chemical	chemical	NOUN
fbem-25594	51	37	medicine	medicine	NOUN
fbem-25594	51	38	,	,	PUNCT
fbem-25594	51	39	the	the	DET
fbem-25594	51	40	registration	registration	NOUN
fbem-25594	51	41	approval	approval	NOUN
fbem-25594	51	42	of	of	ADP
fbem-25594	51	43	risperidone	risperidone	NOUN
fbem-25594	51	44	oral	oral	ADJ
fbem-25594	51	45	solution	solution	NOUN
fbem-25594	51	46	,	,	PUNCT
fbem-25594	51	47	azithromycin	azithromycin	VERB
fbem-25594	51	48	for	for	ADP
fbem-25594	51	49	injection	injection	NOUN
fbem-25594	51	50	,	,	PUNCT
fbem-25594	51	51	piperacillin	piperacillin	PROPN
fbem-25594	51	52	sodium	sodium	NOUN
fbem-25594	51	53	for	for	ADP
fbem-25594	51	54	injection	injection	NOUN
fbem-25594	51	55	and	and	CCONJ
fbem-25594	51	56	tazobactam	tazobactam	NOUN
fbem-25594	51	57	sodium	sodium	NOUN
fbem-25594	51	58	for	for	ADP
fbem-25594	51	59	injection	injection	NOUN
fbem-25594	51	60	,	,	PUNCT
fbem-25594	51	61	20	20	NUM
fbem-25594	51	62	clinical	clinical	ADJ
fbem-25594	51	63	approvals	approval	NOUN
fbem-25594	51	64	of	of	ADP
fbem-25594	51	65	pifenidone	pifenidone	NOUN
fbem-25594	51	66	solution	solution	NOUN
fbem-25594	51	67	for	for	ADP
fbem-25594	51	68	inhalation	inhalation	NOUN
fbem-25594	51	69	;	;	PUNCT
fbem-25594	51	70	20	20	NUM
fbem-25594	51	71	newly	newly	ADV
fbem-25594	51	72	authorized	authorize	VERB
fbem-25594	51	73	patents	patent	NOUN
fbem-25594	51	74	,	,	PUNCT
fbem-25594	51	75	including	include	VERB
fbem-25594	51	76	11	11	NUM
fbem-25594	51	77	invention	invention	NOUN
fbem-25594	51	78	patents	patent	NOUN
fbem-25594	51	79	;	;	PUNCT
fbem-25594	51	80	2.2	2.2	NUM
fbem-25594	51	81	.	.	PUNCT
fbem-25594	52	1	key	key	ADJ
fbem-25594	52	2	areas	area	NOUN
fbem-25594	52	3	of	of	ADP
fbem-25594	52	4	innovation	innovation	NOUN
fbem-25594	52	5	conba	conba	NOUN
fbem-25594	52	6	core	core	NOUN
fbem-25594	52	7	product	product	NOUN
fbem-25594	52	8	enteritis	enteritis	NOUN
fbem-25594	52	9	ning	ning	PROPN
fbem-25594	52	10	series	series	PROPN
fbem-25594	52	11	is	be	AUX
fbem-25594	52	12	mainly	mainly	ADV
fbem-25594	52	13	for	for	ADP
fbem-25594	52	14	stool	stool	NOUN
fbem-25594	52	15	diarrhea	diarrhea	NOUN
fbem-25594	52	16	,	,	PUNCT
fbem-25594	52	17	abdominal	abdominal	ADJ
fbem-25594	52	18	pain	pain	NOUN
fbem-25594	52	19	and	and	CCONJ
fbem-25594	52	20	abdominal	abdominal	ADJ
fbem-25594	52	21	distension	distension	NOUN
fbem-25594	52	22	,	,	PUNCT
fbem-25594	52	23	indigestion	indigestion	NOUN
fbem-25594	52	24	and	and	CCONJ
fbem-25594	52	25	other	other	ADJ
fbem-25594	52	26	symptoms	symptom	NOUN
fbem-25594	52	27	,	,	PUNCT
fbem-25594	52	28	has	have	VERB
fbem-25594	52	29	the	the	DET
fbem-25594	52	30	effect	effect	NOUN
fbem-25594	52	31	of	of	ADP
fbem-25594	52	32	clearing	clear	VERB
fbem-25594	52	33	heat	heat	NOUN
fbem-25594	52	34	and	and	CCONJ
fbem-25594	52	35	dampness	dampness	NOUN
fbem-25594	52	36	,	,	PUNCT
fbem-25594	52	37	can	can	AUX
fbem-25594	52	38	reduce	reduce	VERB
fbem-25594	52	39	acute	acute	ADJ
fbem-25594	52	40	and	and	CCONJ
fbem-25594	52	41	chronic	chronic	ADJ
fbem-25594	52	42	gastroenteritis	gastroenteritis	NOUN
fbem-25594	52	43	.	.	PUNCT
fbem-25594	53	1	according	accord	VERB
fbem-25594	53	2	to	to	ADP
fbem-25594	53	3	the	the	DET
fbem-25594	53	4	latest	late	ADJ
fbem-25594	53	5	annual	annual	ADJ
fbem-25594	53	6	report	report	NOUN
fbem-25594	53	7	of	of	ADP
fbem-25594	53	8	conba	conba	NOUN
fbem-25594	53	9	company	company	NOUN
fbem-25594	53	10	in	in	ADP
fbem-25594	53	11	2023	2023	NUM
fbem-25594	53	12	,	,	PUNCT
fbem-25594	53	13	the	the	DET
fbem-25594	53	14	sales	sale	NOUN
fbem-25594	53	15	revenue	revenue	NOUN
fbem-25594	53	16	is	be	AUX
fbem-25594	53	17	nearly	nearly	ADV
fbem-25594	53	18	1.3	1.3	NUM
fbem-25594	53	19	billion	billion	NUM
fbem-25594	53	20	yuan	yuan	NOUN
fbem-25594	53	21	,	,	PUNCT
fbem-25594	53	22	and	and	CCONJ
fbem-25594	53	23	the	the	DET
fbem-25594	53	24	brand	brand	NOUN
fbem-25594	53	25	of	of	ADP
fbem-25594	53	26	chinese	chinese	ADJ
fbem-25594	53	27	patent	patent	NOUN
fbem-25594	53	28	medicine	medicine	NOUN
fbem-25594	53	29	in	in	ADP
fbem-25594	53	30	the	the	DET
fbem-25594	53	31	digestive	digestive	ADJ
fbem-25594	53	32	system	system	NOUN
fbem-25594	53	33	of	of	ADP
fbem-25594	53	34	physical	physical	ADJ
fbem-25594	53	35	drugstores	drugstore	NOUN
fbem-25594	53	36	ranks	rank	VERB
fbem-25594	53	37	the	the	DET
fbem-25594	53	38	third	third	ADJ
fbem-25594	53	39	,	,	PUNCT
fbem-25594	53	40	accounting	account	VERB
fbem-25594	53	41	for	for	ADP
fbem-25594	53	42	8.18	8.18	NUM
fbem-25594	53	43	%	%	NOUN
fbem-25594	53	44	of	of	ADP
fbem-25594	53	45	the	the	DET
fbem-25594	53	46	market	market	NOUN
fbem-25594	53	47	share	share	NOUN
fbem-25594	53	48	.	.	PUNCT
fbem-25594	54	1	in	in	ADP
fbem-25594	54	2	terms	term	NOUN
fbem-25594	54	3	of	of	ADP
fbem-25594	54	4	specialty	specialty	NOUN
fbem-25594	54	5	chemical	chemical	NOUN
fbem-25594	54	6	drug	drug	NOUN
fbem-25594	54	7	business	business	NOUN
fbem-25594	54	8	,	,	PUNCT
fbem-25594	54	9	the	the	DET
fbem-25594	54	10	sales	sale	NOUN
fbem-25594	54	11	revenue	revenue	NOUN
fbem-25594	54	12	of	of	ADP
fbem-25594	54	13	"	"	PUNCT
fbem-25594	54	14	jinkang	jinkang	PROPN
fbem-25594	54	15	suli	suli	PROPN
fbem-25594	54	16	"	"	PUNCT
fbem-25594	54	17	brand	brand	NOUN
fbem-25594	54	18	acetylcysteine	acetylcysteine	VERB
fbem-25594	54	19	effervescent	effervescent	ADJ
fbem-25594	54	20	tablets	tablet	NOUN
fbem-25594	54	21	increased	increase	VERB
fbem-25594	54	22	by	by	ADP
fbem-25594	54	23	16	16	NUM
fbem-25594	54	24	%	%	NOUN
fbem-25594	54	25	year	year	NOUN
fbem-25594	54	26	on	on	ADP
fbem-25594	54	27	year	year	NOUN
fbem-25594	54	28	in	in	ADP
fbem-25594	54	29	2023	2023	NUM
fbem-25594	54	30	,	,	PUNCT
fbem-25594	54	31	while	while	SCONJ
fbem-25594	54	32	the	the	DET
fbem-25594	54	33	sales	sale	NOUN
fbem-25594	54	34	revenue	revenue	NOUN
fbem-25594	54	35	of	of	ADP
fbem-25594	54	36	"	"	PUNCT
fbem-25594	54	37	jinkang	jinkang	PROPN
fbem-25594	54	38	lingli	lingli	NOUN
fbem-25594	54	39	"	"	PUNCT
fbem-25594	54	40	brand	brand	NOUN
fbem-25594	54	41	galantamine	galantamine	NOUN
fbem-25594	54	42	tablets	tablet	NOUN
fbem-25594	54	43	(	(	PUNCT
fbem-25594	54	44	for	for	ADP
fbem-25594	54	45	the	the	DET
fbem-25594	54	46	treatment	treatment	NOUN
fbem-25594	54	47	of	of	ADP
fbem-25594	54	48	mild	mild	ADJ
fbem-25594	54	49	to	to	ADP
fbem-25594	54	50	moderate	moderate	ADJ
fbem-25594	54	51	alzheimer	alzheimer	NOUN
fbem-25594	54	52	dementia	dementia	NOUN
fbem-25594	54	53	symptoms	symptom	NOUN
fbem-25594	54	54	)	)	PUNCT
fbem-25594	54	55	increased	increase	VERB
fbem-25594	54	56	by	by	ADP
fbem-25594	54	57	55	55	NUM
fbem-25594	54	58	%	%	NOUN
fbem-25594	54	59	year	year	NOUN
fbem-25594	54	60	on	on	ADP
fbem-25594	54	61	year	year	NOUN
fbem-25594	54	62	.	.	PUNCT
fbem-25594	55	1	in	in	ADP
fbem-25594	55	2	2023	2023	NUM
fbem-25594	55	3	,	,	PUNCT
fbem-25594	55	4	the	the	DET
fbem-25594	55	5	revenue	revenue	NOUN
fbem-25594	55	6	of	of	ADP
fbem-25594	55	7	featured	feature	VERB
fbem-25594	55	8	health	health	NOUN
fbem-25594	55	9	consumer	consumer	NOUN
fbem-25594	55	10	goods	good	NOUN
fbem-25594	55	11	business	business	NOUN
fbem-25594	55	12	reached	reach	VERB
fbem-25594	55	13	580	580	NUM
fbem-25594	55	14	million	million	NUM
fbem-25594	55	15	yuan	yuan	NOUN
fbem-25594	55	16	,	,	PUNCT
fbem-25594	55	17	among	among	ADP
fbem-25594	55	18	which	which	PRON
fbem-25594	55	19	the	the	DET
fbem-25594	55	20	sales	sale	NOUN
fbem-25594	55	21	revenue	revenue	NOUN
fbem-25594	55	22	of	of	ADP
fbem-25594	55	23	"	"	PUNCT
fbem-25594	55	24	conba	conba	NOUN
fbem-25594	55	25	"	"	PUNCT
fbem-25594	55	26	brand	brand	NOUN
fbem-25594	55	27	health	health	NOUN
fbem-25594	55	28	food	food	NOUN
fbem-25594	55	29	reached	reach	VERB
fbem-25594	55	30	570	570	NUM
fbem-25594	55	31	million	million	NUM
fbem-25594	55	32	yuan	yuan	NOUN
fbem-25594	55	33	,	,	PUNCT
fbem-25594	55	34	up	up	ADV
fbem-25594	55	35	23	23	NUM
fbem-25594	55	36	%	%	NOUN
fbem-25594	55	37	year	year	NOUN
fbem-25594	55	38	on	on	ADP
fbem-25594	55	39	year	year	NOUN
fbem-25594	55	40	.	.	PUNCT
fbem-25594	56	1	with	with	ADP
fbem-25594	56	2	the	the	DET
fbem-25594	56	3	development	development	NOUN
fbem-25594	56	4	of	of	ADP
fbem-25594	56	5	the	the	DET
fbem-25594	56	6	company	company	NOUN
fbem-25594	56	7	's	's	PART
fbem-25594	56	8	key	key	ADJ
fbem-25594	56	9	varieties	variety	NOUN
fbem-25594	56	10	of	of	ADP
fbem-25594	56	11	characteristic	characteristic	ADJ
fbem-25594	56	12	drugs	drug	NOUN
fbem-25594	56	13	,	,	PUNCT
fbem-25594	56	14	the	the	DET
fbem-25594	56	15	sales	sale	NOUN
fbem-25594	56	16	penetration	penetration	NOUN
fbem-25594	56	17	and	and	CCONJ
fbem-25594	56	18	production	production	NOUN
fbem-25594	56	19	transformation	transformation	NOUN
fbem-25594	56	20	of	of	ADP
fbem-25594	56	21	characteristic	characteristic	ADJ
fbem-25594	56	22	health	health	NOUN
fbem-25594	56	23	consumption	consumption	NOUN
fbem-25594	56	24	,	,	PUNCT
fbem-25594	56	25	the	the	DET
fbem-25594	56	26	characteristic	characteristic	ADJ
fbem-25594	56	27	chemical	chemical	NOUN
fbem-25594	56	28	drugs	drug	NOUN
fbem-25594	56	29	and	and	CCONJ
fbem-25594	56	30	characteristic	characteristic	ADJ
fbem-25594	56	31	health	health	NOUN
fbem-25594	56	32	consumer	consumer	NOUN
fbem-25594	56	33	goods	good	NOUN
fbem-25594	56	34	are	be	AUX
fbem-25594	56	35	expected	expect	VERB
fbem-25594	56	36	to	to	PART
fbem-25594	56	37	create	create	VERB
fbem-25594	56	38	a	a	DET
fbem-25594	56	39	second	second	ADJ
fbem-25594	56	40	growth	growth	NOUN
fbem-25594	56	41	curve	curve	NOUN
fbem-25594	56	42	for	for	ADP
fbem-25594	56	43	the	the	DET
fbem-25594	56	44	company	company	NOUN
fbem-25594	56	45	in	in	ADP
fbem-25594	56	46	the	the	DET
fbem-25594	56	47	future	future	NOUN
fbem-25594	56	48	.	.	PUNCT
fbem-25594	57	1	3	3	X
fbem-25594	57	2	.	.	X
fbem-25594	57	3	performance	performance	NOUN
fbem-25594	57	4	analysis	analysis	NOUN
fbem-25594	57	5	from	from	ADP
fbem-25594	57	6	2019	2019	NUM
fbem-25594	57	7	to	to	ADP
fbem-25594	57	8	the	the	DET
fbem-25594	57	9	first	first	ADJ
fbem-25594	57	10	quarter	quarter	NOUN
fbem-25594	57	11	of	of	ADP
fbem-25594	57	12	2024	2024	NUM
fbem-25594	57	13	,	,	PUNCT
fbem-25594	57	14	conba	conba	NOUN
fbem-25594	57	15	's	's	PART
fbem-25594	57	16	net	net	ADJ
fbem-25594	57	17	profit	profit	NOUN
fbem-25594	57	18	fluctuated	fluctuate	VERB
fbem-25594	57	19	.	.	PUNCT
fbem-25594	58	1	net	net	ADJ
fbem-25594	58	2	profit	profit	NOUN
fbem-25594	58	3	increased	increase	VERB
fbem-25594	58	4	significantly	significantly	ADV
fbem-25594	58	5	in	in	ADP
fbem-25594	58	6	2020	2020	NUM
fbem-25594	58	7	and	and	CCONJ
fbem-25594	58	8	2021	2021	NUM
fbem-25594	58	9	,	,	PUNCT
fbem-25594	58	10	and	and	CCONJ
fbem-25594	58	11	then	then	ADV
fbem-25594	58	12	remained	remain	VERB
fbem-25594	58	13	stable	stable	ADJ
fbem-25594	58	14	in	in	ADP
fbem-25594	58	15	2022	2022	NUM
fbem-25594	58	16	and	and	CCONJ
fbem-25594	58	17	2023	2023	NUM
fbem-25594	58	18	,	,	PUNCT
fbem-25594	58	19	but	but	CCONJ
fbem-25594	58	20	declined	decline	VERB
fbem-25594	58	21	in	in	ADP
fbem-25594	58	22	the	the	DET
fbem-25594	58	23	first	first	ADJ
fbem-25594	58	24	quarter	quarter	NOUN
fbem-25594	58	25	of	of	ADP
fbem-25594	58	26	2024	2024	NUM
fbem-25594	58	27	.	.	PUNCT
fbem-25594	59	1	the	the	DET
fbem-25594	59	2	core	core	NOUN
fbem-25594	59	3	business	business	NOUN
fbem-25594	59	4	of	of	ADP
fbem-25594	59	5	the	the	DET
fbem-25594	59	6	company	company	NOUN
fbem-25594	59	7	's	's	PART
fbem-25594	59	8	traditional	traditional	ADJ
fbem-25594	59	9	chinese	chinese	ADJ
fbem-25594	59	10	medicine	medicine	NOUN
fbem-25594	59	11	health	health	NOUN
fbem-25594	59	12	has	have	AUX
fbem-25594	59	13	accelerated	accelerate	VERB
fbem-25594	59	14	its	its	PRON
fbem-25594	59	15	development	development	NOUN
fbem-25594	59	16	,	,	PUNCT
fbem-25594	59	17	and	and	CCONJ
fbem-25594	59	18	the	the	DET
fbem-25594	59	19	proportion	proportion	NOUN
fbem-25594	59	20	of	of	ADP
fbem-25594	59	21	revenue	revenue	NOUN
fbem-25594	59	22	in	in	ADP
fbem-25594	59	23	the	the	DET
fbem-25594	59	24	company	company	NOUN
fbem-25594	59	25	's	's	PART
fbem-25594	59	26	total	total	ADJ
fbem-25594	59	27	revenue	revenue	NOUN
fbem-25594	59	28	has	have	AUX
fbem-25594	59	29	further	far	ADV
fbem-25594	59	30	increased	increase	VERB
fbem-25594	59	31	.	.	PUNCT
fbem-25594	60	1	in	in	ADP
fbem-25594	60	2	2023	2023	NUM
fbem-25594	60	3	,	,	PUNCT
fbem-25594	60	4	the	the	DET
fbem-25594	60	5	revenue	revenue	NOUN
fbem-25594	60	6	of	of	ADP
fbem-25594	60	7	the	the	DET
fbem-25594	60	8	company	company	NOUN
fbem-25594	60	9	's	's	PART
fbem-25594	60	10	traditional	traditional	ADJ
fbem-25594	60	11	chinese	chinese	ADJ
fbem-25594	60	12	medicine	medicine	PROPN
fbem-25594	60	13	health	health	NOUN
fbem-25594	60	14	business	business	NOUN
fbem-25594	60	15	reached	reach	VERB
fbem-25594	60	16	4.544	4.544	NUM
fbem-25594	60	17	billion	billion	NUM
fbem-25594	60	18	yuan	yuan	NOUN
fbem-25594	60	19	,	,	PUNCT
fbem-25594	60	20	an	an	DET
fbem-25594	60	21	increase	increase	NOUN
fbem-25594	60	22	of	of	ADP
fbem-25594	60	23	16.13	16.13	NUM
fbem-25594	60	24	%	%	NOUN
fbem-25594	60	25	over	over	ADP
fbem-25594	60	26	the	the	DET
fbem-25594	60	27	202	202	NUM
fbem-25594	60	28	previous	previous	ADJ
fbem-25594	60	29	year	year	NOUN
fbem-25594	60	30	,	,	PUNCT
fbem-25594	60	31	accounting	account	VERB
fbem-25594	60	32	for	for	ADP
fbem-25594	60	33	67.49	67.49	NUM
fbem-25594	60	34	%	%	NOUN
fbem-25594	60	35	of	of	ADP
fbem-25594	60	36	the	the	DET
fbem-25594	60	37	company	company	NOUN
fbem-25594	60	38	's	's	PART
fbem-25594	60	39	total	total	ADJ
fbem-25594	60	40	revenue	revenue	NOUN
fbem-25594	60	41	,	,	PUNCT
fbem-25594	60	42	an	an	DET
fbem-25594	60	43	increase	increase	NOUN
fbem-25594	60	44	of	of	ADP
fbem-25594	60	45	2.28	2.28	NUM
fbem-25594	60	46	percentage	percentage	NOUN
fbem-25594	60	47	points	point	NOUN
fbem-25594	60	48	over	over	ADP
fbem-25594	60	49	the	the	DET
fbem-25594	60	50	previous	previous	ADJ
fbem-25594	60	51	year	year	NOUN
fbem-25594	60	52	.	.	PUNCT
fbem-25594	61	1	the	the	DET
fbem-25594	61	2	company	company	NOUN
fbem-25594	61	3	's	's	PART
fbem-25594	61	4	business	business	NOUN
fbem-25594	61	5	structure	structure	NOUN
fbem-25594	61	6	continues	continue	VERB
fbem-25594	61	7	to	to	PART
fbem-25594	61	8	optimize	optimize	VERB
fbem-25594	61	9	,	,	PUNCT
fbem-25594	61	10	and	and	CCONJ
fbem-25594	61	11	the	the	DET
fbem-25594	61	12	core	core	NOUN
fbem-25594	61	13	business	business	NOUN
fbem-25594	61	14	is	be	AUX
fbem-25594	61	15	further	far	ADV
fbem-25594	61	16	strengthened	strengthen	VERB
fbem-25594	61	17	.	.	PUNCT
fbem-25594	62	1	in	in	ADP
fbem-25594	62	2	2023	2023	NUM
fbem-25594	62	3	,	,	PUNCT
fbem-25594	62	4	the	the	DET
fbem-25594	62	5	revenue	revenue	NOUN
fbem-25594	62	6	of	of	ADP
fbem-25594	62	7	all	all	DET
fbem-25594	62	8	traditional	traditional	ADJ
fbem-25594	62	9	chinese	chinese	ADJ
fbem-25594	62	10	medicine	medicine	NOUN
fbem-25594	62	11	business	business	NOUN
fbem-25594	62	12	was	be	AUX
fbem-25594	62	13	3.625	3.625	NUM
fbem-25594	62	14	billion	billion	NUM
fbem-25594	62	15	yuan	yuan	NOUN
fbem-25594	62	16	,	,	PUNCT
fbem-25594	62	17	up	up	ADV
fbem-25594	62	18	16.60	16.60	NUM
fbem-25594	62	19	%	%	NOUN
fbem-25594	62	20	year	year	NOUN
fbem-25594	62	21	on	on	ADP
fbem-25594	62	22	year	year	NOUN
fbem-25594	62	23	;	;	PUNCT
fbem-25594	62	24	2.391	2.391	NUM
fbem-25594	62	25	billion	billion	NUM
fbem-25594	62	26	yuan	yuan	NOUN
fbem-25594	62	27	,	,	PUNCT
fbem-25594	62	28	up	up	ADV
fbem-25594	62	29	2.98	2.98	NUM
fbem-25594	62	30	%	%	NOUN
fbem-25594	62	31	year	year	NOUN
fbem-25594	62	32	on	on	ADP
fbem-25594	62	33	year	year	NOUN
fbem-25594	62	34	;	;	PUNCT
fbem-25594	62	35	featured	feature	VERB
fbem-25594	62	36	health	health	NOUN
fbem-25594	62	37	consumer	consumer	NOUN
fbem-25594	62	38	goods	good	NOUN
fbem-25594	62	39	business	business	NOUN
fbem-25594	62	40	was	be	AUX
fbem-25594	62	41	580	580	NUM
fbem-25594	62	42	million	million	NUM
fbem-25594	62	43	yuan	yuan	NOUN
fbem-25594	62	44	,	,	PUNCT
fbem-25594	62	45	up	up	ADV
fbem-25594	62	46	21.28	21.28	NUM
fbem-25594	62	47	%	%	NOUN
fbem-25594	62	48	year	year	NOUN
fbem-25594	62	49	on	on	ADP
fbem-25594	62	50	year	year	NOUN
fbem-25594	62	51	.	.	PUNCT
fbem-25594	63	1	the	the	DET
fbem-25594	63	2	fluctuation	fluctuation	NOUN
fbem-25594	63	3	in	in	ADP
fbem-25594	63	4	net	net	ADJ
fbem-25594	63	5	profit	profit	NOUN
fbem-25594	63	6	may	may	AUX
fbem-25594	63	7	be	be	AUX
fbem-25594	63	8	related	relate	VERB
fbem-25594	63	9	to	to	ADP
fbem-25594	63	10	the	the	DET
fbem-25594	63	11	company	company	NOUN
fbem-25594	63	12	's	's	PART
fbem-25594	63	13	sales	sale	NOUN
fbem-25594	63	14	revenue	revenue	NOUN
fbem-25594	63	15	,	,	PUNCT
fbem-25594	63	16	cost	cost	NOUN
fbem-25594	63	17	control	control	NOUN
fbem-25594	63	18	and	and	CCONJ
fbem-25594	63	19	expense	expense	NOUN
fbem-25594	63	20	management	management	NOUN
fbem-25594	63	21	.	.	PUNCT
fbem-25594	64	1	the	the	DET
fbem-25594	64	2	increase	increase	NOUN
fbem-25594	64	3	in	in	ADP
fbem-25594	64	4	net	net	ADJ
fbem-25594	64	5	profit	profit	NOUN
fbem-25594	64	6	in	in	ADP
fbem-25594	64	7	2020	2020	NUM
fbem-25594	64	8	and	and	CCONJ
fbem-25594	64	9	2021	2021	NUM
fbem-25594	64	10	reflects	reflect	VERB
fbem-25594	64	11	the	the	DET
fbem-25594	64	12	improvement	improvement	NOUN
fbem-25594	64	13	of	of	ADP
fbem-25594	64	14	the	the	DET
fbem-25594	64	15	company	company	NOUN
fbem-25594	64	16	's	's	PART
fbem-25594	64	17	operations	operation	NOUN
fbem-25594	64	18	and	and	CCONJ
fbem-25594	64	19	the	the	DET
fbem-25594	64	20	increased	increase	VERB
fbem-25594	64	21	market	market	NOUN
fbem-25594	64	22	demand	demand	NOUN
fbem-25594	64	23	.	.	PUNCT
fbem-25594	65	1	among	among	ADP
fbem-25594	65	2	them	they	PRON
fbem-25594	65	3	,	,	PUNCT
fbem-25594	65	4	the	the	DET
fbem-25594	65	5	price	price	NOUN
fbem-25594	65	6	fluctuation	fluctuation	NOUN
fbem-25594	65	7	of	of	ADP
fbem-25594	65	8	production	production	NOUN
fbem-25594	65	9	raw	raw	ADJ
fbem-25594	65	10	materials	material	NOUN
fbem-25594	65	11	in	in	ADP
fbem-25594	65	12	recent	recent	ADJ
fbem-25594	65	13	years	year	NOUN
fbem-25594	65	14	also	also	ADV
fbem-25594	65	15	has	have	VERB
fbem-25594	65	16	a	a	DET
fbem-25594	65	17	great	great	ADJ
fbem-25594	65	18	influence	influence	NOUN
fbem-25594	65	19	on	on	ADP
fbem-25594	65	20	the	the	DET
fbem-25594	65	21	operating	operate	VERB
fbem-25594	65	22	profit	profit	NOUN
fbem-25594	65	23	of	of	ADP
fbem-25594	65	24	comham	comham	PROPN
fbem-25594	65	25	company	company	NOUN
fbem-25594	65	26	.	.	PUNCT
fbem-25594	66	1	although	although	SCONJ
fbem-25594	66	2	,	,	PUNCT
fbem-25594	66	3	comham	comham	PROPN
fbem-25594	66	4	has	have	VERB
fbem-25594	66	5	a	a	DET
fbem-25594	66	6	relatively	relatively	ADV
fbem-25594	66	7	complete	complete	ADJ
fbem-25594	66	8	industrial	industrial	ADJ
fbem-25594	66	9	chain	chain	NOUN
fbem-25594	66	10	in	in	ADP
fbem-25594	66	11	the	the	DET
fbem-25594	66	12	chinese	chinese	ADJ
fbem-25594	66	13	medicine	medicine	NOUN
fbem-25594	66	14	industry	industry	NOUN
fbem-25594	66	15	,	,	PUNCT
fbem-25594	66	16	and	and	CCONJ
fbem-25594	66	17	has	have	AUX
fbem-25594	66	18	built	build	VERB
fbem-25594	66	19	chinese	chinese	ADJ
fbem-25594	66	20	herbal	herbal	ADJ
fbem-25594	66	21	medicine	medicine	NOUN
fbem-25594	66	22	planting	planting	NOUN
fbem-25594	66	23	base	base	NOUN
fbem-25594	66	24	through	through	ADP
fbem-25594	66	25	self	self	NOUN
fbem-25594	66	26	-	-	PUNCT
fbem-25594	66	27	built	build	VERB
fbem-25594	66	28	and	and	CCONJ
fbem-25594	66	29	cooperation	cooperation	NOUN
fbem-25594	66	30	with	with	ADP
fbem-25594	66	31	other	other	ADJ
fbem-25594	66	32	units	unit	NOUN
fbem-25594	66	33	,	,	PUNCT
fbem-25594	66	34	including	include	VERB
fbem-25594	66	35	salvia	salvia	NOUN
fbem-25594	66	36	miltiorrhiza	miltiorrhiza	ADJ
fbem-25594	66	37	,	,	PUNCT
fbem-25594	66	38	ginkgo	ginkgo	NOUN
fbem-25594	66	39	biloba	biloba	NOUN
fbem-25594	66	40	,	,	PUNCT
fbem-25594	66	41	scutellaria	scutellaria	NOUN
fbem-25594	66	42	baicalensis	baicalensis	NOUN
fbem-25594	66	43	,	,	PUNCT
fbem-25594	66	44	houttuynia	houttuynia	NOUN
fbem-25594	66	45	,	,	PUNCT
fbem-25594	66	46	forsythia	forsythia	NOUN
fbem-25594	66	47	,	,	PUNCT
fbem-25594	66	48	summer	summer	NOUN
fbem-25594	66	49	none	none	NOUN
fbem-25594	66	50	,	,	PUNCT
fbem-25594	66	51	honeysuckle	honeysuckle	NOUN
fbem-25594	66	52	and	and	CCONJ
fbem-25594	66	53	breeding	breeding	NOUN
fbem-25594	66	54	,	,	PUNCT
fbem-25594	66	55	etc	etc	X
fbem-25594	66	56	.	.	X
fbem-25594	66	57	;	;	PUNCT
fbem-25594	66	58	but	but	CCONJ
fbem-25594	66	59	it	it	PRON
fbem-25594	66	60	is	be	AUX
fbem-25594	66	61	still	still	ADV
fbem-25594	66	62	affected	affect	VERB
fbem-25594	66	63	by	by	ADP
fbem-25594	66	64	external	external	ADJ
fbem-25594	66	65	price	price	NOUN
fbem-25594	66	66	fluctuations	fluctuation	NOUN
fbem-25594	66	67	.	.	PUNCT
fbem-25594	67	1	figure	figure	VERB
fbem-25594	67	2	1	1	NUM
fbem-25594	67	3	.	.	PUNCT
fbem-25594	68	1	comba	comba	PROPN
fbem-25594	68	2	pharmaceutical	pharmaceutical	PROPN
fbem-25594	68	3	2019	2019	NUM
fbem-25594	68	4	-	-	SYM
fbem-25594	68	5	2024	2024	NUM
fbem-25594	68	6	q1	q1	PROPN
fbem-25594	68	7	profit	profit	NOUN
fbem-25594	68	8	operating	operating	NOUN
fbem-25594	68	9	change	change	NOUN
fbem-25594	68	10	from	from	ADP
fbem-25594	68	11	the	the	DET
fbem-25594	68	12	first	first	ADJ
fbem-25594	68	13	quarter	quarter	NOUN
fbem-25594	68	14	of	of	ADP
fbem-25594	68	15	2020	2020	NUM
fbem-25594	68	16	to	to	ADP
fbem-25594	68	17	the	the	DET
fbem-25594	68	18	first	first	ADJ
fbem-25594	68	19	quarter	quarter	NOUN
fbem-25594	68	20	of	of	ADP
fbem-25594	68	21	2024	2024	NUM
fbem-25594	68	22	,	,	PUNCT
fbem-25594	68	23	the	the	DET
fbem-25594	68	24	net	net	ADJ
fbem-25594	68	25	profit	profit	NOUN
fbem-25594	68	26	showed	show	VERB
fbem-25594	68	27	large	large	ADJ
fbem-25594	68	28	fluctuations	fluctuation	NOUN
fbem-25594	68	29	.	.	PUNCT
fbem-25594	69	1	the	the	DET
fbem-25594	69	2	loss	loss	NOUN
fbem-25594	69	3	began	begin	VERB
fbem-25594	69	4	in	in	ADP
fbem-25594	69	5	the	the	DET
fbem-25594	69	6	first	first	ADJ
fbem-25594	69	7	quarter	quarter	NOUN
fbem-25594	69	8	of	of	ADP
fbem-25594	69	9	2020	2020	NUM
fbem-25594	69	10	,	,	PUNCT
fbem-25594	69	11	and	and	CCONJ
fbem-25594	69	12	then	then	ADV
fbem-25594	69	13	gradually	gradually	ADV
fbem-25594	69	14	recovered	recover	VERB
fbem-25594	69	15	and	and	CCONJ
fbem-25594	69	16	peaked	peak	VERB
fbem-25594	69	17	in	in	ADP
fbem-25594	69	18	the	the	DET
fbem-25594	69	19	first	first	ADJ
fbem-25594	69	20	quarter	quarter	NOUN
fbem-25594	69	21	of	of	ADP
fbem-25594	69	22	2021	2021	NUM
fbem-25594	69	23	.	.	PUNCT
fbem-25594	70	1	after	after	ADP
fbem-25594	70	2	that	that	PRON
fbem-25594	70	3	,	,	PUNCT
fbem-25594	70	4	net	net	ADJ
fbem-25594	70	5	profit	profit	NOUN
fbem-25594	70	6	fluctuated	fluctuate	VERB
fbem-25594	70	7	again	again	ADV
fbem-25594	70	8	,	,	PUNCT
fbem-25594	70	9	reaching	reach	VERB
fbem-25594	70	10	its	its	PRON
fbem-25594	70	11	lowest	low	ADJ
fbem-25594	70	12	point	point	NOUN
fbem-25594	70	13	in	in	ADP
fbem-25594	70	14	the	the	DET
fbem-25594	70	15	third	third	ADJ
fbem-25594	70	16	quarter	quarter	NOUN
fbem-25594	70	17	of	of	ADP
fbem-25594	70	18	2022	2022	NUM
fbem-25594	70	19	,	,	PUNCT
fbem-25594	70	20	and	and	CCONJ
fbem-25594	70	21	then	then	ADV
fbem-25594	70	22	gradually	gradually	ADV
fbem-25594	70	23	recovering	recover	VERB
fbem-25594	70	24	.	.	PUNCT
fbem-25594	71	1	in	in	ADP
fbem-25594	71	2	the	the	DET
fbem-25594	71	3	first	first	ADJ
fbem-25594	71	4	quarter	quarter	NOUN
fbem-25594	71	5	of	of	ADP
fbem-25594	71	6	2021	2021	NUM
fbem-25594	71	7	net	net	ADJ
fbem-25594	71	8	profit	profit	NOUN
fbem-25594	71	9	swings	swing	NOUN
fbem-25594	71	10	to	to	PART
fbem-25594	71	11	peak	peak	VERB
fbem-25594	71	12	related	relate	VERB
fbem-25594	71	13	to	to	ADP
fbem-25594	71	14	enterprise	enterprise	NOUN
fbem-25594	71	15	transformation	transformation	NOUN
fbem-25594	71	16	,	,	PUNCT
fbem-25594	71	17	the	the	DET
fbem-25594	71	18	company	company	NOUN
fbem-25594	71	19	stripped	strip	VERB
fbem-25594	71	20	a	a	DET
fbem-25594	71	21	lot	lot	NOUN
fbem-25594	71	22	of	of	ADP
fbem-25594	71	23	the	the	DET
fbem-25594	71	24	strategic	strategic	ADJ
fbem-25594	71	25	focus	focus	NOUN
fbem-25594	71	26	of	of	ADP
fbem-25594	71	27	assets	asset	NOUN
fbem-25594	71	28	to	to	PART
fbem-25594	71	29	focus	focus	VERB
fbem-25594	71	30	on	on	ADP
fbem-25594	71	31	research	research	NOUN
fbem-25594	71	32	and	and	CCONJ
fbem-25594	71	33	development	development	NOUN
fbem-25594	71	34	core	core	NOUN
fbem-25594	71	35	and	and	CCONJ
fbem-25594	71	36	new	new	ADJ
fbem-25594	71	37	development	development	NOUN
fbem-25594	71	38	industry	industry	NOUN
fbem-25594	71	39	,	,	PUNCT
fbem-25594	71	40	and	and	CCONJ
fbem-25594	71	41	the	the	DET
fbem-25594	71	42	transition	transition	NOUN
fbem-25594	71	43	of	of	ADP
fbem-25594	71	44	the	the	DET
fbem-25594	71	45	2022,2023	2022,2023	NUM
fbem-25594	71	46	the	the	DET
fbem-25594	71	47	company	company	NOUN
fbem-25594	71	48	's	's	PART
fbem-25594	71	49	overall	overall	ADJ
fbem-25594	71	50	profit	profit	NOUN
fbem-25594	71	51	level	level	NOUN
fbem-25594	71	52	has	have	VERB
fbem-25594	71	53	a	a	DET
fbem-25594	71	54	higher	high	ADJ
fbem-25594	71	55	degree	degree	NOUN
fbem-25594	71	56	of	of	ADP
fbem-25594	71	57	growth	growth	NOUN
fbem-25594	71	58	,	,	PUNCT
fbem-25594	71	59	back	back	ADV
fbem-25594	71	60	to	to	ADP
fbem-25594	71	61	the	the	DET
fbem-25594	71	62	transformation	transformation	NOUN
fbem-25594	71	63	before	before	ADP
fbem-25594	71	64	the	the	DET
fbem-25594	71	65	profit	profit	NOUN
fbem-25594	71	66	level	level	NOUN
fbem-25594	71	67	,	,	PUNCT
fbem-25594	71	68	but	but	CCONJ
fbem-25594	71	69	the	the	DET
fbem-25594	71	70	industry	industry	NOUN
fbem-25594	71	71	more	more	ADV
fbem-25594	71	72	concentrated	concentrated	ADJ
fbem-25594	71	73	than	than	ADP
fbem-25594	71	74	before	before	ADV
fbem-25594	71	75	.	.	PUNCT
fbem-25594	72	1	figure	figure	NOUN
fbem-25594	72	2	2	2	NUM
fbem-25594	72	3	.	.	PUNCT
fbem-25594	73	1	statement	statement	NOUN
fbem-25594	73	2	of	of	ADP
fbem-25594	73	3	change	change	NOUN
fbem-25594	73	4	in	in	ADP
fbem-25594	73	5	profit	profit	NOUN
fbem-25594	73	6	for	for	ADP
fbem-25594	73	7	conba	conba	NOUN
fbem-25594	73	8	pharmaceuticals	pharmaceutical	NOUN
fbem-25594	73	9	this	this	DET
fbem-25594	73	10	chart	chart	NOUN
fbem-25594	73	11	shows	show	VERB
fbem-25594	73	12	the	the	DET
fbem-25594	73	13	company	company	NOUN
fbem-25594	73	14	's	's	PART
fbem-25594	73	15	total	total	ADJ
fbem-25594	73	16	assets	asset	NOUN
fbem-25594	73	17	of	of	ADP
fbem-25594	73	18	[	[	X
fbem-25594	73	19	5	5	NUM
fbem-25594	73	20	]	]	PUNCT
fbem-25594	73	21	(	(	PUNCT
fbem-25594	73	22	in	in	ADP
fbem-25594	73	23	$	$	SYM
fbem-25594	73	24	100	100	NUM
fbem-25594	73	25	million	million	NUM
fbem-25594	73	26	)	)	PUNCT
fbem-25594	73	27	and	and	CCONJ
fbem-25594	73	28	return	return	VERB
fbem-25594	73	29	on	on	ADP
fbem-25594	73	30	capital	capital	NOUN
fbem-25594	73	31	(	(	PUNCT
fbem-25594	73	32	roe	roe	NOUN
fbem-25594	73	33	)	)	PUNCT
fbem-25594	73	34	from	from	ADP
fbem-25594	73	35	2019	2019	NUM
fbem-25594	73	36	to	to	ADP
fbem-25594	73	37	the	the	DET
fbem-25594	73	38	first	first	ADJ
fbem-25594	73	39	quarter	quarter	NOUN
fbem-25594	73	40	of	of	ADP
fbem-25594	73	41	2024	2024	NUM
fbem-25594	73	42	.	.	PUNCT
fbem-25594	74	1	between	between	ADP
fbem-25594	74	2	2019	2019	NUM
fbem-25594	74	3	and	and	CCONJ
fbem-25594	74	4	2020	2020	NUM
fbem-25594	74	5	,	,	PUNCT
fbem-25594	74	6	the	the	DET
fbem-25594	74	7	total	total	ADJ
fbem-25594	74	8	assets	asset	NOUN
fbem-25594	74	9	remained	remain	VERB
fbem-25594	74	10	relatively	relatively	ADV
fbem-25594	74	11	stable	stable	ADJ
fbem-25594	74	12	.	.	PUNCT
fbem-25594	75	1	in	in	ADP
fbem-25594	75	2	2021	2021	NUM
fbem-25594	75	3	,	,	PUNCT
fbem-25594	75	4	the	the	DET
fbem-25594	75	5	total	total	ADJ
fbem-25594	75	6	assets	asset	NOUN
fbem-25594	75	7	increased	increase	VERB
fbem-25594	75	8	significantly	significantly	ADV
fbem-25594	75	9	to	to	ADP
fbem-25594	75	10	nearly	nearly	ADV
fbem-25594	75	11	12	12	NUM
fbem-25594	75	12	billion	billion	NUM
fbem-25594	75	13	yuan	yuan	NOUN
fbem-25594	75	14	,	,	PUNCT
fbem-25594	75	15	indicating	indicate	VERB
fbem-25594	75	16	that	that	SCONJ
fbem-25594	75	17	(	(	PUNCT
fbem-25594	75	18	1,000,000,000.00	1,000,000,000.00	NUM
fbem-25594	75	19	)	)	PUNCT
fbem-25594	75	20	1,000,000,000.00	1,000,000,000.00	NUM
fbem-25594	75	21	2,000,000,000.00	2,000,000,000.00	NUM
fbem-25594	76	1	3,000,000,000.00	3,000,000,000.00	NUM
fbem-25594	76	2	4,000,000,000.00	4,000,000,000.00	NUM
fbem-25594	77	1	5,000,000,000.00	5,000,000,000.00	NUM
fbem-25594	78	1	6,000,000,000.00	6,000,000,000.00	NUM
fbem-25594	78	2	7,000,000,000.00	7,000,000,000.00	NUM
fbem-25594	78	3	8,000,000,000.00	8,000,000,000.00	PROPN
fbem-25594	78	4	2019	2019	NUM
fbem-25594	78	5	2020	2020	NUM
fbem-25594	78	6	2021	2021	NUM
fbem-25594	78	7	2022	2022	NUM
fbem-25594	78	8	2023	2023	NUM
fbem-25594	78	9	2024	2024	NUM
fbem-25594	78	10	q1	q1	PROPN
fbem-25594	78	11	comba	comba	NOUN
fbem-25594	78	12	pharmaceutical	pharmaceutical	PROPN
fbem-25594	78	13	2019	2019	NUM
fbem-25594	78	14	-	-	SYM
fbem-25594	78	15	2024	2024	NUM
fbem-25594	78	16	q1	q1	PROPN
fbem-25594	78	17	profit	profit	NOUN
fbem-25594	78	18	operating	operating	NOUN
fbem-25594	78	19	change	change	NOUN
fbem-25594	78	20	retained	retain	VERB
fbem-25594	78	21	profits	profit	NOUN
fbem-25594	78	22	gross	gross	ADJ
fbem-25594	78	23	revenue	revenue	NOUN
fbem-25594	78	24	selling	selling	NOUN
fbem-25594	78	25	expenses	expense	NOUN
fbem-25594	78	26	operating	operating	NOUN
fbem-25594	78	27	costs	cost	NOUN
fbem-25594	78	28	-200.00	-200.00	NOUN
fbem-25594	78	29	%	%	NOUN
fbem-25594	79	1	-100.00	-100.00	PROPN
fbem-25594	79	2	%	%	NOUN
fbem-25594	79	3	0.00	0.00	NUM
fbem-25594	79	4	%	%	NOUN
fbem-25594	79	5	100.00	100.00	NUM
fbem-25594	79	6	%	%	NOUN
fbem-25594	79	7	200.00	200.00	NUM
fbem-25594	79	8	%	%	NOUN
fbem-25594	79	9	300.00	300.00	NUM
fbem-25594	79	10	%	%	NOUN
fbem-25594	79	11	400.00	400.00	NUM
fbem-25594	79	12	%	%	NOUN
fbem-25594	79	13	-5	-5	NOUN
fbem-25594	79	14	0	0	NUM
fbem-25594	79	15	5	5	NUM
fbem-25594	79	16	10	10	NUM
fbem-25594	79	17	15	15	NUM
fbem-25594	79	18	20	20	NUM
fbem-25594	79	19	25	25	NUM
fbem-25594	79	20	statement	statement	NOUN
fbem-25594	79	21	of	of	ADP
fbem-25594	79	22	change	change	NOUN
fbem-25594	79	23	in	in	ADP
fbem-25594	79	24	profit	profit	NOUN
fbem-25594	79	25	for	for	ADP
fbem-25594	79	26	conba	conba	NOUN
fbem-25594	79	27	pharmaceuticals	pharmaceutical	NOUN
fbem-25594	79	28	net	net	ADJ
fbem-25594	79	29	profit	profit	NOUN
fbem-25594	79	30	(	(	PUNCT
fbem-25594	79	31	100	100	NUM
fbem-25594	79	32	million	million	NUM
fbem-25594	79	33	yuan	yuan	NOUN
fbem-25594	79	34	)	)	PUNCT
fbem-25594	79	35	）	）	PUNCT
fbem-25594	80	1	the	the	DET
fbem-25594	80	2	year	year	NOUN
fbem-25594	80	3	-	-	PUNCT
fbem-25594	80	4	on	on	ADP
fbem-25594	80	5	-	-	PUNCT
fbem-25594	80	6	year	year	NOUN
fbem-25594	80	7	growth	growth	NOUN
fbem-25594	80	8	rate(%	rate(%	NOUN
fbem-25594	80	9	)	)	PUNCT
fbem-25594	80	10	203	203	NUM
fbem-25594	80	11	conba	conba	NOUN
fbem-25594	80	12	acquired	acquire	VERB
fbem-25594	80	13	the	the	DET
fbem-25594	80	14	assets	asset	NOUN
fbem-25594	80	15	of	of	ADP
fbem-25594	80	16	core	core	NOUN
fbem-25594	80	17	industries	industry	NOUN
fbem-25594	80	18	on	on	ADP
fbem-25594	80	19	a	a	DET
fbem-25594	80	20	large	large	ADJ
fbem-25594	80	21	scale	scale	NOUN
fbem-25594	80	22	after	after	ADP
fbem-25594	80	23	the	the	DET
fbem-25594	80	24	stripping	stripping	NOUN
fbem-25594	80	25	of	of	ADP
fbem-25594	80	26	invalid	invalid	ADJ
fbem-25594	80	27	assets	asset	NOUN
fbem-25594	80	28	in	in	ADP
fbem-25594	80	29	2021	2021	NUM
fbem-25594	80	30	and	and	CCONJ
fbem-25594	80	31	expanded	expand	VERB
fbem-25594	80	32	the	the	DET
fbem-25594	80	33	production	production	NOUN
fbem-25594	80	34	scale	scale	NOUN
fbem-25594	80	35	.	.	PUNCT
fbem-25594	81	1	after	after	ADP
fbem-25594	81	2	2022	2022	NUM
fbem-25594	81	3	,	,	PUNCT
fbem-25594	81	4	the	the	DET
fbem-25594	81	5	total	total	ADJ
fbem-25594	81	6	operation	operation	NOUN
fbem-25594	81	7	declined	decline	VERB
fbem-25594	81	8	,	,	PUNCT
fbem-25594	81	9	but	but	CCONJ
fbem-25594	81	10	in	in	ADP
fbem-25594	81	11	2023	2023	NUM
fbem-25594	81	12	and	and	CCONJ
fbem-25594	81	13	2024	2024	NUM
fbem-25594	81	14	first	first	ADJ
fbem-25594	81	15	quarter	quarter	NOUN
fbem-25594	81	16	basically	basically	ADV
fbem-25594	81	17	returned	return	VERB
fbem-25594	81	18	to	to	ADP
fbem-25594	81	19	the	the	DET
fbem-25594	81	20	previous	previous	ADJ
fbem-25594	81	21	level	level	NOUN
fbem-25594	81	22	,	,	PUNCT
fbem-25594	81	23	stable	stable	ADJ
fbem-25594	81	24	at	at	ADP
fbem-25594	81	25	around	around	ADP
fbem-25594	81	26	10	10	NUM
fbem-25594	81	27	billion	billion	NUM
fbem-25594	81	28	yuan	yuan	NOUN
fbem-25594	81	29	.	.	PUNCT
fbem-25594	82	1	and	and	CCONJ
fbem-25594	82	2	return	return	VERB
fbem-25594	82	3	on	on	ADP
fbem-25594	82	4	assets	asset	NOUN
fbem-25594	82	5	,	,	PUNCT
fbem-25594	82	6	the	the	DET
fbem-25594	82	7	roe	roe	NOUN
fbem-25594	82	8	gradually	gradually	ADV
fbem-25594	82	9	declined	decline	VERB
fbem-25594	82	10	from	from	ADP
fbem-25594	82	11	2019	2019	NUM
fbem-25594	82	12	to	to	ADP
fbem-25594	82	13	2020	2020	NUM
fbem-25594	82	14	.	.	PUNCT
fbem-25594	83	1	in	in	ADP
fbem-25594	83	2	2021	2021	NUM
fbem-25594	83	3	,	,	PUNCT
fbem-25594	83	4	while	while	SCONJ
fbem-25594	83	5	the	the	DET
fbem-25594	83	6	total	total	ADJ
fbem-25594	83	7	assets	asset	NOUN
fbem-25594	83	8	peaked	peak	VERB
fbem-25594	83	9	,	,	PUNCT
fbem-25594	83	10	the	the	DET
fbem-25594	83	11	roe	roe	NOUN
fbem-25594	83	12	dropped	drop	VERB
fbem-25594	83	13	sharply	sharply	ADV
fbem-25594	83	14	below	below	ADP
fbem-25594	83	15	about	about	ADP
fbem-25594	83	16	10	10	NUM
fbem-25594	83	17	%	%	NOUN
fbem-25594	83	18	,	,	PUNCT
fbem-25594	83	19	and	and	CCONJ
fbem-25594	83	20	connbe	connbe	NOUN
fbem-25594	83	21	expanded	expand	VERB
fbem-25594	83	22	without	without	ADP
fbem-25594	83	23	improving	improve	VERB
fbem-25594	83	24	its	its	PRON
fbem-25594	83	25	capital	capital	NOUN
fbem-25594	83	26	efficiency	efficiency	NOUN
fbem-25594	83	27	or	or	CCONJ
fbem-25594	83	28	had	have	VERB
fbem-25594	83	29	large	large	ADJ
fbem-25594	83	30	capital	capital	NOUN
fbem-25594	83	31	expenditures	expenditure	NOUN
fbem-25594	83	32	.	.	PUNCT
fbem-25594	84	1	after	after	ADP
fbem-25594	84	2	2022	2022	NUM
fbem-25594	84	3	,	,	PUNCT
fbem-25594	84	4	roe	roe	PROPN
fbem-25594	84	5	began	begin	VERB
fbem-25594	84	6	to	to	PART
fbem-25594	84	7	recover	recover	VERB
fbem-25594	84	8	,	,	PUNCT
fbem-25594	84	9	indicating	indicate	VERB
fbem-25594	84	10	that	that	SCONJ
fbem-25594	84	11	the	the	DET
fbem-25594	84	12	company	company	NOUN
fbem-25594	84	13	began	begin	VERB
fbem-25594	84	14	to	to	PART
fbem-25594	84	15	improve	improve	VERB
fbem-25594	84	16	the	the	DET
fbem-25594	84	17	efficiency	efficiency	NOUN
fbem-25594	84	18	and	and	CCONJ
fbem-25594	84	19	profit	profit	NOUN
fbem-25594	84	20	margin	margin	NOUN
fbem-25594	84	21	of	of	ADP
fbem-25594	84	22	capital	capital	NOUN
fbem-25594	84	23	.	.	PUNCT
fbem-25594	85	1	although	although	SCONJ
fbem-25594	85	2	conba	conba	PROPN
fbem-25594	85	3	achieved	achieve	VERB
fbem-25594	85	4	gross	gross	ADJ
fbem-25594	85	5	operating	operating	NOUN
fbem-25594	85	6	volume	volume	NOUN
fbem-25594	85	7	growth	growth	NOUN
fbem-25594	85	8	in	in	ADP
fbem-25594	85	9	2021	2021	NUM
fbem-25594	85	10	,	,	PUNCT
fbem-25594	85	11	the	the	DET
fbem-25594	85	12	decline	decline	NOUN
fbem-25594	85	13	in	in	ADP
fbem-25594	85	14	roe	roe	NOUN
fbem-25594	85	15	indicates	indicate	VERB
fbem-25594	85	16	possible	possible	ADJ
fbem-25594	85	17	lower	low	ADJ
fbem-25594	85	18	profit	profit	NOUN
fbem-25594	85	19	margins	margin	NOUN
fbem-25594	85	20	or	or	CCONJ
fbem-25594	85	21	increased	increase	VERB
fbem-25594	85	22	cost	cost	NOUN
fbem-25594	85	23	of	of	ADP
fbem-25594	85	24	capital	capital	NOUN
fbem-25594	85	25	problems	problem	NOUN
fbem-25594	85	26	.	.	PUNCT
fbem-25594	86	1	the	the	DET
fbem-25594	86	2	rebound	rebound	NOUN
fbem-25594	86	3	in	in	ADP
fbem-25594	86	4	roe	roe	NOUN
fbem-25594	86	5	in	in	ADP
fbem-25594	86	6	subsequent	subsequent	ADJ
fbem-25594	86	7	years	year	NOUN
fbem-25594	86	8	means	mean	VERB
fbem-25594	86	9	that	that	SCONJ
fbem-25594	86	10	management	management	NOUN
fbem-25594	86	11	has	have	AUX
fbem-25594	86	12	made	make	VERB
fbem-25594	86	13	progress	progress	NOUN
fbem-25594	86	14	in	in	ADP
fbem-25594	86	15	optimizing	optimize	VERB
fbem-25594	86	16	costs	cost	NOUN
fbem-25594	86	17	and	and	CCONJ
fbem-25594	86	18	improving	improve	VERB
fbem-25594	86	19	the	the	DET
fbem-25594	86	20	efficiency	efficiency	NOUN
fbem-25594	86	21	of	of	ADP
fbem-25594	86	22	capital	capital	NOUN
fbem-25594	86	23	operations	operation	NOUN
fbem-25594	86	24	.	.	PUNCT
fbem-25594	87	1	figure	figure	VERB
fbem-25594	87	2	3	3	NUM
fbem-25594	87	3	.	.	PUNCT
fbem-25594	87	4	total	total	ADJ
fbem-25594	87	5	assets	asset	NOUN
fbem-25594	87	6	of	of	ADP
fbem-25594	87	7	conba	conba	ADJ
fbem-25594	87	8	pharmaceuticals	pharmaceutical	NOUN
fbem-25594	87	9	4	4	NUM
fbem-25594	87	10	.	.	PUNCT
fbem-25594	87	11	core	core	NOUN
fbem-25594	87	12	product	product	NOUN
fbem-25594	87	13	sales	sale	NOUN
fbem-25594	87	14	after	after	ADP
fbem-25594	87	15	the	the	DET
fbem-25594	87	16	transformation	transformation	NOUN
fbem-25594	87	17	,	,	PUNCT
fbem-25594	87	18	the	the	DET
fbem-25594	87	19	core	core	NOUN
fbem-25594	87	20	products	product	NOUN
fbem-25594	87	21	of	of	ADP
fbem-25594	87	22	conba	conba	NOUN
fbem-25594	87	23	company	company	NOUN
fbem-25594	87	24	have	have	AUX
fbem-25594	87	25	increased	increase	VERB
fbem-25594	87	26	to	to	ADP
fbem-25594	87	27	varying	vary	VERB
fbem-25594	87	28	degrees	degree	NOUN
fbem-25594	87	29	.	.	PUNCT
fbem-25594	88	1	the	the	DET
fbem-25594	88	2	core	core	NOUN
fbem-25594	88	3	products	product	NOUN
fbem-25594	88	4	of	of	ADP
fbem-25594	88	5	kangenbei	kangenbei	NOUN
fbem-25594	88	6	series	series	NOUN
fbem-25594	88	7	,	,	PUNCT
fbem-25594	88	8	baicalensis	baicalensis	NOUN
fbem-25594	88	9	,	,	PUNCT
fbem-25594	88	10	chinese	chinese	ADJ
fbem-25594	88	11	bark	bark	NOUN
fbem-25594	88	12	,	,	PUNCT
fbem-25594	88	13	tangerine	tangerine	ADJ
fbem-25594	88	14	peel	peel	NOUN
fbem-25594	88	15	,	,	PUNCT
fbem-25594	88	16	magnolia	magnolia	NOUN
fbem-25594	88	17	officinalis	officinalis	ADJ
fbem-25594	88	18	,	,	PUNCT
fbem-25594	88	19	licorice	licorice	NOUN
fbem-25594	88	20	,	,	PUNCT
fbem-25594	88	21	licorice	licorice	NOUN
fbem-25594	88	22	,	,	PUNCT
fbem-25594	88	23	aurantia	aurantia	NOUN
fbem-25594	88	24	,	,	PUNCT
fbem-25594	88	25	mainly	mainly	ADV
fbem-25594	88	26	for	for	ADP
fbem-25594	88	27	stool	stool	NOUN
fbem-25594	88	28	diarrhea	diarrhea	NOUN
fbem-25594	88	29	,	,	PUNCT
fbem-25594	88	30	abdominal	abdominal	ADJ
fbem-25594	88	31	pain	pain	NOUN
fbem-25594	88	32	,	,	PUNCT
fbem-25594	88	33	abdominal	abdominal	ADJ
fbem-25594	88	34	distension	distension	NOUN
fbem-25594	88	35	,	,	PUNCT
fbem-25594	88	36	indigestion	indigestion	NOUN
fbem-25594	88	37	and	and	CCONJ
fbem-25594	88	38	other	other	ADJ
fbem-25594	88	39	symptoms	symptom	NOUN
fbem-25594	88	40	,	,	PUNCT
fbem-25594	88	41	with	with	ADP
fbem-25594	88	42	the	the	DET
fbem-25594	88	43	effect	effect	NOUN
fbem-25594	88	44	of	of	ADP
fbem-25594	88	45	clearing	clear	VERB
fbem-25594	88	46	heat	heat	NOUN
fbem-25594	88	47	and	and	CCONJ
fbem-25594	88	48	dampness	dampness	NOUN
fbem-25594	88	49	,	,	PUNCT
fbem-25594	88	50	can	can	AUX
fbem-25594	88	51	reduce	reduce	VERB
fbem-25594	88	52	acute	acute	ADJ
fbem-25594	88	53	and	and	CCONJ
fbem-25594	88	54	chronic	chronic	ADJ
fbem-25594	88	55	gastroenteritis	gastroenteritis	NOUN
fbem-25594	88	56	.	.	PUNCT
fbem-25594	89	1	the	the	DET
fbem-25594	89	2	sales	sale	NOUN
fbem-25594	89	3	revenue	revenue	NOUN
fbem-25594	89	4	was	be	AUX
fbem-25594	89	5	nearly	nearly	ADV
fbem-25594	89	6	1.3	1.3	NUM
fbem-25594	89	7	billion	billion	NUM
fbem-25594	89	8	yuan	yuan	NOUN
fbem-25594	89	9	,	,	PUNCT
fbem-25594	89	10	and	and	CCONJ
fbem-25594	89	11	the	the	DET
fbem-25594	89	12	chinese	chinese	PROPN
fbem-25594	89	13	patent	patent	NOUN
fbem-25594	89	14	medicine	medicine	NOUN
fbem-25594	89	15	brand	brand	NOUN
fbem-25594	89	16	in	in	ADP
fbem-25594	89	17	the	the	DET
fbem-25594	89	18	digestive	digestive	ADJ
fbem-25594	89	19	system	system	NOUN
fbem-25594	89	20	of	of	ADP
fbem-25594	89	21	physical	physical	ADJ
fbem-25594	89	22	pharmacies	pharmacy	NOUN
fbem-25594	89	23	ranked	rank	VERB
fbem-25594	89	24	the	the	DET
fbem-25594	89	25	third	third	NOUN
fbem-25594	89	26	in	in	ADP
fbem-25594	89	27	[	[	X
fbem-25594	89	28	5	5	NUM
fbem-25594	89	29	]	]	PUNCT
fbem-25594	89	30	,	,	PUNCT
fbem-25594	89	31	accounting	account	VERB
fbem-25594	89	32	for	for	ADP
fbem-25594	89	33	8.18	8.18	NUM
fbem-25594	89	34	%	%	NOUN
fbem-25594	89	35	of	of	ADP
fbem-25594	89	36	the	the	DET
fbem-25594	89	37	market	market	NOUN
fbem-25594	89	38	share	share	NOUN
fbem-25594	89	39	.	.	PUNCT
fbem-25594	90	1	in	in	ADP
fbem-25594	90	2	2022	2022	NUM
fbem-25594	90	3	,	,	PUNCT
fbem-25594	90	4	it	it	PRON
fbem-25594	90	5	exceeded	exceed	VERB
fbem-25594	90	6	1	1	NUM
fbem-25594	90	7	billion	billion	NUM
fbem-25594	90	8	for	for	ADP
fbem-25594	90	9	the	the	DET
fbem-25594	90	10	first	first	ADJ
fbem-25594	90	11	time	time	NOUN
fbem-25594	90	12	,	,	PUNCT
fbem-25594	90	13	a	a	DET
fbem-25594	90	14	year	year	NOUN
fbem-25594	90	15	-	-	PUNCT
fbem-25594	90	16	on	on	ADP
fbem-25594	90	17	-	-	PUNCT
fbem-25594	90	18	year	year	NOUN
fbem-25594	90	19	increase	increase	NOUN
fbem-25594	90	20	of	of	ADP
fbem-25594	90	21	17.51	17.51	NUM
fbem-25594	90	22	%	%	NOUN
fbem-25594	90	23	;	;	PUNCT
fbem-25594	90	24	its	its	PRON
fbem-25594	90	25	core	core	NOUN
fbem-25594	90	26	product	product	NOUN
fbem-25594	90	27	in	in	ADP
fbem-25594	90	28	sales	sale	NOUN
fbem-25594	90	29	also	also	ADV
fbem-25594	90	30	increased	increase	VERB
fbem-25594	90	31	significantly	significantly	ADV
fbem-25594	90	32	in	in	ADP
fbem-25594	90	33	2023	2023	NUM
fbem-25594	90	34	,	,	PUNCT
fbem-25594	90	35	the	the	DET
fbem-25594	90	36	sales	sale	NOUN
fbem-25594	90	37	volume	volume	NOUN
fbem-25594	90	38	2	2	NUM
fbem-25594	90	39	increased	increase	VERB
fbem-25594	90	40	32.67	32.67	NUM
fbem-25594	90	41	%	%	NOUN
fbem-25594	90	42	year	year	NOUN
fbem-25594	90	43	on	on	ADP
fbem-25594	90	44	year	year	NOUN
fbem-25594	90	45	.	.	PUNCT
fbem-25594	91	1	with	with	ADP
fbem-25594	91	2	the	the	DET
fbem-25594	91	3	deepening	deepening	NOUN
fbem-25594	91	4	of	of	ADP
fbem-25594	91	5	the	the	DET
fbem-25594	91	6	aging	age	VERB
fbem-25594	91	7	population	population	NOUN
fbem-25594	91	8	and	and	CCONJ
fbem-25594	91	9	the	the	DET
fbem-25594	91	10	gradual	gradual	ADJ
fbem-25594	91	11	attention	attention	NOUN
fbem-25594	91	12	of	of	ADP
fbem-25594	91	13	residents	resident	NOUN
fbem-25594	91	14	to	to	ADP
fbem-25594	91	15	gastrointestinal	gastrointestinal	ADJ
fbem-25594	91	16	health	health	NOUN
fbem-25594	91	17	,	,	PUNCT
fbem-25594	91	18	the	the	DET
fbem-25594	91	19	market	market	NOUN
fbem-25594	91	20	size	size	NOUN
fbem-25594	91	21	of	of	ADP
fbem-25594	91	22	china	china	PROPN
fbem-25594	91	23	's	's	PART
fbem-25594	91	24	gastrointestinal	gastrointestinal	ADJ
fbem-25594	91	25	drug	drug	NOUN
fbem-25594	91	26	market	market	NOUN
fbem-25594	91	27	will	will	AUX
fbem-25594	91	28	increase	increase	VERB
fbem-25594	91	29	significantly	significantly	ADV
fbem-25594	91	30	in	in	ADP
fbem-25594	91	31	2022	2022	NUM
fbem-25594	91	32	,	,	PUNCT
fbem-25594	91	33	and	and	CCONJ
fbem-25594	91	34	the	the	DET
fbem-25594	91	35	demand	demand	NOUN
fbem-25594	91	36	for	for	ADP
fbem-25594	91	37	digestive	digestive	ADJ
fbem-25594	91	38	and	and	CCONJ
fbem-25594	91	39	respiratory	respiratory	ADJ
fbem-25594	91	40	drugs	drug	NOUN
fbem-25594	91	41	will	will	AUX
fbem-25594	91	42	surge	surge	VERB
fbem-25594	91	43	due	due	ADP
fbem-25594	91	44	to	to	ADP
fbem-25594	91	45	the	the	DET
fbem-25594	91	46	epidemic	epidemic	NOUN
fbem-25594	91	47	in	in	ADP
fbem-25594	91	48	2023	2023	NUM
fbem-25594	91	49	q1	q1	NOUN
fbem-25594	91	50	.	.	PUNCT
fbem-25594	92	1	figure	figure	NOUN
fbem-25594	92	2	4	4	NUM
fbem-25594	92	3	.	.	PUNCT
fbem-25594	93	1	sales	sale	NOUN
fbem-25594	93	2	volume	volume	NOUN
fbem-25594	93	3	of	of	ADP
fbem-25594	93	4	yanning	yanne	VERB
fbem-25594	93	5	tablet	tablet	NOUN
fbem-25594	93	6	2020	2020	NUM
fbem-25594	93	7	-	-	SYM
fbem-25594	93	8	2023	2023	NUM
fbem-25594	93	9	"	"	PUNCT
fbem-25594	93	10	tianbao	tianbao	PROPN
fbem-25594	93	11	ning	ning	NOUN
fbem-25594	93	12	"	"	PUNCT
fbem-25594	93	13	ginkgo	ginkgo	NOUN
fbem-25594	93	14	biloba	biloba	NOUN
fbem-25594	93	15	,	,	PUNCT
fbem-25594	93	16	used	use	VERB
fbem-25594	93	17	to	to	PART
fbem-25594	93	18	promote	promote	VERB
fbem-25594	93	19	blood	blood	NOUN
fbem-25594	93	20	circulation	circulation	NOUN
fbem-25594	93	21	to	to	PART
fbem-25594	93	22	remove	remove	VERB
fbem-25594	93	23	blood	blood	NOUN
fbem-25594	93	24	stasis	stasis	NOUN
fbem-25594	93	25	,	,	PUNCT
fbem-25594	93	26	price	price	NOUN
fbem-25594	93	27	fluctuation	fluctuation	NOUN
fbem-25594	93	28	is	be	AUX
fbem-25594	93	29	larger	large	ADJ
fbem-25594	93	30	-10.00	-10.00	NUM
fbem-25594	93	31	%	%	NOUN
fbem-25594	93	32	-5.00	-5.00	NUM
fbem-25594	93	33	%	%	NOUN
fbem-25594	93	34	0.00	0.00	NUM
fbem-25594	93	35	%	%	NOUN
fbem-25594	93	36	5.00	5.00	NUM
fbem-25594	93	37	%	%	NOUN
fbem-25594	93	38	10.00	10.00	NUM
fbem-25594	93	39	%	%	NOUN
fbem-25594	93	40	15.00	15.00	NUM
fbem-25594	93	41	%	%	NOUN
fbem-25594	93	42	20.00	20.00	NUM
fbem-25594	93	43	%	%	NOUN
fbem-25594	93	44	25.00	25.00	NUM
fbem-25594	93	45	%	%	NOUN
fbem-25594	93	46	30.00	30.00	NUM
fbem-25594	93	47	%	%	NOUN
fbem-25594	93	48	35.00	35.00	NUM
fbem-25594	93	49	%	%	NOUN
fbem-25594	93	50	40.00	40.00	NUM
fbem-25594	93	51	%	%	NOUN
fbem-25594	93	52	0	0	NUM
fbem-25594	93	53	20	20	NUM
fbem-25594	94	1	40	40	NUM
fbem-25594	94	2	60	60	NUM
fbem-25594	94	3	80	80	NUM
fbem-25594	94	4	100	100	NUM
fbem-25594	94	5	120	120	NUM
fbem-25594	94	6	2019	2019	NUM
fbem-25594	94	7	2020	2020	NUM
fbem-25594	94	8	2021	2021	NUM
fbem-25594	94	9	2022	2022	NUM
fbem-25594	94	10	2023	2023	NUM
fbem-25594	94	11	2024	2024	NUM
fbem-25594	94	12	q1	q1	NOUN
fbem-25594	94	13	total	total	ADJ
fbem-25594	94	14	assets	asset	NOUN
fbem-25594	94	15	of	of	ADP
fbem-25594	94	16	conba	conba	NOUN
fbem-25594	94	17	pharmaceuticals	pharmaceutical	NOUN
fbem-25594	94	18	total	total	ADJ
fbem-25594	94	19	assets	asset	NOUN
fbem-25594	94	20	roc	roc	PROPN
fbem-25594	94	21	-30.00	-30.00	PROPN
fbem-25594	94	22	%	%	NOUN
fbem-25594	94	23	-20.00	-20.00	NOUN
fbem-25594	94	24	%	%	NOUN
fbem-25594	94	25	-10.00	-10.00	NUM
fbem-25594	94	26	%	%	NOUN
fbem-25594	94	27	0.00	0.00	NUM
fbem-25594	94	28	%	%	NOUN
fbem-25594	94	29	10.00	10.00	NUM
fbem-25594	94	30	%	%	NOUN
fbem-25594	94	31	20.00	20.00	NUM
fbem-25594	94	32	%	%	NOUN
fbem-25594	94	33	30.00	30.00	NUM
fbem-25594	94	34	%	%	NOUN
fbem-25594	94	35	40.00	40.00	NUM
fbem-25594	94	36	%	%	NOUN
fbem-25594	94	37	50.00	50.00	NUM
fbem-25594	94	38	%	%	NOUN
fbem-25594	94	39	0	0	NUM
fbem-25594	94	40	200	200	NUM
fbem-25594	94	41	400	400	NUM
fbem-25594	94	42	600	600	NUM
fbem-25594	94	43	800	800	NUM
fbem-25594	94	44	1000	1000	NUM
fbem-25594	94	45	1200	1200	NUM
fbem-25594	94	46	1400	1400	NUM
fbem-25594	94	47	1600	1600	NUM
fbem-25594	94	48	2020	2020	NUM
fbem-25594	94	49	2021	2021	NUM
fbem-25594	94	50	2022	2022	NUM
fbem-25594	94	51	2023	2023	NUM
fbem-25594	94	52	sales	sale	NOUN
fbem-25594	94	53	volume	volume	NOUN
fbem-25594	94	54	of	of	ADP
fbem-25594	94	55	yanning	yanne	VERB
fbem-25594	94	56	tablet	tablet	NOUN
fbem-25594	94	57	2020	2020	NUM
fbem-25594	94	58	-	-	SYM
fbem-25594	94	59	2023	2023	NUM
fbem-25594	94	60	(	(	PUNCT
fbem-25594	94	61	10,000	10,000	NUM
fbem-25594	94	62	boxes	box	NOUN
fbem-25594	94	63	)	)	PUNCT
fbem-25594	94	64	sales	sale	NOUN
fbem-25594	94	65	volume(10,000	volume(10,000	NUM
fbem-25594	94	66	boxes	box	NOUN
fbem-25594	94	67	)	)	PUNCT
fbem-25594	94	68	change	change	NOUN
fbem-25594	94	69	rate	rate	NOUN
fbem-25594	94	70	of	of	ADP
fbem-25594	94	71	sales	sale	NOUN
fbem-25594	94	72	volume	volume	NOUN
fbem-25594	94	73	compared	compare	VERB
fbem-25594	94	74	with	with	ADP
fbem-25594	94	75	the	the	DET
fbem-25594	94	76	previous	previous	ADJ
fbem-25594	94	77	year	year	NOUN
fbem-25594	94	78	204	204	NUM
fbem-25594	94	79	but	but	CCONJ
fbem-25594	94	80	the	the	DET
fbem-25594	94	81	price	price	NOUN
fbem-25594	94	82	drop	drop	NOUN
fbem-25594	94	83	is	be	AUX
fbem-25594	94	84	limited	limit	VERB
fbem-25594	94	85	,	,	PUNCT
fbem-25594	94	86	in	in	ADP
fbem-25594	94	87	2023	2023	NUM
fbem-25594	94	88	tianbao	tianbao	VERB
fbem-25594	94	89	ning	ning	NOUN
fbem-25594	94	90	sales	sale	NOUN
fbem-25594	94	91	decreased	decrease	VERB
fbem-25594	94	92	by	by	ADP
fbem-25594	94	93	4	4	NUM
fbem-25594	94	94	%	%	NOUN
fbem-25594	94	95	year	year	NOUN
fbem-25594	94	96	on	on	ADP
fbem-25594	94	97	year	year	NOUN
fbem-25594	94	98	,	,	PUNCT
fbem-25594	94	99	still	still	ADV
fbem-25594	94	100	maintained	maintain	VERB
fbem-25594	94	101	26.3871	26.3871	NUM
fbem-25594	94	102	million	million	NUM
fbem-25594	94	103	boxes	box	NOUN
fbem-25594	94	104	of	of	ADP
fbem-25594	94	105	high	high	ADJ
fbem-25594	94	106	sales	sale	NOUN
fbem-25594	94	107	,	,	PUNCT
fbem-25594	94	108	the	the	DET
fbem-25594	94	109	company	company	NOUN
fbem-25594	94	110	also	also	ADV
fbem-25594	94	111	actively	actively	ADV
fbem-25594	94	112	carried	carry	VERB
fbem-25594	94	113	out	out	ADP
fbem-25594	94	114	"	"	PUNCT
fbem-25594	94	115	based	base	VERB
fbem-25594	94	116	on	on	ADP
fbem-25594	94	117	integrated	integrate	VERB
fbem-25594	94	118	pharmacology	pharmacology	NOUN
fbem-25594	94	119	from	from	ADP
fbem-25594	94	120	ginkgo	ginkgo	NOUN
fbem-25594	94	121	biloba	biloba	NOUN
fbem-25594	94	122	varieties	variety	NOUN
fbem-25594	94	123	to	to	PART
fbem-25594	94	124	improve	improve	VERB
fbem-25594	94	125	research	research	NOUN
fbem-25594	94	126	"	"	PUNCT
fbem-25594	94	127	and	and	CCONJ
fbem-25594	94	128	the	the	DET
fbem-25594	94	129	secondary	secondary	ADJ
fbem-25594	94	130	development	development	NOUN
fbem-25594	94	131	of	of	ADP
fbem-25594	94	132	ginkgo	ginkgo	NOUN
fbem-25594	94	133	biloba	biloba	NOUN
fbem-25594	94	134	products	product	NOUN
fbem-25594	94	135	,	,	PUNCT
fbem-25594	94	136	hope	hope	NOUN
fbem-25594	94	137	can	can	AUX
fbem-25594	94	138	further	far	ADV
fbem-25594	94	139	improve	improve	VERB
fbem-25594	94	140	sales	sale	NOUN
fbem-25594	94	141	through	through	ADP
fbem-25594	94	142	innovation	innovation	NOUN
fbem-25594	94	143	.	.	PUNCT
fbem-25594	95	1	figure	figure	NOUN
fbem-25594	95	2	5	5	NUM
fbem-25594	95	3	.	.	PUNCT
fbem-25594	96	1	"	"	PUNCT
fbem-25594	96	2	tianbao	tianbao	PROPN
fbem-25594	96	3	ning	ning	NOUN
fbem-25594	96	4	"	"	PUNCT
fbem-25594	96	5	ginkgo	ginkgo	NOUN
fbem-25594	96	6	leaf	leaf	NOUN
fbem-25594	96	7	sales	sale	NOUN
fbem-25594	96	8	2020	2020	NUM
fbem-25594	96	9	-	-	SYM
fbem-25594	96	10	2023	2023	NUM
fbem-25594	96	11	"	"	PUNCT
fbem-25594	96	12	jinkang	jinkang	PROPN
fbem-25594	96	13	speed	speed	PROPN
fbem-25594	96	14	force	force	NOUN
fbem-25594	96	15	"	"	PUNCT
fbem-25594	96	16	acetylcysteine	acetylcysteine	ADJ
fbem-25594	96	17	effervescent	effervescent	ADJ
fbem-25594	96	18	tablets	tablet	NOUN
fbem-25594	96	19	grow	grow	VERB
fbem-25594	96	20	steadily	steadily	ADV
fbem-25594	96	21	,	,	PUNCT
fbem-25594	96	22	suitable	suitable	ADJ
fbem-25594	96	23	for	for	ADP
fbem-25594	96	24	patients	patient	NOUN
fbem-25594	96	25	with	with	ADP
fbem-25594	96	26	chronic	chronic	ADJ
fbem-25594	96	27	bronchitis	bronchitis	NOUN
fbem-25594	96	28	and	and	CCONJ
fbem-25594	96	29	other	other	ADJ
fbem-25594	96	30	pharyngeal	pharyngeal	ADJ
fbem-25594	96	31	diseases	disease	NOUN
fbem-25594	96	32	.	.	PUNCT
fbem-25594	97	1	in	in	ADP
fbem-25594	97	2	2022	2022	NUM
fbem-25594	97	3	,	,	PUNCT
fbem-25594	97	4	it	it	PRON
fbem-25594	97	5	ranked	rank	VERB
fbem-25594	97	6	the	the	DET
fbem-25594	97	7	7th	7th	NOUN
fbem-25594	97	8	among	among	ADP
fbem-25594	97	9	the	the	DET
fbem-25594	97	10	top20	top20	NOUN
fbem-25594	97	11	brands	brand	NOUN
fbem-25594	97	12	of	of	ADP
fbem-25594	97	13	terminal	terminal	ADJ
fbem-25594	97	14	cough	cough	NOUN
fbem-25594	97	15	and	and	CCONJ
fbem-25594	97	16	cold	cold	ADJ
fbem-25594	97	17	medicine	medicine	NOUN
fbem-25594	97	18	in	in	ADP
fbem-25594	97	19	public	public	ADJ
fbem-25594	97	20	hospitals	hospital	NOUN
fbem-25594	97	21	in	in	ADP
fbem-25594	97	22	key	key	ADJ
fbem-25594	97	23	provinces	province	NOUN
fbem-25594	97	24	and	and	CCONJ
fbem-25594	97	25	cities	city	NOUN
fbem-25594	97	26	,	,	PUNCT
fbem-25594	97	27	occupying	occupy	VERB
fbem-25594	97	28	2.75	2.75	NUM
fbem-25594	97	29	%	%	NOUN
fbem-25594	97	30	of	of	ADP
fbem-25594	97	31	the	the	DET
fbem-25594	97	32	market	market	NOUN
fbem-25594	97	33	share	share	NOUN
fbem-25594	97	34	.	.	PUNCT
fbem-25594	98	1	in	in	ADP
fbem-25594	98	2	2020	2020	NUM
fbem-25594	98	3	,	,	PUNCT
fbem-25594	98	4	"	"	PUNCT
fbem-25594	98	5	jinkang	jinkang	PROPN
fbem-25594	98	6	kuuli	kuuli	PROPN
fbem-25594	98	7	"	"	PUNCT
fbem-25594	98	8	brand	brand	NOUN
fbem-25594	98	9	acetylcysteine	acetylcysteine	VERB
fbem-25594	98	10	effervescent	effervescent	ADJ
fbem-25594	98	11	tablets	tablet	NOUN
fbem-25594	98	12	were	be	AUX
fbem-25594	98	13	transferred	transfer	VERB
fbem-25594	98	14	to	to	ADP
fbem-25594	98	15	the	the	DET
fbem-25594	98	16	national	national	PROPN
fbem-25594	98	17	medical	medical	PROPN
fbem-25594	98	18	insurance	insurance	PROPN
fbem-25594	98	19	catalog	catalog	NOUN
fbem-25594	98	20	to	to	PART
fbem-25594	98	21	increase	increase	VERB
fbem-25594	98	22	the	the	DET
fbem-25594	98	23	coverage	coverage	NOUN
fbem-25594	98	24	of	of	ADP
fbem-25594	98	25	the	the	DET
fbem-25594	98	26	grass	grass	NOUN
fbem-25594	98	27	-	-	PUNCT
fbem-25594	98	28	roots	root	NOUN
fbem-25594	98	29	market	market	NOUN
fbem-25594	98	30	.	.	PUNCT
fbem-25594	99	1	in	in	ADP
fbem-25594	99	2	2022	2022	NUM
fbem-25594	99	3	,	,	PUNCT
fbem-25594	99	4	the	the	DET
fbem-25594	99	5	sales	sale	NOUN
fbem-25594	99	6	revenue	revenue	NOUN
fbem-25594	99	7	increased	increase	VERB
fbem-25594	99	8	by	by	ADP
fbem-25594	99	9	more	more	ADJ
fbem-25594	99	10	than	than	ADP
fbem-25594	99	11	35	35	NUM
fbem-25594	99	12	%	%	NOUN
fbem-25594	99	13	year	year	NOUN
fbem-25594	99	14	on	on	ADP
fbem-25594	99	15	year	year	NOUN
fbem-25594	99	16	,	,	PUNCT
fbem-25594	99	17	and	and	CCONJ
fbem-25594	99	18	in	in	ADP
fbem-25594	99	19	2023	2023	NUM
fbem-25594	99	20	,	,	PUNCT
fbem-25594	99	21	it	it	PRON
fbem-25594	99	22	maintained	maintain	VERB
fbem-25594	99	23	a	a	DET
fbem-25594	99	24	stable	stable	ADJ
fbem-25594	99	25	growth	growth	NOUN
fbem-25594	99	26	of	of	ADP
fbem-25594	99	27	16	16	NUM
fbem-25594	99	28	%	%	NOUN
fbem-25594	99	29	.	.	PUNCT
fbem-25594	100	1	the	the	DET
fbem-25594	100	2	sales	sale	NOUN
fbem-25594	100	3	volume	volume	NOUN
fbem-25594	100	4	reached	reach	VERB
fbem-25594	100	5	13.9748	13.9748	NUM
fbem-25594	100	6	million	million	NUM
fbem-25594	100	7	boxes	box	NOUN
fbem-25594	100	8	.	.	PUNCT
fbem-25594	101	1	with	with	ADP
fbem-25594	101	2	being	be	AUX
fbem-25594	101	3	selected	select	VERB
fbem-25594	101	4	as	as	ADP
fbem-25594	101	5	the	the	DET
fbem-25594	101	6	ninth	ninth	ADJ
fbem-25594	101	7	batch	batch	NOUN
fbem-25594	101	8	of	of	ADP
fbem-25594	101	9	drug	drug	NOUN
fbem-25594	101	10	centralized	centralize	VERB
fbem-25594	101	11	procurement	procurement	NOUN
fbem-25594	101	12	in	in	ADP
fbem-25594	101	13	2023	2023	NUM
fbem-25594	101	14	,	,	PUNCT
fbem-25594	101	15	the	the	DET
fbem-25594	101	16	product	product	NOUN
fbem-25594	101	17	began	begin	VERB
fbem-25594	101	18	to	to	PART
fbem-25594	101	19	be	be	AUX
fbem-25594	101	20	sold	sell	VERB
fbem-25594	101	21	in	in	ADP
fbem-25594	101	22	large	large	ADJ
fbem-25594	101	23	volume	volume	NOUN
fbem-25594	101	24	,	,	PUNCT
fbem-25594	101	25	helping	help	VERB
fbem-25594	101	26	to	to	PART
fbem-25594	101	27	further	far	ADV
fbem-25594	101	28	increase	increase	VERB
fbem-25594	101	29	the	the	DET
fbem-25594	101	30	sales	sale	NOUN
fbem-25594	101	31	.	.	PUNCT
fbem-25594	102	1	figure	figure	NOUN
fbem-25594	102	2	6	6	NUM
fbem-25594	102	3	.	.	PUNCT
fbem-25594	103	1	"	"	PUNCT
fbem-25594	103	2	jinkang	jinkang	PROPN
fbem-25594	103	3	suli	suli	PROPN
fbem-25594	103	4	"	"	PUNCT
fbem-25594	103	5	acetylcysteine	acetylcysteine	VERB
fbem-25594	103	6	effervescent	effervescent	ADJ
fbem-25594	103	7	tablet	tablet	NOUN
fbem-25594	103	8	sales	sale	NOUN
fbem-25594	103	9	2020	2020	NUM
fbem-25594	103	10	-	-	SYM
fbem-25594	103	11	2023	2023	NUM
fbem-25594	103	12	5	5	NUM
fbem-25594	103	13	.	.	PUNCT
fbem-25594	104	1	summary	summary	VERB
fbem-25594	104	2	the	the	DET
fbem-25594	104	3	study	study	NOUN
fbem-25594	104	4	found	find	VERB
fbem-25594	104	5	that	that	SCONJ
fbem-25594	104	6	the	the	DET
fbem-25594	104	7	main	main	ADJ
fbem-25594	104	8	drivers	driver	NOUN
fbem-25594	104	9	of	of	ADP
fbem-25594	104	10	conba	conba	NOUN
fbem-25594	104	11	's	's	PART
fbem-25594	104	12	transition	transition	NOUN
fbem-25594	104	13	to	to	ADP
fbem-25594	104	14	innovative	innovative	ADJ
fbem-25594	104	15	drugs	drug	NOUN
fbem-25594	104	16	include	include	VERB
fbem-25594	104	17	internal	internal	ADJ
fbem-25594	104	18	growth	growth	NOUN
fbem-25594	104	19	bottlenecks	bottleneck	NOUN
fbem-25594	104	20	and	and	CCONJ
fbem-25594	104	21	changes	change	NOUN
fbem-25594	104	22	in	in	ADP
fbem-25594	104	23	external	external	ADJ
fbem-25594	104	24	market	market	NOUN
fbem-25594	104	25	demand	demand	NOUN
fbem-25594	104	26	,	,	PUNCT
fbem-25594	104	27	as	as	ADV
fbem-25594	104	28	well	well	ADV
fbem-25594	104	29	as	as	ADP
fbem-25594	104	30	government	government	NOUN
fbem-25594	104	31	policy	policy	NOUN
fbem-25594	104	32	support	support	NOUN
fbem-25594	104	33	.	.	PUNCT
fbem-25594	105	1	together	together	ADV
fbem-25594	105	2	,	,	PUNCT
fbem-25594	105	3	these	these	DET
fbem-25594	105	4	factors	factor	NOUN
fbem-25594	105	5	drive	drive	VERB
fbem-25594	105	6	the	the	DET
fbem-25594	105	7	company	company	NOUN
fbem-25594	105	8	's	's	PART
fbem-25594	105	9	strategic	strategic	ADJ
fbem-25594	105	10	transformation	transformation	NOUN
fbem-25594	105	11	.	.	PUNCT
fbem-25594	106	1	a	a	DET
fbem-25594	106	2	detailed	detailed	ADJ
fbem-25594	106	3	analysis	analysis	NOUN
fbem-25594	106	4	of	of	ADP
fbem-25594	106	5	conba	conba	NOUN
fbem-25594	106	6	reveals	reveal	VERB
fbem-25594	106	7	significant	significant	ADJ
fbem-25594	106	8	progress	progress	NOUN
fbem-25594	106	9	in	in	ADP
fbem-25594	106	10	the	the	DET
fbem-25594	106	11	field	field	NOUN
fbem-25594	106	12	of	of	ADP
fbem-25594	106	13	innovative	innovative	ADJ
fbem-25594	106	14	drug	drug	NOUN
fbem-25594	106	15	development	development	NOUN
fbem-25594	106	16	.	.	PUNCT
fbem-25594	107	1	the	the	DET
fbem-25594	107	2	company	company	NOUN
fbem-25594	107	3	has	have	AUX
fbem-25594	107	4	successfully	successfully	ADV
fbem-25594	107	5	built	build	VERB
fbem-25594	107	6	a	a	DET
fbem-25594	107	7	technology	technology	NOUN
fbem-25594	107	8	platform	platform	NOUN
fbem-25594	107	9	,	,	PUNCT
fbem-25594	107	10	introduced	introduce	VERB
fbem-25594	107	11	and	and	CCONJ
fbem-25594	107	12	trained	train	VERB
fbem-25594	107	13	a	a	DET
fbem-25594	107	14	number	number	NOUN
fbem-25594	107	15	of	of	ADP
fbem-25594	107	16	innovative	innovative	ADJ
fbem-25594	107	17	talents	talent	NOUN
fbem-25594	107	18	,	,	PUNCT
fbem-25594	107	19	greatly	greatly	ADV
fbem-25594	107	20	increased	increase	VERB
fbem-25594	107	21	the	the	DET
fbem-25594	107	22	r	r	NOUN
fbem-25594	107	23	&	&	CCONJ
fbem-25594	107	24	d	d	NOUN
fbem-25594	107	25	investment	investment	NOUN
fbem-25594	107	26	,	,	PUNCT
fbem-25594	107	27	and	and	CCONJ
fbem-25594	107	28	launched	launch	VERB
fbem-25594	107	29	a	a	DET
fbem-25594	107	30	series	series	NOUN
fbem-25594	107	31	of	of	ADP
fbem-25594	107	32	innovative	innovative	ADJ
fbem-25594	107	33	drug	drug	NOUN
fbem-25594	107	34	products	product	NOUN
fbem-25594	107	35	with	with	ADP
fbem-25594	107	36	market	market	NOUN
fbem-25594	107	37	competitiveness	competitiveness	NOUN
fbem-25594	107	38	.	.	PUNCT
fbem-25594	108	1	after	after	ADP
fbem-25594	108	2	the	the	DET
fbem-25594	108	3	transformation	transformation	NOUN
fbem-25594	108	4	,	,	PUNCT
fbem-25594	108	5	conba	conba	NOUN
fbem-25594	108	6	's	's	PART
fbem-25594	108	7	financial	financial	ADJ
fbem-25594	108	8	performance	performance	NOUN
fbem-25594	108	9	and	and	CCONJ
fbem-25594	108	10	market	market	NOUN
fbem-25594	108	11	performance	performance	NOUN
fbem-25594	108	12	have	have	AUX
fbem-25594	108	13	improved	improve	VERB
fbem-25594	108	14	,	,	PUNCT
fbem-25594	108	15	the	the	DET
fbem-25594	108	16	revenue	revenue	NOUN
fbem-25594	108	17	share	share	NOUN
fbem-25594	108	18	of	of	ADP
fbem-25594	108	19	innovative	innovative	ADJ
fbem-25594	108	20	drug	drug	NOUN
fbem-25594	108	21	business	business	NOUN
fbem-25594	108	22	has	have	AUX
fbem-25594	108	23	increased	increase	VERB
fbem-25594	108	24	year	year	NOUN
fbem-25594	108	25	by	by	ADP
fbem-25594	108	26	year	year	NOUN
fbem-25594	108	27	,	,	PUNCT
fbem-25594	108	28	and	and	CCONJ
fbem-25594	108	29	its	its	PRON
fbem-25594	108	30	market	market	NOUN
fbem-25594	108	31	share	share	NOUN
fbem-25594	108	32	has	have	AUX
fbem-25594	108	33	been	be	AUX
fbem-25594	108	34	expanding	expand	VERB
fbem-25594	108	35	.	.	PUNCT
fbem-25594	109	1	after	after	ADP
fbem-25594	109	2	a	a	DET
fbem-25594	109	3	brief	brief	ADJ
fbem-25594	109	4	twists	twist	NOUN
fbem-25594	109	5	and	and	CCONJ
fbem-25594	109	6	turns	turn	VERB
fbem-25594	109	7	in	in	ADP
fbem-25594	109	8	the	the	DET
fbem-25594	109	9	transition	transition	NOUN
fbem-25594	109	10	period	period	NOUN
fbem-25594	109	11	,	,	PUNCT
fbem-25594	109	12	the	the	DET
fbem-25594	109	13	profits	profit	NOUN
fbem-25594	109	14	of	of	ADP
fbem-25594	109	15	conba	conba	NOUN
fbem-25594	109	16	began	begin	VERB
fbem-25594	109	17	new	new	ADJ
fbem-25594	109	18	growth	growth	NOUN
fbem-25594	109	19	,	,	PUNCT
fbem-25594	109	20	and	and	CCONJ
fbem-25594	109	21	the	the	DET
fbem-25594	109	22	company	company	NOUN
fbem-25594	109	23	's	's	PART
fbem-25594	109	24	core	core	NOUN
fbem-25594	109	25	business	business	NOUN
fbem-25594	109	26	products	product	NOUN
fbem-25594	109	27	have	have	VERB
fbem-25594	109	28	-30.00	-30.00	VERB
fbem-25594	110	1	%	%	NOUN
fbem-25594	110	2	-20.00	-20.00	NOUN
fbem-25594	110	3	%	%	NOUN
fbem-25594	110	4	-10.00	-10.00	NUM
fbem-25594	110	5	%	%	NOUN
fbem-25594	110	6	0.00	0.00	NUM
fbem-25594	110	7	%	%	NOUN
fbem-25594	110	8	10.00	10.00	NUM
fbem-25594	110	9	%	%	NOUN
fbem-25594	110	10	20.00	20.00	NUM
fbem-25594	110	11	%	%	NOUN
fbem-25594	110	12	30.00	30.00	NUM
fbem-25594	110	13	%	%	NOUN
fbem-25594	110	14	40.00	40.00	NUM
fbem-25594	110	15	%	%	NOUN
fbem-25594	110	16	50.00	50.00	NUM
fbem-25594	110	17	%	%	NOUN
fbem-25594	110	18	0	0	NUM
fbem-25594	111	1	200	200	NUM
fbem-25594	111	2	400	400	NUM
fbem-25594	111	3	600	600	NUM
fbem-25594	111	4	800	800	NUM
fbem-25594	111	5	1000	1000	NUM
fbem-25594	111	6	1200	1200	NUM
fbem-25594	111	7	1400	1400	NUM
fbem-25594	111	8	1600	1600	NUM
fbem-25594	111	9	2020	2020	NUM
fbem-25594	111	10	2021	2021	NUM
fbem-25594	111	11	2022	2022	NUM
fbem-25594	111	12	2023	2023	NUM
fbem-25594	111	13	"	"	PUNCT
fbem-25594	111	14	tianbao	tianbao	PROPN
fbem-25594	111	15	ning	ning	NOUN
fbem-25594	111	16	"	"	PUNCT
fbem-25594	111	17	ginkgo	ginkgo	NOUN
fbem-25594	111	18	leaf	leaf	NOUN
fbem-25594	111	19	sales	sale	NOUN
fbem-25594	111	20	2020	2020	NUM
fbem-25594	111	21	-	-	SYM
fbem-25594	111	22	2023	2023	NUM
fbem-25594	111	23	sales	sale	NOUN
fbem-25594	111	24	volume(10,000	volume(10,000	NUM
fbem-25594	111	25	boxes	box	NOUN
fbem-25594	111	26	)	)	PUNCT
fbem-25594	111	27	change	change	NOUN
fbem-25594	111	28	rate	rate	NOUN
fbem-25594	111	29	of	of	ADP
fbem-25594	111	30	sales	sale	NOUN
fbem-25594	111	31	volume	volume	NOUN
fbem-25594	111	32	compared	compare	VERB
fbem-25594	111	33	with	with	ADP
fbem-25594	111	34	the	the	DET
fbem-25594	111	35	previous	previous	ADJ
fbem-25594	111	36	year	year	NOUN
fbem-25594	111	37	-30.00	-30.00	NOUN
fbem-25594	111	38	%	%	NOUN
fbem-25594	111	39	-20.00	-20.00	NOUN
fbem-25594	111	40	%	%	NOUN
fbem-25594	111	41	-10.00	-10.00	NUM
fbem-25594	111	42	%	%	NOUN
fbem-25594	111	43	0.00	0.00	NUM
fbem-25594	111	44	%	%	NOUN
fbem-25594	111	45	10.00	10.00	NUM
fbem-25594	111	46	%	%	NOUN
fbem-25594	111	47	20.00	20.00	NUM
fbem-25594	111	48	%	%	NOUN
fbem-25594	111	49	30.00	30.00	NUM
fbem-25594	111	50	%	%	NOUN
fbem-25594	111	51	40.00	40.00	NUM
fbem-25594	111	52	%	%	NOUN
fbem-25594	111	53	50.00	50.00	NUM
fbem-25594	111	54	%	%	NOUN
fbem-25594	111	55	0	0	NUM
fbem-25594	111	56	200	200	NUM
fbem-25594	111	57	400	400	NUM
fbem-25594	111	58	600	600	NUM
fbem-25594	111	59	800	800	NUM
fbem-25594	111	60	1000	1000	NUM
fbem-25594	111	61	1200	1200	NUM
fbem-25594	111	62	1400	1400	NUM
fbem-25594	111	63	1600	1600	NUM
fbem-25594	111	64	2020	2020	NUM
fbem-25594	111	65	2021	2021	NUM
fbem-25594	111	66	2022	2022	NUM
fbem-25594	111	67	2023	2023	NUM
fbem-25594	111	68	"	"	PUNCT
fbem-25594	111	69	jinkang	jinkang	PROPN
fbem-25594	111	70	suli	suli	PROPN
fbem-25594	111	71	"	"	PUNCT
fbem-25594	111	72	acetylcysteine	acetylcysteine	VERB
fbem-25594	111	73	effervescent	effervescent	ADJ
fbem-25594	111	74	tablet	tablet	NOUN
fbem-25594	111	75	sales	sale	NOUN
fbem-25594	111	76	2020	2020	NUM
fbem-25594	111	77	-	-	SYM
fbem-25594	111	78	2023	2023	NUM
fbem-25594	111	79	sales	sale	NOUN
fbem-25594	111	80	volume(10,000	volume(10,000	NUM
fbem-25594	111	81	boxes	box	NOUN
fbem-25594	111	82	)	)	PUNCT
fbem-25594	111	83	change	change	NOUN
fbem-25594	111	84	rate	rate	NOUN
fbem-25594	111	85	of	of	ADP
fbem-25594	111	86	sales	sale	NOUN
fbem-25594	111	87	volume	volume	NOUN
fbem-25594	111	88	compared	compare	VERB
fbem-25594	111	89	with	with	ADP
fbem-25594	111	90	the	the	DET
fbem-25594	111	91	previous	previous	ADJ
fbem-25594	111	92	year	year	NOUN
fbem-25594	111	93	205	205	NUM
fbem-25594	111	94	increased	increase	VERB
fbem-25594	111	95	to	to	ADP
fbem-25594	111	96	varying	vary	VERB
fbem-25594	111	97	degrees	degree	NOUN
fbem-25594	111	98	.	.	PUNCT
fbem-25594	112	1	this	this	PRON
fbem-25594	112	2	shows	show	VERB
fbem-25594	112	3	that	that	SCONJ
fbem-25594	112	4	conba	conba	NOUN
fbem-25594	112	5	's	's	PART
fbem-25594	112	6	transformation	transformation	NOUN
fbem-25594	112	7	has	have	AUX
fbem-25594	112	8	achieved	achieve	VERB
fbem-25594	112	9	positive	positive	ADJ
fbem-25594	112	10	results	result	NOUN
fbem-25594	112	11	at	at	ADP
fbem-25594	112	12	both	both	CCONJ
fbem-25594	112	13	the	the	DET
fbem-25594	112	14	economic	economic	ADJ
fbem-25594	112	15	and	and	CCONJ
fbem-25594	112	16	strategic	strategic	ADJ
fbem-25594	112	17	levels	level	NOUN
fbem-25594	112	18	.	.	PUNCT
fbem-25594	113	1	among	among	ADP
fbem-25594	113	2	them	they	PRON
fbem-25594	113	3	,	,	PUNCT
fbem-25594	113	4	the	the	DET
fbem-25594	113	5	success	success	NOUN
fbem-25594	113	6	of	of	ADP
fbem-25594	113	7	conbe	conbe	NOUN
fbem-25594	113	8	's	's	PART
fbem-25594	113	9	transformation	transformation	NOUN
fbem-25594	113	10	is	be	AUX
fbem-25594	113	11	mainly	mainly	ADV
fbem-25594	113	12	attributed	attribute	VERB
fbem-25594	113	13	to	to	ADP
fbem-25594	113	14	the	the	DET
fbem-25594	113	15	government	government	NOUN
fbem-25594	113	16	's	's	PART
fbem-25594	113	17	policy	policy	NOUN
fbem-25594	113	18	support	support	NOUN
fbem-25594	113	19	for	for	ADP
fbem-25594	113	20	the	the	DET
fbem-25594	113	21	innovative	innovative	ADJ
fbem-25594	113	22	pharmaceutical	pharmaceutical	NOUN
fbem-25594	113	23	industry	industry	NOUN
fbem-25594	113	24	,	,	PUNCT
fbem-25594	113	25	which	which	PRON
fbem-25594	113	26	provides	provide	VERB
fbem-25594	113	27	a	a	DET
fbem-25594	113	28	strong	strong	ADJ
fbem-25594	113	29	guarantee	guarantee	NOUN
fbem-25594	113	30	for	for	ADP
fbem-25594	113	31	conbe	conbe	NOUN
fbem-25594	113	32	's	's	PART
fbem-25594	113	33	transformation	transformation	NOUN
fbem-25594	113	34	and	and	CCONJ
fbem-25594	113	35	conbe	conbe	NOUN
fbem-25594	113	36	's	's	PART
fbem-25594	113	37	continuous	continuous	ADJ
fbem-25594	113	38	investment	investment	NOUN
fbem-25594	113	39	in	in	ADP
fbem-25594	113	40	research	research	NOUN
fbem-25594	113	41	and	and	CCONJ
fbem-25594	113	42	development	development	NOUN
fbem-25594	113	43	and	and	CCONJ
fbem-25594	113	44	the	the	DET
fbem-25594	113	45	establishment	establishment	NOUN
fbem-25594	113	46	of	of	ADP
fbem-25594	113	47	a	a	DET
fbem-25594	113	48	technology	technology	NOUN
fbem-25594	113	49	platform	platform	NOUN
fbem-25594	113	50	.	.	PUNCT
fbem-25594	114	1	secondly	secondly	ADV
fbem-25594	114	2	,	,	PUNCT
fbem-25594	114	3	the	the	DET
fbem-25594	114	4	company	company	NOUN
fbem-25594	114	5	is	be	AUX
fbem-25594	114	6	market	market	NOUN
fbem-25594	114	7	-	-	PUNCT
fbem-25594	114	8	oriented	orient	VERB
fbem-25594	114	9	,	,	PUNCT
fbem-25594	114	10	accurately	accurately	ADV
fbem-25594	114	11	grasp	grasp	VERB
fbem-25594	114	12	the	the	DET
fbem-25594	114	13	market	market	NOUN
fbem-25594	114	14	demand	demand	NOUN
fbem-25594	114	15	and	and	CCONJ
fbem-25594	114	16	quickly	quickly	ADV
fbem-25594	114	17	respond	respond	VERB
fbem-25594	114	18	to	to	ADP
fbem-25594	114	19	market	market	NOUN
fbem-25594	114	20	changes	change	NOUN
fbem-25594	114	21	,	,	PUNCT
fbem-25594	114	22	attention	attention	NOUN
fbem-25594	114	23	and	and	CCONJ
fbem-25594	114	24	talent	talent	NOUN
fbem-25594	114	25	strategy	strategy	NOUN
fbem-25594	114	26	reserve	reserve	PROPN
fbem-25594	114	27	however	however	ADV
fbem-25594	114	28	,	,	PUNCT
fbem-25594	114	29	connbe	connbe	NOUN
fbem-25594	114	30	faces	face	VERB
fbem-25594	114	31	many	many	ADJ
fbem-25594	114	32	challenges	challenge	NOUN
fbem-25594	114	33	after	after	ADP
fbem-25594	114	34	the	the	DET
fbem-25594	114	35	transition	transition	NOUN
fbem-25594	114	36	period	period	NOUN
fbem-25594	114	37	,	,	PUNCT
fbem-25594	114	38	such	such	ADJ
fbem-25594	114	39	as	as	ADP
fbem-25594	114	40	capital	capital	NOUN
fbem-25594	114	41	pressure	pressure	NOUN
fbem-25594	114	42	.	.	PUNCT
fbem-25594	115	1	the	the	DET
fbem-25594	115	2	research	research	NOUN
fbem-25594	115	3	and	and	CCONJ
fbem-25594	115	4	development	development	NOUN
fbem-25594	115	5	of	of	ADP
fbem-25594	115	6	innovative	innovative	ADJ
fbem-25594	115	7	drugs	drug	NOUN
fbem-25594	115	8	requires	require	VERB
fbem-25594	115	9	long	long	ADJ
fbem-25594	115	10	-	-	PUNCT
fbem-25594	115	11	term	term	NOUN
fbem-25594	115	12	capital	capital	NOUN
fbem-25594	115	13	investment	investment	NOUN
fbem-25594	115	14	,	,	PUNCT
fbem-25594	115	15	and	and	CCONJ
fbem-25594	115	16	capital	capital	NOUN
fbem-25594	115	17	pressure	pressure	NOUN
fbem-25594	115	18	is	be	AUX
fbem-25594	115	19	still	still	ADV
fbem-25594	115	20	the	the	DET
fbem-25594	115	21	main	main	ADJ
fbem-25594	115	22	challenge	challenge	NOUN
fbem-25594	115	23	facing	face	VERB
fbem-25594	115	24	connbe	connbe	NOUN
fbem-25594	115	25	.	.	PUNCT
fbem-25594	116	1	technology	technology	NOUN
fbem-25594	116	2	risk	risk	NOUN
fbem-25594	116	3	,	,	PUNCT
fbem-25594	116	4	innovative	innovative	ADJ
fbem-25594	116	5	drug	drug	NOUN
fbem-25594	116	6	research	research	NOUN
fbem-25594	116	7	and	and	CCONJ
fbem-25594	116	8	development	development	NOUN
fbem-25594	116	9	has	have	VERB
fbem-25594	116	10	high	high	ADJ
fbem-25594	116	11	risk	risk	NOUN
fbem-25594	116	12	,	,	PUNCT
fbem-25594	116	13	high	high	ADJ
fbem-25594	116	14	failure	failure	NOUN
fbem-25594	116	15	rate	rate	NOUN
fbem-25594	116	16	possibility	possibility	NOUN
fbem-25594	116	17	,	,	PUNCT
fbem-25594	116	18	the	the	DET
fbem-25594	116	19	company	company	NOUN
fbem-25594	116	20	needs	need	VERB
fbem-25594	116	21	to	to	PART
fbem-25594	116	22	constantly	constantly	ADV
fbem-25594	116	23	innovate	innovate	VERB
fbem-25594	116	24	and	and	CCONJ
fbem-25594	116	25	adjust	adjust	VERB
fbem-25594	116	26	strategies	strategy	NOUN
fbem-25594	116	27	to	to	PART
fbem-25594	116	28	reduce	reduce	VERB
fbem-25594	116	29	the	the	DET
fbem-25594	116	30	risk	risk	NOUN
fbem-25594	116	31	.	.	PUNCT
fbem-25594	117	1	and	and	CCONJ
fbem-25594	117	2	as	as	SCONJ
fbem-25594	117	3	more	more	ADJ
fbem-25594	117	4	enterprises	enterprise	NOUN
fbem-25594	117	5	enter	enter	VERB
fbem-25594	117	6	the	the	DET
fbem-25594	117	7	field	field	NOUN
fbem-25594	117	8	of	of	ADP
fbem-25594	117	9	innovative	innovative	ADJ
fbem-25594	117	10	drugs	drug	NOUN
fbem-25594	117	11	,	,	PUNCT
fbem-25594	117	12	the	the	DET
fbem-25594	117	13	market	market	NOUN
fbem-25594	117	14	competition	competition	NOUN
fbem-25594	117	15	intensifies	intensifie	NOUN
fbem-25594	117	16	,	,	PUNCT
fbem-25594	117	17	the	the	DET
fbem-25594	117	18	company	company	NOUN
fbem-25594	117	19	needs	need	VERB
fbem-25594	117	20	to	to	PART
fbem-25594	117	21	continuously	continuously	ADV
fbem-25594	117	22	improve	improve	VERB
fbem-25594	117	23	the	the	DET
fbem-25594	117	24	product	product	NOUN
fbem-25594	117	25	innovation	innovation	NOUN
fbem-25594	117	26	and	and	CCONJ
fbem-25594	117	27	market	market	NOUN
fbem-25594	117	28	share	share	NOUN
fbem-25594	117	29	.	.	PUNCT
fbem-25594	118	1	long	long	ADJ
fbem-25594	118	2	-	-	PUNCT
fbem-25594	118	3	term	term	NOUN
fbem-25594	118	4	performance	performance	NOUN
fbem-25594	118	5	evaluation	evaluation	NOUN
fbem-25594	118	6	,	,	PUNCT
fbem-25594	118	7	industry	industry	NOUN
fbem-25594	118	8	comparative	comparative	ADJ
fbem-25594	118	9	analysis	analysis	NOUN
fbem-25594	118	10	and	and	CCONJ
fbem-25594	118	11	international	international	ADJ
fbem-25594	118	12	market	market	NOUN
fbem-25594	118	13	research	research	NOUN
fbem-25594	118	14	on	on	ADP
fbem-25594	118	15	the	the	DET
fbem-25594	118	16	possible	possible	ADJ
fbem-25594	118	17	future	future	ADJ
fbem-25594	118	18	research	research	NOUN
fbem-25594	118	19	directions	direction	NOUN
fbem-25594	118	20	of	of	ADP
fbem-25594	118	21	conba	conba	NOUN
fbem-25594	118	22	.	.	PUNCT
fbem-25594	119	1	it	it	PRON
fbem-25594	119	2	is	be	AUX
fbem-25594	119	3	recommended	recommend	VERB
fbem-25594	119	4	to	to	PART
fbem-25594	119	5	conduct	conduct	VERB
fbem-25594	119	6	a	a	DET
fbem-25594	119	7	continuous	continuous	ADJ
fbem-25594	119	8	evaluation	evaluation	NOUN
fbem-25594	119	9	of	of	ADP
fbem-25594	119	10	the	the	DET
fbem-25594	119	11	long	long	ADJ
fbem-25594	119	12	-	-	PUNCT
fbem-25594	119	13	term	term	NOUN
fbem-25594	119	14	performance	performance	NOUN
fbem-25594	119	15	of	of	ADP
fbem-25594	119	16	the	the	DET
fbem-25594	119	17	enterprise	enterprise	NOUN
fbem-25594	119	18	after	after	SCONJ
fbem-25594	119	19	the	the	DET
fbem-25594	119	20	transformation	transformation	NOUN
fbem-25594	119	21	to	to	PART
fbem-25594	119	22	better	well	ADV
fbem-25594	119	23	understand	understand	VERB
fbem-25594	119	24	the	the	DET
fbem-25594	119	25	overall	overall	ADJ
fbem-25594	119	26	impact	impact	NOUN
fbem-25594	119	27	of	of	ADP
fbem-25594	119	28	the	the	DET
fbem-25594	119	29	transformation	transformation	NOUN
fbem-25594	119	30	.	.	PUNCT
fbem-25594	120	1	and	and	CCONJ
fbem-25594	120	2	by	by	ADP
fbem-25594	120	3	comparing	compare	VERB
fbem-25594	120	4	the	the	DET
fbem-25594	120	5	transformation	transformation	NOUN
fbem-25594	120	6	paths	path	NOUN
fbem-25594	120	7	of	of	ADP
fbem-25594	120	8	different	different	ADJ
fbem-25594	120	9	chinese	chinese	ADJ
fbem-25594	120	10	patent	patent	NOUN
fbem-25594	120	11	medicine	medicine	NOUN
fbem-25594	120	12	enterprises	enterprise	NOUN
fbem-25594	120	13	,	,	PUNCT
fbem-25594	120	14	to	to	PART
fbem-25594	120	15	explore	explore	VERB
fbem-25594	120	16	a	a	DET
fbem-25594	120	17	wider	wide	ADJ
fbem-25594	120	18	range	range	NOUN
fbem-25594	120	19	of	of	ADP
fbem-25594	120	20	successful	successful	ADJ
fbem-25594	120	21	models	model	NOUN
fbem-25594	120	22	and	and	CCONJ
fbem-25594	120	23	experience	experience	NOUN
fbem-25594	120	24	.	.	PUNCT
fbem-25594	121	1	through	through	ADP
fbem-25594	121	2	the	the	DET
fbem-25594	121	3	in	in	ADP
fbem-25594	121	4	-	-	PUNCT
fbem-25594	121	5	depth	depth	NOUN
fbem-25594	121	6	study	study	NOUN
fbem-25594	121	7	of	of	ADP
fbem-25594	121	8	conba	conba	NOUN
fbem-25594	121	9	company	company	NOUN
fbem-25594	121	10	in	in	ADP
fbem-25594	121	11	this	this	DET
fbem-25594	121	12	paper	paper	NOUN
fbem-25594	121	13	,	,	PUNCT
fbem-25594	121	14	the	the	DET
fbem-25594	121	15	key	key	ADJ
fbem-25594	121	16	success	success	NOUN
fbem-25594	121	17	factors	factor	NOUN
fbem-25594	121	18	and	and	CCONJ
fbem-25594	121	19	challenges	challenge	NOUN
fbem-25594	121	20	of	of	ADP
fbem-25594	121	21	chinese	chinese	ADJ
fbem-25594	121	22	patent	patent	NOUN
fbem-25594	121	23	medicine	medicine	NOUN
fbem-25594	121	24	enterprises	enterprise	NOUN
fbem-25594	121	25	in	in	ADP
fbem-25594	121	26	the	the	DET
fbem-25594	121	27	transformation	transformation	NOUN
fbem-25594	121	28	to	to	ADP
fbem-25594	121	29	innovative	innovative	ADJ
fbem-25594	121	30	drug	drug	NOUN
fbem-25594	121	31	research	research	NOUN
fbem-25594	121	32	and	and	CCONJ
fbem-25594	121	33	development	development	NOUN
fbem-25594	121	34	strategy	strategy	NOUN
fbem-25594	121	35	are	be	AUX
fbem-25594	121	36	revealed	reveal	VERB
fbem-25594	121	37	.	.	PUNCT
fbem-25594	122	1	this	this	PRON
fbem-25594	122	2	not	not	PART
fbem-25594	122	3	only	only	ADV
fbem-25594	122	4	provides	provide	VERB
fbem-25594	122	5	important	important	ADJ
fbem-25594	122	6	reference	reference	NOUN
fbem-25594	122	7	experience	experience	NOUN
fbem-25594	122	8	for	for	ADP
fbem-25594	122	9	other	other	ADJ
fbem-25594	122	10	chinese	chinese	ADJ
fbem-25594	122	11	patent	patent	NOUN
fbem-25594	122	12	medicine	medicine	NOUN
fbem-25594	122	13	enterprises	enterprise	NOUN
fbem-25594	122	14	,	,	PUNCT
fbem-25594	122	15	but	but	CCONJ
fbem-25594	122	16	also	also	ADV
fbem-25594	122	17	provides	provide	VERB
fbem-25594	122	18	possibilities	possibility	NOUN
fbem-25594	122	19	for	for	ADP
fbem-25594	122	20	policy	policy	NOUN
fbem-25594	122	21	makers	maker	NOUN
fbem-25594	122	22	with	with	ADP
fbem-25594	122	23	future	future	ADJ
fbem-25594	122	24	development	development	NOUN
fbem-25594	122	25	.	.	PUNCT
fbem-25594	123	1	in	in	ADP
fbem-25594	123	2	the	the	DET
fbem-25594	123	3	future	future	NOUN
fbem-25594	123	4	,	,	PUNCT
fbem-25594	123	5	chinese	chinese	ADJ
fbem-25594	123	6	patent	patent	NOUN
fbem-25594	123	7	medicine	medicine	NOUN
fbem-25594	123	8	enterprises	enterprise	NOUN
fbem-25594	123	9	need	need	VERB
fbem-25594	123	10	to	to	PART
fbem-25594	123	11	continue	continue	VERB
fbem-25594	123	12	to	to	PART
fbem-25594	123	13	explore	explore	VERB
fbem-25594	123	14	and	and	CCONJ
fbem-25594	123	15	innovate	innovate	VERB
fbem-25594	123	16	to	to	PART
fbem-25594	123	17	cope	cope	VERB
fbem-25594	123	18	with	with	ADP
fbem-25594	123	19	the	the	DET
fbem-25594	123	20	changing	change	VERB
fbem-25594	123	21	market	market	NOUN
fbem-25594	123	22	environment	environment	NOUN
fbem-25594	123	23	and	and	CCONJ
fbem-25594	123	24	achieve	achieve	VERB
fbem-25594	123	25	sustainable	sustainable	ADJ
fbem-25594	123	26	development	development	NOUN
fbem-25594	123	27	.	.	PUNCT
fbem-25594	124	1	references	reference	NOUN
fbem-25594	124	2	[	[	X
fbem-25594	124	3	1	1	NUM
fbem-25594	124	4	]	]	X
fbem-25594	124	5	china	china	PROPN
fbem-25594	124	6	pharmaceutical	pharmaceutical	PROPN
fbem-25594	124	7	industry	industry	PROPN
fbem-25594	124	8	information	information	NOUN
fbem-25594	124	9	center.(2023	center.(2023	NOUN
fbem-25594	124	10	)	)	PUNCT
fbem-25594	124	11	.	.	PUNCT
fbem-25594	125	1	the	the	DET
fbem-25594	125	2	operation	operation	NOUN
fbem-25594	125	3	situation	situation	NOUN
fbem-25594	125	4	of	of	ADP
fbem-25594	125	5	the	the	DET
fbem-25594	125	6	pharmaceutical	pharmaceutical	ADJ
fbem-25594	125	7	industry	industry	NOUN
fbem-25594	125	8	in	in	ADP
fbem-25594	125	9	2023	2023	NUM
fbem-25594	125	10	.	.	PUNCT
fbem-25594	126	1	[	[	X
fbem-25594	126	2	report	report	NOUN
fbem-25594	126	3	]	]	X
fbem-25594	126	4	.	.	PUNCT
fbem-25594	127	1	beijing	beijing	PROPN
fbem-25594	127	2	:	:	PUNCT
fbem-25594	128	1	china	china	PROPN
fbem-25594	128	2	pharmaceutical	pharmaceutical	PROPN
fbem-25594	128	3	industry	industry	NOUN
fbem-25594	128	4	information	information	NOUN
fbem-25594	128	5	center	center	NOUN
fbem-25594	128	6	.	.	PUNCT
fbem-25594	129	1	[	[	X
fbem-25594	129	2	2	2	NUM
fbem-25594	129	3	]	]	PUNCT
fbem-25594	129	4	meinenet	meinenet	NOUN
fbem-25594	129	5	.	.	PUNCT
fbem-25594	130	1	(	(	PUNCT
fbem-25594	130	2	2024	2024	NUM
fbem-25594	130	3	)	)	PUNCT
fbem-25594	130	4	.	.	PUNCT
fbem-25594	131	1	,	,	PUNCT
fbem-25594	131	2	the	the	DET
fbem-25594	131	3	connbe	connbe	NOUN
fbem-25594	131	4	data.[data	data.[data	ADJ
fbem-25594	131	5	base	base	NOUN
fbem-25594	131	6	]	]	PUNCT
fbem-25594	131	7	.	.	PUNCT
fbem-25594	132	1	available	available	ADJ
fbem-25594	132	2	from	from	ADP
fbem-25594	132	3	the	the	DET
fbem-25594	132	4	http	http	NOUN
fbem-25594	132	5	:	:	PUNCT
fbem-25594	132	6	/	/	SYM
fbem-25594	132	7	/	/	SYM
fbem-25594	132	8	www.minet.com	www.minet.com	NOUN
fbem-25594	132	9	acquire	acquire	NOUN
fbem-25594	132	10	.	.	PUNCT
fbem-25594	133	1	[	[	X
fbem-25594	133	2	3	3	X
fbem-25594	133	3	]	]	X
fbem-25594	133	4	guosheng	guosheng	PROPN
fbem-25594	133	5	securities	security	NOUN
fbem-25594	133	6	.	.	PUNCT
fbem-25594	134	1	(	(	PUNCT
fbem-25594	134	2	2024	2024	NUM
fbem-25594	134	3	)	)	PUNCT
fbem-25594	134	4	.	.	PUNCT
fbem-25594	135	1	in	in	ADP
fbem-25594	135	2	the	the	DET
fbem-25594	135	3	connbe	connbe	NOUN
fbem-25594	135	4	research	research	NOUN
fbem-25594	135	5	report	report	NOUN
fbem-25594	135	6	.	.	PUNCT
fbem-25594	136	1	[	[	X
fbem-25594	136	2	memoir	memoir	X
fbem-25594	136	3	]	]	X
fbem-25594	136	4	.	.	PUNCT
fbem-25594	137	1	shanghai	shanghai	PROPN
fbem-25594	137	2	:	:	PUNCT
fbem-25594	137	3	guosheng	guosheng	PROPN
fbem-25594	137	4	securities	security	NOUN
fbem-25594	137	5	.	.	PUNCT
fbem-25594	138	1	[	[	X
fbem-25594	138	2	4	4	NUM
fbem-25594	138	3	]	]	X
fbem-25594	138	4	conbe	conbe	NOUN
fbem-25594	138	5	pharma	pharma	PROPN
fbem-25594	138	6	,	,	PUNCT
fbem-25594	138	7	inc.(2023	inc.(2023	NOUN
fbem-25594	138	8	)	)	PUNCT
fbem-25594	138	9	.	.	PUNCT
fbem-25594	139	1	conbe	conbe	NOUN
fbem-25594	139	2	2023	2023	NUM
fbem-25594	139	3	annual	annual	ADJ
fbem-25594	139	4	report	report	NOUN
fbem-25594	139	5	.	.	PUNCT
fbem-25594	140	1	[	[	X
fbem-25594	140	2	annual	annual	ADJ
fbem-25594	140	3	report	report	NOUN
fbem-25594	140	4	]	]	PUNCT
fbem-25594	140	5	.	.	PUNCT
fbem-25594	141	1	shanghai	shanghai	PROPN
fbem-25594	141	2	:	:	PUNCT
fbem-25594	141	3	conba	conba	PROPN
fbem-25594	141	4	pharmaceutical	pharmaceutical	PROPN
fbem-25594	141	5	co.	co.	PROPN
fbem-25594	141	6	,	,	PUNCT
fbem-25594	141	7	ltd	ltd	PROPN
fbem-25594	141	8	.	.	PROPN
fbem-25594	141	9	conbe	conbe	PROPN
fbem-25594	141	10	pharma	pharma	PROPN
fbem-25594	141	11	,	,	PUNCT
fbem-25594	141	12	inc	inc	PROPN
fbem-25594	141	13	.	.	PROPN
fbem-25594	141	14	(	(	PUNCT
fbem-25594	141	15	2022	2022	NUM
fbem-25594	141	16	)	)	PUNCT
fbem-25594	141	17	.	.	PUNCT
fbem-25594	142	1	conbe	conbe	PROPN
fbem-25594	142	2	pharmaceutical	pharmaceutical	NOUN
fbem-25594	142	3	2022	2022	NUM
fbem-25594	142	4	annual	annual	ADJ
fbem-25594	142	5	report	report	NOUN
fbem-25594	142	6	.	.	PUNCT
fbem-25594	143	1	[	[	X
fbem-25594	143	2	annual	annual	ADJ
fbem-25594	143	3	report	report	NOUN
fbem-25594	143	4	]	]	PUNCT
fbem-25594	143	5	.	.	PUNCT
fbem-25594	144	1	shanghai	shanghai	PROPN
fbem-25594	144	2	:	:	PUNCT
fbem-25594	144	3	conba	conba	PROPN
fbem-25594	144	4	pharmaceutical	pharmaceutical	PROPN
fbem-25594	144	5	co.	co.	PROPN
fbem-25594	144	6	,	,	PUNCT
fbem-25594	144	7	ltd	ltd	PROPN
fbem-25594	144	8	.	.	PROPN
fbem-25594	144	9	conbe	conbe	PROPN
fbem-25594	144	10	pharma	pharma	PROPN
fbem-25594	144	11	,	,	PUNCT
fbem-25594	144	12	inc	inc	PROPN
fbem-25594	144	13	.	.	PROPN
fbem-25594	144	14	(	(	PUNCT
fbem-25594	144	15	2021	2021	NUM
fbem-25594	144	16	)	)	PUNCT
fbem-25594	144	17	.	.	PUNCT
fbem-25594	145	1	conbe	conbe	NOUN
fbem-25594	145	2	2021	2021	NUM
fbem-25594	145	3	annual	annual	ADJ
fbem-25594	145	4	report	report	NOUN
fbem-25594	145	5	.	.	PUNCT
fbem-25594	146	1	[	[	X
fbem-25594	146	2	annual	annual	ADJ
fbem-25594	146	3	report	report	NOUN
fbem-25594	146	4	]	]	PUNCT
fbem-25594	146	5	.	.	PUNCT
fbem-25594	147	1	shanghai	shanghai	PROPN
fbem-25594	147	2	:	:	PUNCT
fbem-25594	147	3	conba	conba	PROPN
fbem-25594	147	4	pharmaceutical	pharmaceutical	PROPN
fbem-25594	147	5	co.	co.	PROPN
fbem-25594	147	6	,	,	PUNCT
fbem-25594	147	7	ltd	ltd	PROPN
fbem-25594	147	8	.	.	PROPN
fbem-25594	147	9	conbe	conbe	PROPN
fbem-25594	147	10	pharma	pharma	PROPN
fbem-25594	147	11	,	,	PUNCT
fbem-25594	147	12	inc	inc	PROPN
fbem-25594	147	13	.	.	PROPN
fbem-25594	147	14	(	(	PUNCT
fbem-25594	147	15	2020	2020	NUM
fbem-25594	147	16	)	)	PUNCT
fbem-25594	147	17	.	.	PUNCT
fbem-25594	148	1	connbe	connbe	PROPN
fbem-25594	148	2	pharmaceutical	pharmaceutical	NOUN
fbem-25594	148	3	2020	2020	NUM
fbem-25594	148	4	annual	annual	ADJ
fbem-25594	148	5	report	report	NOUN
fbem-25594	148	6	.	.	PUNCT
fbem-25594	149	1	[	[	X
fbem-25594	149	2	annual	annual	ADJ
fbem-25594	149	3	report	report	NOUN
fbem-25594	149	4	]	]	PUNCT
fbem-25594	149	5	.	.	PUNCT
fbem-25594	150	1	shanghai	shanghai	PROPN
fbem-25594	150	2	:	:	PUNCT
fbem-25594	150	3	conba	conba	PROPN
fbem-25594	150	4	pharmaceutical	pharmaceutical	PROPN
fbem-25594	150	5	co.	co.	PROPN
fbem-25594	150	6	,	,	PUNCT
fbem-25594	150	7	ltd	ltd	PROPN
fbem-25594	150	8	.	.	PROPN
fbem-25594	150	9	conbe	conbe	PROPN
fbem-25594	150	10	pharma	pharma	PROPN
fbem-25594	150	11	,	,	PUNCT
fbem-25594	150	12	inc	inc	PROPN
fbem-25594	150	13	.	.	PROPN
fbem-25594	150	14	(	(	PUNCT
fbem-25594	150	15	2019	2019	NUM
fbem-25594	150	16	)	)	PUNCT
fbem-25594	150	17	.	.	PUNCT
fbem-25594	151	1	conbe	conbe	PROPN
fbem-25594	151	2	2029	2029	NUM
fbem-25594	151	3	annual	annual	ADJ
fbem-25594	151	4	report	report	NOUN
fbem-25594	151	5	.	.	PUNCT
fbem-25594	152	1	[	[	X
fbem-25594	152	2	annual	annual	ADJ
fbem-25594	152	3	report	report	NOUN
fbem-25594	152	4	]	]	PUNCT
fbem-25594	152	5	.	.	PUNCT
fbem-25594	153	1	shanghai	shanghai	PROPN
fbem-25594	153	2	:	:	PUNCT
fbem-25594	153	3	conba	conba	PROPN
fbem-25594	153	4	pharmaceutical	pharmaceutical	PROPN
fbem-25594	153	5	co.	co.	PROPN
fbem-25594	153	6	,	,	PUNCT
fbem-25594	153	7	ltd	ltd	PROPN
fbem-25594	153	8	.	.	PUNCT
fbem-25594	154	1	[	[	X
fbem-25594	154	2	5	5	NUM
fbem-25594	154	3	]	]	PUNCT
fbem-25594	154	4	sequence	sequence	NOUN
fbem-25594	154	5	.	.	PUNCT
fbem-25594	155	1	(	(	PUNCT
fbem-25594	155	2	2024	2024	NUM
fbem-25594	155	3	)	)	PUNCT
fbem-25594	155	4	.	.	PUNCT
fbem-25594	156	1	,	,	PUNCT
fbem-25594	156	2	the	the	DET
fbem-25594	156	3	connbe	connbe	NOUN
fbem-25594	156	4	data	datum	NOUN
fbem-25594	156	5	.	.	PUNCT
fbem-25594	157	1	[	[	X
fbem-25594	157	2	data	data	X
fbem-25594	157	3	]	]	PUNCT
fbem-25594	157	4	.	.	PUNCT
fbem-25594	158	1	available	available	ADJ
fbem-25594	158	2	from	from	ADP
fbem-25594	158	3	the	the	DET
fbem-25594	158	4	http://www.10jqka.com.cn	http://www.10jqka.com.cn	PROPN
fbem-25594	158	5	acquire	acquire	NOUN
fbem-25594	158	6	.	.	PUNCT